
<html lang="en"     class="pb-page"  data-request-id="144d2692-6ce2-44da-8936-f85d0384f1ee"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b00741;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-15"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma" /></meta><meta name="dc.Creator" content="Satoshi  Itadani" /></meta><meta name="dc.Creator" content="Kentaro  Yashiro" /></meta><meta name="dc.Creator" content="Yoshiyuki  Aratani" /></meta><meta name="dc.Creator" content="Tetsuya  Sekiguchi" /></meta><meta name="dc.Creator" content="Atsushi  Kinoshita" /></meta><meta name="dc.Creator" content="Hideki  Moriguchi" /></meta><meta name="dc.Creator" content="Nobukazu  Ohta" /></meta><meta name="dc.Creator" content="Shinya  Takahashi" /></meta><meta name="dc.Creator" content="Akiharu  Ishida" /></meta><meta name="dc.Creator" content="Yohei  Tajima" /></meta><meta name="dc.Creator" content="Katsuya  Hisaichi" /></meta><meta name="dc.Creator" content="Masaki  Ima" /></meta><meta name="dc.Creator" content="Junya  Ueda" /></meta><meta name="dc.Creator" content="Hiromu  Egashira" /></meta><meta name="dc.Creator" content="Tomohiko  Sekioka" /></meta><meta name="dc.Creator" content="Michiaki  Kadode" /></meta><meta name="dc.Creator" content="Yasuo  Yonetomi" /></meta><meta name="dc.Creator" content="Takafumi  Nakao" /></meta><meta name="dc.Creator" content="Atsuto  Inoue" /></meta><meta name="dc.Creator" content="Hiroaki  Nomura" /></meta><meta name="dc.Creator" content="Tetsuya  Kitamine" /></meta><meta name="dc.Creator" content="Manabu  Fujita" /></meta><meta name="dc.Creator" content="Takeshi  Nabe" /></meta><meta name="dc.Creator" content="Yoshiyuki  Yamaura" /></meta><meta name="dc.Creator" content="Naoya  Matsumura" /></meta><meta name="dc.Creator" content="Akira  Imagawa" /></meta><meta name="dc.Creator" content="Yoshisuke  Nakayama" /></meta><meta name="dc.Creator" content="Jun  Takeuchi" /></meta><meta name="dc.Creator" content="Kazuyuki  Ohmoto" /></meta><meta name="dc.Description" content="An orally active dual CysLT1 and CysLT2 antagonist possessing a distinctive structure which consists of triple bond and dicarboxylic acid moieties is described. Gemilukast (ONO-6950) was generated ..." /></meta><meta name="Description" content="An orally active dual CysLT1 and CysLT2 antagonist possessing a distinctive structure which consists of triple bond and dicarboxylic acid moieties is described. Gemilukast (ONO-6950) was generated ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 22, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00741" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00741" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00741" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00741" /></link>
        
    
    

<title>Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00741" /></meta><meta property="og:title" content="Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0023.jpeg" /></meta><meta property="og:description" content="An orally active dual CysLT1 and CysLT2 antagonist possessing a distinctive structure which consists of triple bond and dicarboxylic acid moieties is described. Gemilukast (ONO-6950) was generated via isomerization of the core indole and the incorporation of a triple bond into a lead compound. Gemilukast exhibited antagonist activities with IC50 values of 1.7 and 25 nM against human CysLT1 and human CysLT2, respectively, and potent efficacy at an oral dose of 0.1 mg/kg given 24 h before LTD4 challenge in a CysLT1-dependent guinea pig asthmatic model. In addition, gemilukast dose-dependently reduced LTC4-induced bronchoconstriction in both CysLT1- and CysLT2-dependent guinea pig asthmatic models, and it reduced antigen-induced constriction of isolated human bronchi. Gemilukast is currently being evaluated in phase II trials for the treatment of asthma." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00741"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00741">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00741&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00741&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00741&amp;href=/doi/10.1021/acs.jmedchem.5b00741" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6093-6113</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00689" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00737" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Gemilukast (ONO-6950), a Dual CysLT<sub>1</sub> and CysLT<sub>2</sub> Antagonist As a Therapeutic Agent for Asthma</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satoshi++Itadani">Satoshi Itadani</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kentaro++Yashiro">Kentaro Yashiro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshiyuki++Aratani">Yoshiyuki Aratani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tetsuya++Sekiguchi">Tetsuya Sekiguchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atsushi++Kinoshita">Atsushi Kinoshita</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hideki++Moriguchi">Hideki Moriguchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nobukazu++Ohta">Nobukazu Ohta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shinya++Takahashi">Shinya Takahashi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akiharu++Ishida">Akiharu Ishida</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yohei++Tajima">Yohei Tajima</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katsuya++Hisaichi">Katsuya Hisaichi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masaki++Ima">Masaki Ima</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junya++Ueda">Junya Ueda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiromu++Egashira">Hiromu Egashira</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tomohiko++Sekioka">Tomohiko Sekioka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michiaki++Kadode">Michiaki Kadode</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yasuo++Yonetomi">Yasuo Yonetomi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takafumi++Nakao">Takafumi Nakao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atsuto++Inoue">Atsuto Inoue</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroaki++Nomura">Hiroaki Nomura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tetsuya++Kitamine">Tetsuya Kitamine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manabu++Fujita">Manabu Fujita</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takeshi++Nabe">Takeshi Nabe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshiyuki++Yamaura">Yoshiyuki Yamaura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naoya++Matsumura">Naoya Matsumura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akira++Imagawa">Akira Imagawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshisuke++Nakayama">Yoshisuke Nakayama</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Takeuchi">Jun Takeuchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kazuyuki++Ohmoto">Kazuyuki Ohmoto</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Medicinal Chemistry Research Laboratories, <sup>‡</sup>Department of Biology & Pharmacology and <sup>§</sup>Pharmaceutical Technology Laboratories, Ono Pharmaceutical Co., Ltd. 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">∥</span> <span class="aff-text">Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div><div class="corresp-info"><strong>*</strong>For S.I.; phone, +81-75-961-1151; fax, +81-75-962-9314; E-mail, <a href="/cdn-cgi/l/email-protection#2f465b4e4b4e41466f404140014c4001455f"><span class="__cf_email__" data-cfemail="b3dac7d2d7d2dddaf3dcdddc9dd0dc9dd9c3">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For K.O.; phone, +81-75-961-1151; fax, +81-75-962-9314; E-mail, <a href="/cdn-cgi/l/email-protection#442f6a2b2c292b302b042b2a2b6a272b6a2e34"><span class="__cf_email__" data-cfemail="f299dc9d9a9f9d869db29d9c9ddc919ddc9882">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00741&amp;href=/doi/10.1021%2Facs.jmedchem.5b00741" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6093–6113</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 6, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 May 2015</li><li><span class="item_label"><b>Published</b> online</span>22 July 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00741" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00741</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6093%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSatoshi%2BItadani%252C%2BKentaro%2BYashiro%252C%2BYoshiyuki%2BAratani%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D15%26contentID%3Dacs.jmedchem.5b00741%26title%3DDiscovery%2Bof%2BGemilukast%2B%2528ONO-6950%2529%252C%2Ba%2BDual%2BCysLT1%2Band%2BCysLT2%2BAntagonist%2BAs%2Ba%2BTherapeutic%2BAgent%2Bfor%2BAsthma%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6113%26publicationDate%3DAugust%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00741"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1860</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00741" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Satoshi&quot;,&quot;last_name&quot;:&quot;Itadani&quot;},{&quot;first_name&quot;:&quot;Kentaro&quot;,&quot;last_name&quot;:&quot;Yashiro&quot;},{&quot;first_name&quot;:&quot;Yoshiyuki&quot;,&quot;last_name&quot;:&quot;Aratani&quot;},{&quot;first_name&quot;:&quot;Tetsuya&quot;,&quot;last_name&quot;:&quot;Sekiguchi&quot;},{&quot;first_name&quot;:&quot;Atsushi&quot;,&quot;last_name&quot;:&quot;Kinoshita&quot;},{&quot;first_name&quot;:&quot;Hideki&quot;,&quot;last_name&quot;:&quot;Moriguchi&quot;},{&quot;first_name&quot;:&quot;Nobukazu&quot;,&quot;last_name&quot;:&quot;Ohta&quot;},{&quot;first_name&quot;:&quot;Shinya&quot;,&quot;last_name&quot;:&quot;Takahashi&quot;},{&quot;first_name&quot;:&quot;Akiharu&quot;,&quot;last_name&quot;:&quot;Ishida&quot;},{&quot;first_name&quot;:&quot;Yohei&quot;,&quot;last_name&quot;:&quot;Tajima&quot;},{&quot;first_name&quot;:&quot;Katsuya&quot;,&quot;last_name&quot;:&quot;Hisaichi&quot;},{&quot;first_name&quot;:&quot;Masaki&quot;,&quot;last_name&quot;:&quot;Ima&quot;},{&quot;first_name&quot;:&quot;Junya&quot;,&quot;last_name&quot;:&quot;Ueda&quot;},{&quot;first_name&quot;:&quot;Hiromu&quot;,&quot;last_name&quot;:&quot;Egashira&quot;},{&quot;first_name&quot;:&quot;Tomohiko&quot;,&quot;last_name&quot;:&quot;Sekioka&quot;},{&quot;first_name&quot;:&quot;Michiaki&quot;,&quot;last_name&quot;:&quot;Kadode&quot;},{&quot;first_name&quot;:&quot;Yasuo&quot;,&quot;last_name&quot;:&quot;Yonetomi&quot;},{&quot;first_name&quot;:&quot;Takafumi&quot;,&quot;last_name&quot;:&quot;Nakao&quot;},{&quot;first_name&quot;:&quot;Atsuto&quot;,&quot;last_name&quot;:&quot;Inoue&quot;},{&quot;first_name&quot;:&quot;Hiroaki&quot;,&quot;last_name&quot;:&quot;Nomura&quot;},{&quot;first_name&quot;:&quot;Tetsuya&quot;,&quot;last_name&quot;:&quot;Kitamine&quot;},{&quot;first_name&quot;:&quot;Manabu&quot;,&quot;last_name&quot;:&quot;Fujita&quot;},{&quot;first_name&quot;:&quot;Takeshi&quot;,&quot;last_name&quot;:&quot;Nabe&quot;},{&quot;first_name&quot;:&quot;Yoshiyuki&quot;,&quot;last_name&quot;:&quot;Yamaura&quot;},{&quot;first_name&quot;:&quot;Naoya&quot;,&quot;last_name&quot;:&quot;Matsumura&quot;},{&quot;first_name&quot;:&quot;Akira&quot;,&quot;last_name&quot;:&quot;Imagawa&quot;},{&quot;first_name&quot;:&quot;Yoshisuke&quot;,&quot;last_name&quot;:&quot;Nakayama&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Takeuchi&quot;},{&quot;first_name&quot;:&quot;Kazuyuki&quot;,&quot;last_name&quot;:&quot;Ohmoto&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;6093-6113&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00741&quot;},&quot;abstract&quot;:&quot;An orally active dual CysLT1 and CysLT2 antagonist possessing a distinctive structure which consists of triple bond and dicarboxylic acid moieties is described. Gemilukast (ONO-6950) was generated via isomerization of the core indole and the incorporation of a triple bond into a lead compound. Gemilukast exhibited antagonist activities with IC50 values of 1.7 and 25 nM against human CysLT1 and human CysLT2, respectively, and potent efficacy at an oral dose of 0.1 mg/kg given 24 h before LTD4 challenge in a CysLT1-dependent guinea pig asthmatic model. In addition, gemilukast dose-dependently reduced LTC4-induced bronchoconstriction in both CysLT1- and CysLT2-dependent guinea pig asthmatic models, and it reduced antigen-induced constriction of isolated human bronchi. Gemilukast is currently being evaluated in phase II trials for the treatment of asthma.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00741&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00741" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00741&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00741" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00741&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00741" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00741&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00741&amp;href=/doi/10.1021/acs.jmedchem.5b00741" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00741" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00741" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00741%26sid%3Dliteratum%253Aachs%26pmid%3D26200813%26genre%3Darticle%26aulast%3DItadani%26date%3D2015%26atitle%3DDiscovery%2Bof%2BGemilukast%2B%2528ONO-6950%2529%252C%2Ba%2BDual%2BCysLT1%2Band%2BCysLT2%2BAntagonist%2BAs%2Ba%2BTherapeutic%2BAgent%2Bfor%2BAsthma%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D15%26spage%3D6093%26epage%3D6113%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/jmcmar.2015.58.issue-15/20150813/jmcmar.2015.58.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">An orally active dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist possessing a distinctive structure which consists of triple bond and dicarboxylic acid moieties is described. Gemilukast (ONO-6950) was generated via isomerization of the core indole and the incorporation of a triple bond into a lead compound. Gemilukast exhibited antagonist activities with IC<sub>50</sub> values of 1.7 and 25 nM against human CysLT<sub>1</sub> and human CysLT<sub>2</sub>, respectively, and potent efficacy at an oral dose of 0.1 mg/kg given 24 h before LTD<sub>4</sub> challenge in a CysLT<sub>1</sub>-dependent guinea pig asthmatic model. In addition, gemilukast dose-dependently reduced LTC<sub>4</sub>-induced bronchoconstriction in both CysLT<sub>1</sub>- and CysLT<sub>2</sub>-dependent guinea pig asthmatic models, and it reduced antigen-induced constriction of isolated human bronchi. Gemilukast is currently being evaluated in phase II trials for the treatment of asthma.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cysteinyl leukotrienes (CysLTs), LTC<sub>4</sub>, LTD<sub>4</sub>, and LTE<sub>4</sub> are lipid mediators derived from arachidonic acid via the 5-lipoxygenase pathway,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> and they are involved in various inflammatory diseases, including asthma and allergic rhinitis. CysLTs are known to cause constriction of smooth muscle and the migration of inflammatory cells via certain receptors. Pharmacological studies have revealed the existence of two classes of receptors to which CysLTs can bind. They are the CysLT<sub>1</sub> and CysLT<sub>2</sub> receptors, which were identified and cloned in 1999 and 2000, respectively.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> shows several CysLT<sub>1</sub> selective antagonists. Pranlukast, montelukast, and zafirlukast, which are in clinical use, have demonstrated clinical benefit for the treatment of bronchial asthma and allergic rhinitis. Nonetheless, approximately half of the patients treated with these agents are nonresponders.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Thus, more effective drugs than CysLT<sub>1</sub>-selective antagonists are needed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CysLT<sub>1</sub>-selective antagonists. IC<sub>50</sub> values were quoted from refs <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">5</a> (CysLT<sub>1</sub> antagonist activities) and <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a> (CysLT<sub>2</sub> antagonist activities).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">CysLT<sub>2</sub> receptors were reported to be expressed on airway smooth muscle cells,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> inflammatory cells,<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> and vascular endothelial cells<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> similar to CysLT<sub>1</sub> receptors. In addition, the urine concentration of LTE<sub>4</sub>, which is a metabolite of LTD<sub>4</sub>, is increased in aspirin-sensitive asthmatics or severe asthmatic patients.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19 ref20">(15-20)</a> LTD<sub>4</sub> likely binds to both receptors in severe asthma but more tightly to CysLT<sub>1</sub> than CysLT<sub>2</sub> because the severity is linked to the amount of LTD<sub>4</sub> production. The involvement of CysLT<sub>2</sub> in severe asthma is anticipated. Therefore, dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonists may be more attractive as therapeutics for asthma.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, two potent CysLT<sub>2</sub> selective antagonists have been reported.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> However, there are no reports of effective dual antagonists.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27">(23-27)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CysLT<sub>2</sub>-selective antagonists. IC<sub>50</sub> values were quoted from refs <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a> (HAMI3378) and <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a> (BayCysLT<sub>2</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our previous report,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (2<i>S</i>)-4-(3-carboxypropyl)-8-{[4-(4-phenylbutoxy)benzoyl]amino}-3,4-dihydro-2<i>H</i>-1,4-benzoxazine-2-carboxylic acid (ONO-2050297, the <i>S</i>-isomer of <b>1</b>) was identified as the first potent dual antagonist, with IC<sub>50</sub> values of 17 and 0.87 nM for human CysLT<sub>1</sub> (hCysLT<sub>1</sub>) and human CysLT<sub>2</sub> (hCysLT<sub>2</sub>), respectively. As shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, the PK profile of <b>1</b> was very poor, and its bioavailability was only 1.5% in rats.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, further modification resulted in 4-(3-(carboxymethyl)-4-{(<i>E</i>)-2-[4-(4-phenoxybutoxy)phenyl]vinyl}-1<i>H</i>-indol-1-yl)butanoic acid (<b>2</b>, ONO-4310321), which had a significantly improved PK profile in rats.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Compound <b>2</b> demonstrated a reduction in bronchoconstriction in a dose-dependent manner and complete inhibition at an oral dose of 10 mg/kg in a CysLT<sub>1</sub>-dependent guinea pig bronchoconstriction model. However, compound <b>2</b> was unfit as a clinical candidate because the strength and duration of its in vivo efficacy were inadequate.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacokinetic Profiles and In Vivo Efficacy of <b>1</b> and <b>2</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0014.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Compound <b>1</b>: Rat bioavailability was calculated based on an intravenous (iv) dose of 1 mg/kg and an oral administration (po) dose of 30 mg/kg. guinea pig bioavailability was calculated based on an iv dose of 0.1 mg/kg and a po dose of 30 mg/kg. Mean values (<i>n</i> = 3).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Compound <b>2</b>: Rat and guinea pig bioavailability was calculated based on an iv dose of 1 mg/kg and a po dose of 10 mg/kg. Mean values (<i>n</i> = 3).</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> values and 95% confidence intervals of each compound were obtained with Prism 5 software (GraphPad) (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">LTD<sub>4</sub>-induced bronchoconstriction model dependent on CysLT<sub>1</sub>. Mean values (<i>n</i> = 3).</p></div></div><div></div></div><div class="NLM_p last">In this article, further modification to create an orally active dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist compatible with once daily administration will be described. After structural optimizations based on the duration of efficacy and penetration into lung tissue, 4,4′-[4-fluoro-7-(2-{4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indole-1,3-diyl]dibutanoic acid (<b>35</b>, ONO-6950, gemilukast) was identified as a clinical candidate.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Lead Optimization</h3><div class="NLM_p">The isomer of the core indole ring was initially investigated. The indole-3-acetic acid derivative <b>2</b> was previously reported.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> shows that indole-1-acetic acid derivative <b>3</b>, an isomer, is a more potent dual antagonist, with IC<sub>50</sub> values of 1.5 and 6.0 nM against hCysLT<sub>1</sub> and hCysLT<sub>2</sub>, respectively. In addition, both compounds <b>2</b> and <b>3</b> were orally administered 1 h before LTD<sub>4</sub> challenge at 1 mg/kg, and compound <b>3</b> showed potent in vivo efficacy (97% inhibition of bronchoconstriction) compared to compound <b>2</b> (48% inhibition). Indole-1-acetic acid derivatives appeared more amenable to further modification, although their bioavailability in guinea pigs was moderate.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Indole-3-acetic Acid (<b>2</b>) and Indole-1-acetic Acid (<b>3</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0015.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0016.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Assay protocols are provided in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values and 95% confidence intervals of each compound were obtained with Prism 5 software (GraphPad) (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Effects on a LTD<sub>4</sub>-induced bronchoconstriction model dependent on CysLT<sub>1</sub>. The values represent the mean for <i>n</i> = 3. The compounds were orally administered 1 h before LTD<sub>4</sub> challenge.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">p<i>K</i><sub>a</sub>: Predicted by ADMET Predictor version 7 (Simulations Plus, Inc.).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last"><i>F</i> (%) was calculated using the mean of AUC (po) and the mean of AUC (iv) (<i>n</i> = 3).</p></div></div><div></div></div><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, both compounds <b>2</b> and <b>3</b> demonstrated much lower bioavailability in guinea pigs than in rats. Generally, the more basic pH of the small intestine reduces the permeability of acidic compounds. Indeed, compounds <b>2</b> and <b>3</b> showed lower permeability at pH 7.4 than at pH 6.2 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The pH in the small intestine of guinea pigs is greater than that for other species (pH 7.6–8.2 for guinea pigs, pH 6.5–7.1 for rats, pH 6.6–7.5 for dogs, pH 5.5–6.0 for monkeys, and pH 5.0–7.0 for humans),<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> and this basic pH explains why these compounds are less bioavailable in guinea pigs. This species difference should be considered when evaluating compounds in guinea pigs.</div><div class="NLM_p"><a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> shows the effects of introducing a methyl group at the 2-position of the indole and other substitutions on the terminal phenyl group. As indicated by a comparison of compounds <b>9</b>–<b>16</b> and <b>4</b>–<b>8</b>, the incorporation of the methyl group into the indole improved permeability at pH 7.4. This improvement appears to result from the diminished acidity of the 1-acetic acid moiety due to the electron donation of the methyl group.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Introduction of a Methyl Group into the 2-Position of the Indole and Substitutions on the Terminal Phenyl Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0017.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0018.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Assay protocols are provided in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values and 95% confidence intervals of each compound were obtained with Prism 5 software (GraphPad) (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Effects on LTD<sub>4</sub>-induced bronchoconstriction model dependent on CysLT<sub>1</sub> (<i>n</i> = 3).</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> values were quoted from refs <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">5</a> (CysLT<sub>1</sub> antagonist activity) and <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a> (CysLT<sub>2</sub> antagonist activity).</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> values were quoted from ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div></div><div></div></div><div class="NLM_p">In addition, the hCysLT<sub>2</sub> antagonist activity of 2<i>H</i>-indole-1-acetic acid derivatives tended to be much weaker in guinea pigs (IC<sub>50</sub> value of >100 nM, data not shown) compared with humans. Ultimately, 2-methyl-indole was considered a more suitable core structure.</div><div class="NLM_p">Upon the addition of substitutions to the terminal phenyl group, no significant differences in hCysLT<sub>1</sub> or hCysLT<sub>2</sub> antagonist activities were achieved. However, the compounds possessing certain substituents on the terminal phenyl group had a tendency toward improved antagonist activities and permeability. Thus, these compounds were evaluated in a CysLT<sub>1</sub>-dependent guinea pig asthmatic model at doses of 1, 0.3, or 0.1 mg/kg. The compounds were orally administered 1 h before LTD<sub>4</sub> challenge.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, some of the compounds demonstrated high inhibitory activity at 0.3 mg/kg. In particular, compounds <b>8</b> and <b>16</b>, both possessing a 3-chloro-2-methylphenyl group at the terminus, exhibited approximately 50% inhibition at 0.1 mg/kg. Both compounds appeared equivalent. However, compound <b>16</b> was selected for further profiling because 2-methyl-indole-1-acetic acid derivatives are more promising in terms of the species differences in antagonist activities and permeability, as discussed above.</div><div class="NLM_p"><a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> shows the pharmacokinetic profile of <b>16</b> in rats, guinea pigs, and dogs. Compound <b>16</b> demonstrated a low oral bioavailability of 11% in guinea pigs, whereas it demonstrated good oral bioavailability of 56% and a long half-life of 8.9 h in rats. As shown above, compound <b>16</b> showed in vivo efficacy even at the lowest dose. Thus, the concentration of <b>16</b> in the plasma and lung tissue of guinea pigs was measured (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The concentration of <b>16</b> remained high (<i>K</i><sub>p</sub> value of 15) for over 24 h in lung tissue.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Parameters of <b>16</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">iv</th><th class="colsep0 rowsep0" align="center" char=".">po</th><th class="colsep0 rowsep0" align="center" char="±">iv <i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (h)</th><th class="colsep0 rowsep0" align="center" char="±">iv CL<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>V</i><sub>dss</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="±">po AUC<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (μg·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="±">8.9 ± 8.5</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">39 ± 12</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">guinea pig</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">10 ± 4.1</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">4.7 ± 5.0</td><td class="colsep0 rowsep0" align="char" char="±">5.5 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">0.38 ± 0.33</td><td class="colsep0 rowsep0" align="char" char="±">0.65 ± 0.16</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The value are expressed as the mean ± standard deviation (<i>n</i> = 3).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last"><i>F</i> (%) was calculated using the mean of AUC (po) and the mean of AUC (iv).</p></div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration of <b>16</b> in plasma or lung tissue of guinea pigs. The value are expressed as the mean ± SD (<i>n</i> = 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Lakshminarayana et al. reported that tuberculosis drugs whose <i>K</i><sub>p</sub> values are at least 2 can be efficient.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In addition, the <i>K</i><sub>p</sub> value of montelukast was reported to be greater than 5 at 24 h according to its FDA pharmacology review.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Thus, the 2-methyl-indole derivative represented by <b>16</b> appears to possess a profile appropriate for the treatment agent of asthma.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Further Optimization of Advanced Lead toward a Once-Daily Drug</h3><div class="NLM_p">From <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, it appeared that there was room to improve the pharmacokinetic properties of compound <b>16</b> as a clinical candidate, although it was active in the in vivo model. In particular, the permeability of <b>16</b> was still low. Two options for improving the low permeability were deduced: reducing (1) flexibility and (2) acidity. In a situation where target proteins are related to lipid mediators, in our experience there is a trend toward an elongated and flapping compound as a ligand. Thus, it is difficult to make dual antagonists rigid. For example, shortening or fixing the side chain to reduce flexibility decreases antagonist activity. Therefore, we focused on the trans-double bond in the core structure and attempted its replacement with a triple bond. Because a triple bond is more linear than a double bond, the potential spatial area occupied by the side chain was expected to decrease.</div><div class="NLM_p">Compounds possessing a triple bond instead of the double bond were synthesized and evaluated as shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. Interestingly, compound <b>19</b>, which corresponds to compound <b>16</b>, retained dual antagonist activities; if anything, hCysLT<sub>2</sub> antagonist activity increased. Thus, the compatibility of the triple bond was confirmed. In addition, the permeability of <b>19</b> was improved by <i>P</i><sub>app</sub> (pH 7.4) = 3.2 × 10<sup>–6</sup> cm/s as expected.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Length of Two Carboxylic Acid Side Chains of 2-Methyl-indole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0019.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">m</th><th class="colsep0 rowsep0" align="center" char=".">n</th><th class="colsep0 rowsep0" align="center">hCysLT<sub>1</sub></th><th class="colsep0 rowsep0" align="center">hCysLT<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">permeability PAMPA × 10<sup>–6</sup> cm/s pH 7.4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">0.47 (0.29–0.76)</td><td class="colsep0 rowsep0" align="center">0.89 (0.81–0.97)</td><td class="colsep0 rowsep0" align="char" char="."><0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">0.32 (0.20–0.50)</td><td class="colsep0 rowsep0" align="center">5.7 (4.9–6.8)</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center">0.22 (0.17–0.27)</td><td class="colsep0 rowsep0" align="center">0.88 (0.71–1.1)</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">12 (8.3–16)</td><td class="colsep0 rowsep0" align="center">96 (84–110)</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">10 (6.2–17)</td><td class="colsep0 rowsep0" align="center">78 (48–127)</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center">17 (13–23)</td><td class="colsep0 rowsep0" align="center">22 (14–35)</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">5.5 (3.6–8.5)</td><td class="colsep0 rowsep0" align="center">55 (46–65)</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">0.79 (0.54–1.2)</td><td class="colsep0 rowsep0" align="center">15 (11–20)</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center">1.5 (1.2–2.0)</td><td class="colsep0 rowsep0" align="center">5.5 (4.3–7.1)</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">65 (56–75)</td><td class="colsep0 rowsep0" align="center">248 (73–847)</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">25 (17–36)</td><td class="colsep0 rowsep0" align="center">60 (26–138)</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center">56 (46–69)</td><td class="colsep0 rowsep0" align="center">30 (23–41)</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Assay protocols are provided in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values and 95% confidence intervals of each compound were obtained with Prism 5 software (GraphPad) (<i>n</i> ≥ 2).</p></div></div></div><div class="NLM_p">The acidity of carboxylic acids should correlate with distance from the indole ring. As previously reported for the benzoxazine analogues,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> the length of the carboxylic acid side chain is an important factor that affects antagonist activities. Thus, several analogues with various carboxylic acid side chains lengths were synthesized to better balance permeability with dual antagonist activities. Compound <b>25</b> was the best among these analogues in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>.</div><div class="NLM_p">A triple bond is generally considered unstable under a certain condition. Thus, the stability of <b>25</b> was assessed under various severe conditions. Surprisingly, <b>25</b> was stable under acidic conditions (1 mol/L H<sub>2</sub>SO<sub>4</sub> in DME/H<sub>2</sub>O at 50 °C for 24 h) or basic conditions (1 mol/L NaOH in DME/EtOH/H<sub>2</sub>O at 50 °C for 24 h). Furthermore, degradation of <b>25</b> in ambient light was not observed even under the conditions where the compounds with a double bond such as <b>16</b> easily decomposed. In the case of <b>16</b>, the isomerization of the trans-double bond by ambient light caused oxidation and decomposition.</div><div class="NLM_p">Next, the effects of substitution at the benzene ring of the core indole were investigated. <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> shows 4-, 5-, and 6-fluoro derivatives of <b>25</b>. Only compound <b>29</b> exhibited dual antagonist activities comparable to <b>25</b>. <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> also shows the in vivo efficacies and PK profiles of <b>25</b> and <b>29</b>. Both compounds were evaluated in a LTD<sub>4</sub>-induced bronchoconstriction model. They demonstrated sufficient efficacies at an oral dose even 24 h before LTD<sub>4</sub> challenge. Compound <b>29</b> demonstrated similar in vivo efficacy despite its poor PK profile, likely attributable to better penetration into lung tissue.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Incorporation of a Fluorine Atom into the Core Indole Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0020.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> (nM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">In vivo efficacy<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>, po % Inhibition</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">pharmacokinetics guinea pig<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center">hCysLT<sub>1</sub></th><th class="colsep0 rowsep0" align="center">hCysLT<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">0.3 mg/kg, 1 h</th><th class="colsep0 rowsep0" align="center" char=".">1 mg/kg, 24 h</th><th class="colsep0 rowsep0" align="center" char="±">AUC<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (μg·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><a class="ref internalNav" href="#t6fn4" aria-label="d">d</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1.5 (1.2–2.0)</td><td class="colsep0 rowsep0" align="center">5.5 (4.3–7.1)</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char="±">10.5 ± 2.7</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">3.4 (2.1–5.3)</td><td class="colsep0 rowsep0" align="center">12 (9.9–15)</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 0.9</td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">16 (6.6–38)</td><td class="colsep0 rowsep0" align="center">31 (15–63)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="center">11 (8.2–15)</td><td class="colsep0 rowsep0" align="center">48 (33–70)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Assay protocols are provided in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values and 95% confidence intervals of each compound were obtained with Prism 5 software (GraphPad) (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Effects on LTD<sub>4</sub>-induced bronchoconstriction model dependent on CysLT<sub>1</sub>. The values represent the means for <i>n</i> = 6.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Guinea pig cassette dosing at 0.2 mg/kg, iv and 1 mg/kg, po (nonfasted). The value are expressed as the mean ± SD (<i>n</i> = 3).</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last"><i>F</i> (%) was calculated using the mean of AUC (po) and the mean of AUC (iv).</p></div></div></div><div class="NLM_p"><a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a> shows the optimization of substitutions to the phenyl group in the 2-methyl-indole-1-butanoic acid derivatives <b>25</b> and <b>29</b>. All compounds exhibited potent antagonist activities against not only hCysLT<sub>1</sub> and hCysLT<sub>2</sub> but also guinea pig CysLT<sub>1</sub> (gCysLT<sub>1</sub>) and guinea pig CysLT<sub>2</sub> (gCysLT<sub>2</sub>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Substitution on the Terminal Phenyl Group of 2-Methyl-indole-1-butanoic Acid Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0021.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0022.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">Assay protocols are provided in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values and 95% confidence intervals of each compound were obtained with Prism 5 software (GraphPad) (<i>n</i> ≥ 6).</p></div><div class="footnote" id="t7fn2"><sup>Table b</sup><p class="last">Effects on LTD<sub>4</sub>-induced bronchoconstriction model dependent on CysLT<sub>1</sub>. The values represent the means for <i>n</i> = 6.</p></div></div><div></div></div><div class="NLM_p last">These compounds were evaluated in a LTD<sub>4</sub>-induced bronchoconstriction model at an oral dose of 0.3 or 0.1 mg/kg 24 h prior to LTD<sub>4</sub> challenge. As shown in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>, 2,3,4,6-tetrafluorophenyl derivatives <b>32</b> and <b>33</b> and 3-fluoro-2-methylphenyl derivatives <b>34</b> and <b>35</b> demonstrated more than 70% inhibition of bronchoconstriction at 0.3 mg/kg. Furthermore, compounds <b>34</b> and <b>35</b> demonstrated potent in vivo efficacy (approximately 70% inhibition) and a long duration of action even at 0.1 mg/kg. Compound <b>35</b> (ONO-6950, gemilukast) was ultimately chosen as a clinical candidate based upon further evaluation, including a safety study.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Further Biological Profiling of <b>35</b></h3><div class="NLM_p"><a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a> shows that <b>35</b> demonstrated acceptable bioavailability (35% in rats, 51% in dogs, 56% in guinea pigs) and low clearance values (0.68 mL/min/kg in rats, 1.10 mL/min/kg in guinea pigs, 0.64 mL/min/kg in dogs). In particular, the clearance of <b>35</b> in dogs was much lower compared to <b>16</b>, and this resulted in an improved pharmacokinetic profile in dogs. For example, <b>35</b> had a long half-life (7.6 h) and abundant blood exposure (28.2 μg·h/mL). An excellent pharmacokinetic profile for <b>35</b> in humans was expected because much lower clearance (0.2 mL/min/kg) in humans was estimated based upon allometric scaling of the animal results.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, 2-methyl-indole derivatives such as <b>35</b> tended to penetrate lung tissue well. Thus, a ratio (<i>K</i><sub>p</sub> value) of the concentration of <b>35</b> in lung tissue to the concentration in plasma was calculated from the observed data in guinea pigs. As expected, the <i>K</i><sub>p</sub> value was very high: approximately 8 at an oral dose of 3 mg/kg or 30 at an oral dose of 0.3 mg/kg.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pharmacokinetic Parameters of <b>35</b> in Rats and Dogs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">iv</th><th class="colsep0 rowsep0" align="center" char=".">po</th><th class="colsep0 rowsep0" align="center" char="±">iv <i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a> (h)</th><th class="colsep0 rowsep0" align="center" char="±">CL<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>V</i><sub>dss</sub><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="±">po <i>C</i><sub>max</sub><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a> (μg/mL)</th><th class="colsep0 rowsep0" align="center" char="±">po AUC<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a> (μg·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><a class="ref internalNav" href="#t8fn4" aria-label="d">d</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">9.6 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">0.68 ± 0.26</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.19 ± 0.59</td><td class="colsep0 rowsep0" align="char" char="±">9.33 ± 1.45</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">guinea pig<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">7.1 ± 3.8</td><td class="colsep0 rowsep0" align="char" char="±">1.10 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">0.31 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">1.01 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">8.51 ± 1.49</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">7.6 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">3.69 ± 0.74</td><td class="colsep0 rowsep0" align="char" char="±">28.2 ± 8.70</td><td class="colsep0 rowsep0" align="char" char=".">51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Single intravenous and oral administration.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Cassette dosing.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">The value are expressed as the mean ± standard deviation (<i>n</i> = 3).</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last"><i>F</i> (%) was calculated using the mean of AUC (po) and the mean of AUC (iv).</p></div></div></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plasma and lung tissue concentrations of <b>35</b> in guinea pigs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Regarding the risk assessment of <b>35</b>, the result (11% inhibition at 10 μM) of an in vitro hERG assay indicated low risk for QT interval prolongation, and the Ames test was negative. Further evaluation of <b>35</b> as a clinical candidate was then conducted.</div><div class="NLM_p last">The value are expressed as the mean ± SE (<i>n</i> = 8). The compound was administered once daily.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Asthmatic Model Mediated via CysLT<sub>2</sub> in Guinea Pigs</h3><div class="NLM_p">LTC<sub>4</sub> is reported to be a guinea pig CysLT<sub>2</sub> selective ligand, unlike the case in humans.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> It is difficult to evaluate pharmacological effects involving CysLT<sub>2</sub> in guinea pigs because LTC<sub>4</sub> is immediately metabolized by γ-glutamyltranspeptidase. Yonetomi et al. reported a novel asthmatic model mediated via the CysLT<sub>2</sub> receptor in guinea pigs.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In the reported CysLT<sub>2</sub> dependent model, the metabolism of LTC<sub>4</sub> was inhibited, and the effect of montelukast (CysLT<sub>1</sub> selective antagonist) on LTC<sub>4</sub>-induced bronchoconstriction was only partial. In contrast, as shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, <b>35</b> (dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist) significantly reduced the bronchoconstriction in a dose-dependent manner. Thus, <b>35</b> is expected to be a more useful treatment agent for asthma because of the potential involvement of CysLT<sub>2</sub> in severe symptoms.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Efficacy of <b>35</b> in an asthmatic model mediated via CysLT<sub>2</sub> in guinea pigs. (<i>a</i>) ML (montelukast) was orally administered at 0.1 mg/kg. Each column represents the means ± SE of 5–10 animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Antigen-Induced Constriction in Isolated Human Bronchi</h3><div class="NLM_p">A study using human tissue increases the probability of success in clinical trials. An evaluation of <b>35</b> using human bronchi was performed. Isolated human bronchi were passively sensitized by incubation with human atopic serum, and the resulting bronchial strip was suspended in a Magnus bath. Test compound or vehicle was applied 30 min before mite antigen challenge. In addition, a cyclooxygenase inhibitor (indomethacin) and an antihistamine drug (pyrilamine) were applied 10 and 5 min, respectively, before antigen challenge such that the antigen-induced contractile response was dependent on CysLTs. The detailed procedure is described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_p"><a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> shows that 100 nmol/L of <b>35</b> reduced the constriction of isolated human bronchi. The in vitro CysLT<sub>1</sub> or CysLT<sub>2</sub> antagonist activity of <b>35</b> was several times weaker than that of montelukast (CysLT<sub>1</sub>) or BayCysLT<sub>2</sub>RA<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (CysLT<sub>2</sub>), so compound <b>35</b> was used at a higher concentration. As a result, the inhibitory activity of <b>35</b> (blue line) was comparable to that of a combination treatment of montelukast and BayCysLT<sub>2</sub>RA (green line). Recently, the expression of CysLT<sub>2</sub> in airways of asthma subjects was reported to be higher than for nonasthma subjects.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> This result suggests that dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonists could be more effective and useful.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>35</b> on antigen-induced constriction of isolated human bronchi. (<i>a</i>) Concentration of both montelukast and BayCysLT<sub>2</sub>RA was 10 nmol/L (<i>n</i> = 4). (<i>b</i>) Concentration of <b>35</b> was 100 nmol/L (<i>n</i> = 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Syntheses of the compounds herein are outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Syntheses of <b>38a</b>–<b>f</b> are described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Compounds <b>36a</b>–<b>f</b> were subjected to Sonogashira coupling with 3-butyn-1-ol. The resulting acetylene derivatives <b>37a</b>–<b>f</b> were converted to alcohol derivatives <b>38a</b>–<b>f</b> with Pd/C under a hydrogen atmosphere. Tosyl derivatives <b>38aa</b> and <b>38ba</b> were afforded by tosylation of <b>38a</b> and <b>38b</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Side Chains <b>38a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-butyn-1-ol, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Ph<sub>3</sub>P, CuI, Et<sub>3</sub>N, rt–80 °C, 33–99%; (b) H<sub>2</sub> gas, 10% Pd–C(wet), EtOH, rt, 52–95%; (c) <i>p</i>-toluenesulfonyl chloride, Et<sub>3</sub>N, Me<sub>3</sub>N·HCl, toluene, rt, 80–95%.</p></p></figure><div class="NLM_p">Compounds <b>4</b>–<b>16</b> were prepared as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Commercially available indole derivatives <b>39a</b> or <b>39b</b> were converted to ketoesters <b>40a</b> or <b>40b</b> by Friedel–Crafts acylation followed by reduction with sodium borohydride to prepare monoester <b>41a</b> or <b>41b</b>. <i>N</i>-Alkylation of <b>41a</b> and <b>41b</b> with ethyl bromoacetate using K<sub>2</sub>CO<sub>3</sub> as the base afforded diesters <b>42a</b> and <b>42b</b>. Heck reaction of <b>42a</b> and <b>42b</b> and 4-acetoxystyrene, deprotection of the acetoxy group, and Mitsunobu reaction with the corresponding alcohols gave diesters <b>44a</b>–<b>m</b>. Carboxylic acid derivatives <b>4</b>–<b>16</b> were afforded by alkaline hydrolysis of <b>44a</b>–<b>m</b>.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Compounds <b>4</b>–<b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AlCl<sub>3</sub>, ethyl succinyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 83%–34%; (b) NaBH<sub>4</sub>, BF<sub>3</sub>·OEt<sub>2</sub>, THF, 0 °C, 54%–76%; (c) ethyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C, 99%–86%; (d) 4-acetoxystyrene, palladium(II)acetate, tri<i>o</i>-tolylphoshine, Et<sub>3</sub>N, dioxane, 100 °C; (e) K<sub>2</sub>CO<sub>3</sub>, THF, EtOH, 50 °C, 89–96% (2 steps); (f) 4-phenyl-1-butanol, 4-(2-methoxyphenyl)-1-butanol, 4-(3-chlorophenyl)-1-butanol, or <b>38a</b>–<b>g</b>, ADDP, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g) NaOHaq, EtOH–DME, rt-50 °C, 51–97% (2 steps).</p></p></figure><div class="NLM_p">Compound <b>3</b> was prepared as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Heck reaction of the indole derivative <b>42a</b> with 1-(4-phenoxybutoxy)-4-vinylbenzene followed by alkaline hydrolysis gave carboxylic acid derivative <b>3</b>.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(4-phenoxybutoxy)-4-vinylbenzene, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>tert</i>-Bu<sub>3</sub>P, Cy<sub>2</sub>NMe, 1,4-dioxane, 100 °C; (b) NaOHaq, EtOH–DME, rt–50 °C, 92% (2 steps).</p></p></figure><div class="NLM_p">Syntheses of <b>17</b>–<b>19</b> and <b>23</b>–<b>28</b> are described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. <i>N</i>-alkylation of indole derivatives <b>46a</b>, <b>46b</b>, and <b>41b</b> prepared via Fischer indole synthesis was performed with the corresponding bromide to afford diesters <b>47a</b> and <b>47b</b>, <b>42b</b>, and <b>47d</b>–<b>i</b>. These compounds were subjected to Sonogashira coupling with 4-ethynylphenyl acetate, and then the acetoxy group was deprotected. The resulting phenols <b>48a</b>–<b>i</b> were converted to dicarboxylic acid derivatives <b>17</b>–<b>19</b> and <b>23</b>–<b>28</b> by <i>O</i>-alkylation with tosylate <b>38ba</b>, which was followed by alkaline hydrolysis.</div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of Compounds <b>17</b>–<b>19</b> and <b>23</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, EtOH, 4-oxopentanoic acid (<i>n</i> = 1), 5-oxohexanoic acid (<i>n</i> = 2), or 6-oxoheptanoic acid (<i>n</i> = 3), 100 °C, 58–60%; (b) Br-(CH<sub>2</sub>)<sub>m</sub>-CO<sub>2</sub>Et (<i>m</i> = 1–4) Cs<sub>2</sub>CO<sub>3</sub>, rt–50 °C, 58–99%; (c) 4-ethynylphenyl acetate, Pd(<i>tert</i>-Bu<sub>3</sub>P)<sub>2</sub>, <sup>i</sup>Pr<sub>2</sub>NH, CH<sub>3</sub>CN, rt; (d) K<sub>2</sub>CO<sub>3</sub>, DME–EtOH, rt, 62–78% (2 steps); (e) <b>38ba</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (f) NaOHaq, EtOH–DME, rt–50 °C, 67–97% (2 steps).</p></p></figure><div class="NLM_p">Syntheses of <b>20</b>–<b>22</b> are described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. <i>N</i>-Alkylation and selective deprotection of indole derivatives <b>46a</b>, <b>46b</b>, and <b>41b</b> resulted in monocarboxylic acids <b>51a</b>–<b>c</b>. For one-carbon extension of <b>51a</b>–<b>c</b>, diazoketone intermediates <b>52a</b>–<b>c</b> were prepared with the use of trimethylsilyldiazomethane and treated under Wolff rearrangement conditions. The resulting C1 extended diesters <b>53a</b>–<b>c</b> were converted to dicarboxylic acid compounds <b>20</b>–<b>22</b> as in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Compounds <b>20</b>–<b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-methyl-2-propanyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, 45 °C, 100%; (b) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, rt, 91–100%; (c) isobutyl chloroformate, triethylamine, THF then CH<sub>2</sub>N<sub>2</sub>/diethyl ether, −10 °C to 0 °C; (d) silver(I) benzoate, triethylamine, EtOH, rt–50 °C, 44–52% (2 steps); (e) 4-ethynylphenyl acetate, Pd(P<i>t</i>-Bu<sub>3</sub>)<sub>2</sub>, <sup>i</sup>Pr<sub>2</sub>NH, CH<sub>3</sub>CN, rt; (f) K<sub>2</sub>CO<sub>3</sub>, DME–EtOH, rt–50 °C, 35–84% for 2 steps; (g) <b>38ba</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (h) NaOHaq, DME–EtOH, rt–50 °C, 86–95%.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a> shows the preparation of the fluorine-substituted derivatives <b>29</b>–<b>35</b>. These compounds were also synthesized with the use of the corresponding synthetic materials according to the method described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Syntheses of Compounds <b>29</b>–<b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, EtOH, 6-oxoheptanoic acid 100 °C, 35–75%; (b) ethyl 4-bromobutanoate, Cs<sub>2</sub>CO<sub>3</sub>, 55 °C, 95–97%; (c) 4-ethynylphenyl acetate, Pd(<i>tert</i>-Bu<sub>3</sub>P)<sub>2</sub>, <sup>i</sup>Pr<sub>2</sub>NH, CH<sub>3</sub>CN, rt; (d) K<sub>2</sub>CO<sub>3</sub>, DME–EtOH, rt, 77–95% (2 steps); (e) <b>38aa</b> or <b>38ba</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, or <b>38a</b> or <b>38e</b>, ADDP, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) NaOHaq, EtOH–DME, rt–50 °C, 72–98% (2 steps).</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, the structure of <b>35</b> (gemilukast) was confirmed with an X-ray crystallographic analysis of a single crystal (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Interestingly, the terminal alkyloxyphenyl ring is orthogonal to the indole ring. In general, two aromatic rings at either end of a triple bond tend to be in the same plane. The fluorine atom at the 4-position of the indole is thought to be causally related to this twisted formation based on the tendencies of its analogues. This conformation is considered reasonable for gemilukast and its analogues.</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. ORTEP drawing of compound <b>35</b> (ONO-6950, gemilukast). Data and refinement statistics are summarized in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, the isomerization of the core indole and the incorporation of a triple bond significantly improved in vivo efficacy, and <b>35</b> (ONO-6950, gemilukast) was determined to be a novel, highly potent, and orally available dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist. Gemilukast showed good PK properties in rats, guinea pigs, and dogs without species differences, promising excellent PK in humans. Gemilukast also showed excellent efficacy in two guinea pig asthmatic models: 74% inhibition of bronchoconstriction in a CysLT<sub>1</sub>-dependent model at an oral dose of 0.1 mg/kg 24 h before LTD<sub>4</sub> challenge, and 87% inhibition of bronchoconstriction in both CysLT<sub>1</sub>- and CysLT<sub>2</sub>-dependent models at an oral dose of 3 mg/kg 24 h before LTC<sub>4</sub> challenge. Furthermore, gemilukast reduced the antigen-induced constriction of isolated human bronchi, and its effect was comparable to that of combination treatment with antagonists against CysLT<sub>1</sub> and CysLT<sub>2</sub>. On the basis of the strength of the data presented herein, gemilukast was selected as a clinical candidate. Gemilukast is currently being evaluated in phase II clinical trials. The results will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Remarks</h3><div class="NLM_p">Analytical samples were homogeneous as confirmed by TLC, and spectroscopic results were consistent with the assigned structures. NMR spectra were recorded as designated on either a Varian Mercury 300 spectrometer or INOVA-500 spectrometer using deuterated chloroform (CDCl<sub>3</sub>), deuterated methanol (CD<sub>3</sub>OD), or deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>) as the solvent. Fast atom bombardment (FABMS, HRMS) and electron ionization (EI) were performed on a JEOL JMS-DX303HF spectrometer. Atmospheric pressure chemical ionization (APCI) mass spectra were determined with a Hitachi M-1200H spectrometer. IR spectra were measured on a JASCO FTIR-430 spectrometer. Elemental analyses were performed with a Perkin–Elmer PE2400 series II CHNS/O analyzer and were only indicated as the elements within ±0.4% of the theoretical values unless otherwise noted. Purity analyses were performed on the following HPLC systems: HPLC, Agilent Technologies 1200 series with Unison UK-C18 (4.6 mm × 150 mm). Method A: Unison UK-C18 (4.6 mm × 150 mm), eluting over 60 min with 30–80% acetonitrile in 20 mM KH<sub>2</sub>PO<sub>4</sub> aq (pH = 2.0), flow rate of 1 mL/min, column temperature of 35 °C, detection with UV (210 nm). Method B: Unison UK-C18 (4.6 mm × 150 mm), eluting over 60 min with 30–80% acetonitrile in 20 mM K<sub>2</sub>HPO<sub>4</sub> aq (pH = 7.0), flow rate of 1 mL/min, column temperature of 35 °C, detection with UV (210 nm). Column chromatography was performed with silica gel [Merck Silica Gel 60 (0.063–0.200 μm), Wako gel C-200, or Fuji Silysia FL60D]. Thin layer chromatography was performed with silica gel (Merck TLC or HPTLC plates, Silica Gel 60 F254) or with a medium-pressure preparative liquid chromatograph W-prep 2XY (manufactured by Yamazen Corporation; column: main column size S-5L, inject column size SS-2L). The following abbreviations for solvents and reagents are used: DMF, <i>N</i>,<i>N</i>-dimethylformamide; DMSO, dimethyl sulfoxide; EtOH, ethanol; EtOAc, ethyl acetate; MeOH methanol; THF, tetrahydrofuran; CH<sub>2</sub>Cl<sub>2</sub>, dichloromethane; <i>tert</i>-BuOMe, <i>tert</i>-butyl methyl ether; <sup>i</sup>Pr<sub>2</sub>O, diisopropyl ether; CH<sub>3</sub>CN, acetonitrile; Et<sub>3</sub>N, triethylamine; TFA, trifluoroacetic acid; ADDP, 1,1′-(azodicarbonyl)-dipiperidine. All animal experiments were approved by the Animal Ethical Committee of Ono Pharmaceutical Co., Ltd. and were performed in accordance with institutional animal care guidelines.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(3-Fluoro-2-methylphenyl)-1-butanol (<b>38a</b>)</h4><div class="NLM_p last">3-Butyn-1-ol (0.38 mL, 5.0 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (175 mg, 0.26 mmol), Ph<sub>3</sub>P (131 mg, 0.53 mmol), and CuI (95 mg, 0.53 mmol) were added to a solution of <b>36a</b> (1.0 g 5.29 mmol) in Et<sub>3</sub>N (5.0 mL) at room temperature. The reaction mixture was stirred for 1 h at 80 °C. <sup>i</sup>Pr<sub>2</sub>O was added to the reaction mixture; this mixture was filtered and the filtrate was concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>37a</b> (357 mg, 40%). <b>37a</b> (313 mg, 1.76 mmol) and platinum dioxide (30 mg) in EtOH (2.0 mL) were stirred for 3 h under a hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated to give <b>38a</b> (304 mg, 95%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.14–1.44 (m, 1H), 1.57–1.73 (m, 4H), 2.16–2.26 (m, 3H), 2.62 (t, <i>J</i> = 7.2 Hz, 2H), 3.61–3.76 (m, 2H), 6.82–6.90 (m, 1H), 6.90–6.95 (m, 1H), 7.02–7.12 (m, 1H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(3-Chloro-2-methylphenyl)-1-butanol (<b>38b</b>)</h4><div class="NLM_p last">Compound <b>38b</b> was prepared from compound <b>36b</b> in a manner similar to that described for compound <b>38a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.27 (t, <i>J</i> = 5.1 Hz, 1H), 1.61–1.68 (m, 4H), 2.35 (s, 3H), 2.62–2.72 (m, 2H), 3.63–3.75 (m, 2H), 7.00–7.09 (m, 2H), 7.17–7.26 (m, 1H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-(3-Chloro-2-methylphenyl)butyl 4-methylbenzenesulfonate (<b>38ba</b>)</h4><div class="NLM_p last">Triethylamine (7.9 mL, 56.9 mmol), trimethylamine hydrochloride (272 mg, 2.84 mmol), and <i>p</i>-toluenesulfonyl chloride (7.05 g, 37.0 mmol) were added to a solution of compound <b>38b</b> (5.65 g, 28.4 mmol) in toluene (57 mL) at 0 °C, and the mixture was stirred for 2.5 h at 0 °C. The reaction mixture was poured into H<sub>2</sub>O, and the resulting mixture was extracted with EtOAc. The organic layer was washed with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>38ba</b> (9.49 g, 95%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.51–1.64 (m, 2H), 1.64–1.78 (m, 2H), 2.29 (s, 3H), 2.44 (s, 3H), 2.52–2.65 (m, 2H), 4.05 (t, <i>J</i> = 6.2 Hz, 2H), 6.93–7.05 (m, 2H), 7.21 (dd, <i>J</i> = 7.7 Hz, 1.5 Hz, 1H), 7.33 (d, <i>J</i> = 8.2 Hz, 2H), 7.78 (d, <i>J</i> = 8.2 Hz, 2H).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(3-Fluoro-2-methylphenyl)butyl 4-Methylbenzenesulfonate (<b>38aa</b>)</h4><div class="NLM_p last">Compound <b>38aa</b> was prepared from compound <b>38a</b> in a manner similar to that described for compound <b>38ba</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.51–1.64 (m, 2H), 1.65–1.78 (m, 2H), 2.15 (d, <i>J</i> = 2.2 Hz, 3H), 2.44 (s, 3H), 2.57 (t, <i>J</i> = 7.7 Hz, 2H), 4.05 (t, <i>J</i> = 6.2 Hz, 2H), 6.77–6.91 (m, 2H), 6.97–7.13 (m, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 2H), 7.78 (d, <i>J</i> = 8.4 Hz, 2H).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(4,5-Difluoro-2-methylphenyl)-1-butanol (<b>38c</b>)</h4><div class="NLM_p last">Compound <b>38c</b> was prepared from compound <b>36c</b> in a manner similar to that described for compound <b>38a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.59–1.69 (m, 5H), 2.24 (s, 3H), 2.53–2.58 (m, 2H), 3.67–3.71 (m, 2H), 6.89–6.95 (m, 2H).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-(2,3,6-Trifluorophenyl)-1-butanol (<b>38d</b>)</h4><div class="NLM_p last">Compound <b>38d</b> was prepared from compound <b>36d</b> in a manner similar to that described for compound <b>38a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.14–1.15 (m, 1H), 1.52–1.82 (m, 4H), 2.63–2.86 (m, 2H), 3.58–3.77 (m, 2H), 6.71–6.81 (m, 1H), 6.88–7.05 (m, 1H).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-(2,3,5,6-Tetrafluorophenyl)-1-butanol (<b>38e</b>)</h4><div class="NLM_p last">Compound <b>38e</b> was prepared from compound <b>36e</b> in a manner similar to that described for compound <b>38a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.20–1.35 (m, 1H), 1.52–1.80 (m 4H), 2.69–2.87 (m, 2H), 3.56–3.77 (m, 2H), 6.82–7.01 (m, 1H).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-(2,3,4,6-Tetrafluorophenyl)-1-butanol (<b>38f</b>)</h4><div class="NLM_p last">Compound <b>38f</b> was prepared from compound <b>36f</b> in a manner similar to that described for compound <b>38a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.15–1.39 (m, 1H), 1.51–1.79 (m, 4H), 2.68 (t, <i>J</i> = 6.0 Hz, 2H), 3.67 (t, <i>J</i> = 5.9 Hz, 2H), 6.71 (m, 1H).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-(2,3,4,5-Tetrafluorophenyl)-1-butanol (<b>38g</b>)</h4><div class="NLM_p last">Compound <b>38g</b> was prepared from compound <b>36g</b> in a manner similar to that described for compound <b>38a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.39 (brs, 1H), 1.60–1.74 (m, 4H), 2.63–2.68 (m, 2H), 3.65–3.69 (m, 2H), 6.75–6.84 (m, 1H).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Ethyl 4-(7-Bromo-1<i>H</i>-indol-3-yl)-4-oxobutanoate (<b>40a</b>)</h4><div class="NLM_p last">AlCl<sub>3</sub> (1.36 g, 10.2 mmol) and <b>39a</b> (1.0 g, 5.10 mmol) were added to ethyl 4-chloro-4-oxobutanoate (1.68 g, 10.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> at 0 °C, which was followed by stirring for 5 h at room temperature. H<sub>2</sub>O was added to the reaction mixture, and the resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was stirred for 30 min in EtOAc and filtered to obtain a solid. The resulting solid was dried to give <b>40a</b> (1.37 g, 83%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.27 (t, <i>J</i> = 7.2 Hz, 3H), 2.79 (t, <i>J</i> = 6.9 Hz, 2H), 3.23 (t, <i>J</i> = 6.9 Hz, 2H), 4.17 (q, <i>J</i> = 7.2 Hz, 2H), 7.16 (t, <i>J</i> = 7.8 Hz, 1H), 7.43 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H), 7.96 (t, <i>J</i> = 0.9 Hz, 1H), 8.30 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H), 8.76 (brs, 1H).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Ethyl 4-(7-Bromo-2-methyl-1<i>H</i>-indol-3-yl)-4-oxobutanoate (<b>40b</b>)</h4><div class="NLM_p last">Compound <b>40b</b> was prepared from compound <b>39b</b> in a manner similar to that described for compound <b>40a</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.28 (t, <i>J</i> = 7.2 Hz, 3H), 2.79 (s, 3H), 2.79 (t, <i>J</i> = 6.6 Hz, 2H), 3.28 (t, <i>J</i> = 6.6 Hz, 2H), 4.19 (q, <i>J</i> = 7.2 Hz, 2H), 7.09 (t, <i>J</i> = 8.1 Hz, 1H), 7.33 (d, <i>J</i> = 8.1, Hz, 1H), 7.96 (d, <i>J</i> = 8.1 Hz, 1H), 8.75 (brs, 1H).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Ethyl 4-(7-Bromo-1<i>H</i>-indol-3-yl)butanoate (<b>41a</b>)</h4><div class="NLM_p last">NaBH<sub>4</sub> (118 mg, 3.11 mmol) and boron trifluoride–ethyl ether complex (0.66 mL, 5.19 mmol) were added to compound <b>40a</b> (560 mg, 1.73 mmol) in THF at −20 °C, which was followed by stirring for 2.5 h at −10 °C. Saturated ammonium chloride solution was added to the reaction mixture, and the resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>41a</b> (292 mg, 54%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.24 (t, <i>J</i> = 7.2 Hz, 3H), 1.98–2.08 (m, 2H), 2.36 (t, <i>J</i> = 7.5 Hz, 2H), 2.79 (t, <i>J</i> = 7.2 Hz, 2H), 4.12 (q, <i>J</i> = 7.2 Hz, 2H), 6.99 (t, <i>J</i> = 7.5 Hz, 1H), 7.10–7.08 (m, 1H), 7.34 (dd, <i>J</i> = 7.5, 0.6 Hz, 1H), 7.55 (dt, <i>J</i> = 7.5, 0.6 Hz, 1H), 8.12 (brs, 1H).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Ethyl 4-(7-Bromo-2-methyl-1<i>H</i>-indol-3-yl)butanoate (<b>41b</b>)</h4><div id="sec5_1_13_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Procedure 1</h5><div class="NLM_p last">Starting with <b>40b</b>, following the procedures above resulted in compound <b>41a</b>.</div></div><div id="sec5_1_13_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Procedure 2</h5><div class="NLM_p last">Fisher indole synthesis: Concentrated H<sub>2</sub>SO<sub>4</sub> (12 mL) was added to a solution of <b>45</b> (25 g, 112 mmol) and 6-oxoheptanoic acid (16.1 g, 112 mmol) in EtOH (120 mL) at room temperature. The reaction mixture was stirred for 1.5 h at reflux. The resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>41b</b> (27.5 g, 76%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 1.89–2.00 (m, 2H), 2.30 (t, <i>J</i> = 7.2 Hz, 2H), 2.39 (s, 3H), 2.71 (t, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 6.94 (t, <i>J</i> = 8.1 Hz, 1H), 7.24 (d, <i>J</i> = 8.1 Hz, 1H), 7.43 (d, <i>J</i> = 8.1 Hz, 1H), 7.91 (brs, 1H).</div></div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Ethyl 4-[7-Bromo-1-(2-ethoxy-2-oxoethyl)-1<i>H</i>-indol-3-yl]butanoate (<b>42a</b>)</h4><div class="NLM_p last">Cs<sub>2</sub>CO<sub>3</sub> (8.4 g, 25.8 mmol) and ethyl bromoacetate (1.51 mL, 13.5 mmol) were added to compound <b>41a</b> (4.0 g, 12.9 mmol) in DMF (40 mL) at 0 °C, which was followed by stirring for 1 h at 0 °C. H<sub>2</sub>O was added to the reaction mixture, and the resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>42a</b> (4.98 g, 97%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.25 (t, <i>J</i> = 7.2 H, 3H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H), 1.93–2.09 (m, 2H), 2.36 (t, <i>J</i> = 7.4 Hz, 2H), 2.69–2.82 (m, 2H), 4.12 (q, <i>J</i> = 7.2 Hz, 2H), 4.23 (q, <i>J</i> = 7.2 Hz, 2H), 5.22 (s, 2H), 6.80 (s, 1H), 6.94 (dd, <i>J</i> = 7.9, 7.6 Hz, 1H), 7.33 (dd, <i>J</i> = 7.6, 1.0 Hz, 1H), 7.52 (dd, <i>J</i> = 7.9, 1.1 Hz, 1H).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Ethyl 4-[7-Bromo-1-(2-ethoxy-2-oxoethyl)-2-methyl-1<i>H</i>-indol-3-yl]butanoate (<b>42b</b>)</h4><div class="NLM_p last">Compound <b>42b</b> was prepared from compound <b>41b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H), 1.86–1.97 (m, 2H), 2.27 (s, 3H), 2.30 (t, <i>J</i> = 7.5 Hz, 2H), 2.74 (t, <i>J</i> = 7.2 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.23 (q, <i>J</i> = 7.2 Hz, 2H), 5.27 (s, 2H), 6.90 (t, <i>J</i> = 7.8 Hz, 1H), 7.25 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H), 7.44 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Ethyl 4-{1-(2-Ethoxy-2-oxoethyl)-7-[(<i>E</i>)-2-(4-hydroxyphenyl)vinyl]-1<i>H</i>-indol-3-yl}butanoate (<b>43a</b>)</h4><div class="NLM_p last">Dicyclohexylmethylamine (3.24 mL, 15.1 mmol) and a solution of <sup><i>t</i></sup>Bu<sub>3</sub>P (7.08 mL, 2.52 mmol, 10 w/w % hexane solution) were added to a solution of <b>42a</b> (5.00 g, 12.6 mmol), 4-acetoxystyrene (2.02 mL, 13.2 mmol), and tris(dibenzylideneacetone)dipalladium(0) (1.15 g, 1.26 mmol) in dioxane (60 mL) at room temperature under an argon atmosphere. The reaction mixture was stirred for 3 h at 100 °C. The reaction mixture was filtered, the filtrate was poured into water, and the resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with aqueous saturated ammonium chloride solution, water, and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give acetoxy derivative (5.90 g, 98%). Potassium carbonate (857 mg, 6.2 mmol) was added to a solution of the acetoxy derivative (5.90 g, 12.3 mmol) in THF (40 mL) and EtOH (40 mL), and the mixture was stirred for 17 h at room temperature. The reaction mixture was poured into water, and the resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with water, saturated aqueous ammonium chloride solution, and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>43a</b> (4.61 g, 87%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.19 (t, <i>J</i> = 7.2 Hz, 3H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 2.78 (t, <i>J</i> = 7.5 Hz, 2H), 2.04 (t, <i>J</i> = 7.5 Hz, 2H), 2.39 (t, <i>J</i> = 7.5 Hz, 2H), 4.13 (q, <i>J</i> = 7.2 Hz, 2H), 4.16 (q, <i>J</i> = 7.2 Hz, 2H), 4.98 (s, 2H), 5.19 (s, 1H), 6.80 (s, 1H), 6.82 (d, <i>J</i> = 15.0 Hz, 1H), 6.83 (d, <i>J</i> = 8.7 Hz, 2H), 7.10 (t, <i>J</i> = 7.5 Hz, 1H), 7.24 (d, <i>J</i> = 7.5 Hz, 1H), 7.38 (d, <i>J</i> = 8.7 Hz, 2H), 7.42 (d, <i>J</i> = 15.0 Hz, 1H), 7.51(d, <i>J</i> = 7.5 Hz, 1H).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Ethyl 4-{1-(2-Ethoxy-2-oxoethyl)-7-[(<i>E</i>)-2-(4-hydroxyphenyl)vinyl]-2-methyl-1<i>H</i>-indol-3-yl}butanoate (<b>43b</b>)</h4><div class="NLM_p last">Compound <b>43b</b> was prepared from compound <b>42b</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.17–1.29 (m, 6H), 1.90–1.98 (m, 2H), 2.29(s, 3H), 2.32 (t, <i>J</i> = 7.3 Hz, 2H), 2.76 (t, <i>J</i> = 7.3 Hz, 2H), 4.11 (q, <i>J</i> = 7.0 Hz, 2H), 4.20 (q, <i>J</i> = 7.2 Hz, 2H), 4.89 (s, 1H), 4.97 (s, 2H), 6.77–6.86 (m, 3H), 7.06 (t, <i>J</i> = 7.3 Hz, 1H), 7.15 (d, <i>J</i> = 7.3 Hz, 1H), 7.35–7.46 (m, 4H).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-(1-(Carboxymethyl)-7-{(<i>E</i>)-2-[4-(4-phenoxybutoxy)phenyl]vinyl}-1<i>H</i>-indol-3-yl)butanoic Acid (<b>3</b>)</h4><div class="NLM_p last">1-(4-Phenoxybutoxy)-4-vinylbenzene<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (0.78 g, 2.91 mmol), tris(dibenzylideneacetone)dipalladium(0) (243 mg, 0.27 mmol), dicyclohexylmethylamine (0.62 g, 3.2 mmol), and a solution of <i>tert</i>-Bu<sub>3</sub>P (1.08 g, 0.53 mmol, 10 w/w % hexane solution) were added to a solution of <b>42a</b> (1.05 g, 2.65 mmol) in dioxane (14 mL) at room temperature under an argon atmosphere. The reaction mixture was stirred for 3 h at 105 °C. The reaction mixture was then filtered, the filtrate was poured into water, and the resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with aqueous saturated ammonium chloride solution, water, and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>44n</b> (1.29 g, 83%). A 2 mol/L aqueous solution of sodium hydroxide (2.8 mL) was added to a solution of <b>44n</b> (1.1 g, 1.9 mmol) in DME (18 mL), and the mixture was stirred for 5 h at room temperature. Hydrochloric acid (1 mol/L) and water were added to the reaction mixture, and the resulting mixture was extracted with EtOAc. The organic layer was washed with water and brine sequentially, dried over anhydrous sodium sulfate, and concentrated. The residue was washed with <sup>i</sup>Pr<sub>2</sub>O to give <b>3</b> (890 mg, 90%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.78–1.93 (m, 6H), 2.28 (t, <i>J</i> = 7.2 Hz, 2H), 2.67 (t, <i>J</i> = 7.4 Hz, 2H), 3.97–4.12 (m, 4H), 5.13 (s, 2H), 6.86–6.97 (m, 6H), 7.02 (dd, <i>J</i> = 7.6 Hz, 1H), 7.08 (s, 1H), 7.22–7.31 (m, 3H), 7.40–7.58 (m, 4H), 12.29 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 23.67, 25.07, 25.39, 33.30, 50.40, 66.92, 67.11, 113.62, 114.39, 114.64, 118.02, 119.02, 120.14, 120.36, 122.41, 123.07, 127.65, 128.84, 129.24, 129.40, 129.89, 130.14, 133.62, 158.23, 158.56, 171.15, 174.37. MS (FAB, neg) <i>m</i>/<i>z</i> 526 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>32</sub>H<sub>33</sub>NO<sub>6</sub> (M – H)<sup>−</sup> calcd mass 526.2230, found 526.2233. LCMS (ELSD) RT = 1.17 min (>98%). HPLC purity 96% (method A).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-(1-(Carboxymethyl)-7-{(<i>E</i>)-2-[4-(4-phenylbutoxy)phenyl]vinyl}-1<i>H</i>-indol-3-yl)butanoic Acid (<b>4</b>)</h4><div class="NLM_p last">Compound <b>4</b> was prepared from compound <b>43a</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.66–1.78 (m, 4H), 1.78–1.93 (m, 2H), 2.28 (t, <i>J</i> = 7.5 Hz, 2H), 2.58–2.76 (m, 4H), 3.91–4.10 (m, 2H), 5.11 (s, 2H), 6.87–6.95 (m, 4H), 7.01 (t, <i>J</i> = 7.8 Hz, 1H), 7.07 (s, 1H), 7.14–7.32 (m, 6H), 7.41–7.57 (m, 3H), 12.05 (brs, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 510 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>32</sub>H<sub>33</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 510.2280, found 510.2269. HPLC purity 95% (method B).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-{1-(Carboxymethyl)-7-[(<i>E</i>)-2-{4-[4-(3-chlorophenyl)butoxy]phenyl}vinyl]-1<i>H</i>-indol-3-yl}butanoic Acid (<b>5</b>)</h4><div class="NLM_p last">Compound <b>5</b> was prepared from compound <b>43a</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.67–1.77 (m, 4H), 1.78–1.91 (m, 2H), 2.28 (t, <i>J</i> = 7.5 Hz, 2H), 2.61–2.72 (m, 4H), 3.96–4.04 (m, 2H), 5.11 (s, 2H), 6.91 (d, <i>J</i> = 15.9 Hz, 1H), 6.92 (d, <i>J</i> = 9.0 Hz, 2H), 7.01 (t, <i>J</i> = 7.5 Hz, 1H), 7.07 (s, 1H), 7.16–7.57 (m, 9H), 12.15 (brs, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 544 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>32</sub>H<sub>32</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 544.1891, found 544.1895. HPLC purity 93% (method B).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-{1-(Carboxymethyl)-7-[(<i>E</i>)-2-{4-[4-(2,3,6-trifluorophenyl)butoxy]phenyl}vinyl]-1<i>H</i>-indol-3-yl}butanoic Acid (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was prepared from compound <b>43a</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.62–1.92 (m, 6H), 2.28 (t, <i>J</i> = 7.2 Hz, 2H), 2.66 (t, <i>J</i> = 7.2 Hz, 2H), 2.70–2.79 (m, 2H), 4.00 (t, <i>J</i> = 6.0 Hz, 2H), 5.13 (s, 2H), 6.87–6.96 (m, 3H), 7.01 (t, <i>J</i> = 7.5 Hz, 1H), 7.08 (s, 1H), 7.10–7.17 (m, 1H), 7.25 (d, <i>J</i> = 7.5 Hz, 1H), 7.30–7.57 (m, 5H),12.31 (brs, 1H), 12.85 (brs, 1H). MS (FAB, neg) <i>m</i>/<i>z</i> 564 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>30</sub>F<sub>3</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 564.1998, found 564.1996. HPLC purity 99% (method B).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-{1-(Carboxymethyl)-7-[(<i>E</i>)-2-{4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}vinyl]-1<i>H</i>-indol-3-yl}butanoic Acid (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was prepared from compound <b>43a</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59–1.92 (m, 6H), 2.17 (d, <i>J</i> = 2.0 Hz, 3H), 2.22–2.34 (m, 2H), 2.61–2.73 (m, 4H), 4.02 (t, <i>J</i> = 6.2 Hz, 2H), 5.13 (s, 2H), 6.86–7.05 (m, 6H), 7.06–7.18 (m, 2H), 7.26 (d, <i>J</i> = 7.3 Hz, 1H), 7.40–7.58 (m, 4H), 12.15 (brs, 1H), 12.95 (brs, 1H). MS (FAB, neg) <i>m</i>/<i>z</i> 542 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>34</sub>FNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 542.5343, found 542.2343. HPLC purity 95% (method B).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-{1-(Carboxymethyl)-7-[(<i>E</i>)-2-{4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}vinyl]-1<i>H</i>-indol-3-yl}butanoic Acid (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was prepared from compound <b>43a</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.53–1.94 (m, 6H), 2.23–2.35 (m, 5H), 2.60–2.77 (m, 4H), 4.02 (t, <i>J</i> = 5.9 Hz, 2H), 5.13 (s, 2H), 6.86–6.97 (m, 3H), 7.02 (t, <i>J</i> = 7.7 Hz, 1H), 7.06–7.18 (m, 3H), 7.22–7.29 (m, 2H), 7.40–7.57 (m, 4H), 12.21 (brs, 1H), 12.81 (brs, 1H). MS (FAB, neg) <i>m</i>/<i>z</i> 558 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>34</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 558.2047, found 558.2058. HPLC purity 96% (method B).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-[1-(Carboxymethyl)-2-methyl-7-{(<i>E</i>)-2-[4-(4-phenylbutoxy)phenyl]vinyl}-1<i>H</i>-indol-3-yl]butanoic Acid (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was prepared from compound <b>43b</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.61–1.84 (m, 6H), 2.13–2.30 (m, 5H), 2.58–2.76 (m, 4H), 3.93–4.07 (m, 2H), 5.01 (s, 2H), 6.81–7.03 (m, 4H), 7.09–7.32 (m, 6H), 7.38 (d, <i>J</i> = 7.3 Hz, 1 H), 7.43–7.55 (m, 3H), 12.20 (brs, 1H), 13.10 (brs, 1H). MS (FAB, neg) <i>m</i>/<i>z</i> 524 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>35</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 524.2437, found 524.2446. HPLC purity 96% (method B).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-{1-(Carboxymethyl)-7-[(<i>E</i>)-2-{4-[4-(2-methoxyphenyl)butoxy]phenyl}vinyl]-2-methyl-1<i>H</i>-indol-3-yl}butanoic Acid (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was prepared from compound <b>43b</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.62–1.80 (m, 6H), 2.21 (t, <i>J</i> = 7.3 Hz, 2H), 2.25 (s, 3H), 2.61 (t, <i>J</i> = 7.3 Hz, 2H), 2.66 (t, <i>J</i> = 7.1 Hz, 2H), 3.77 (s, 3H), 3.95–4.04 (m, 2H), 5.01 (s, 2H), 6.82–7.02 (m, 6H), 7.11–7.21 (m, 3H), 7.39 (d, <i>J</i> = 7.7 Hz, 1H), 7.48 (d, <i>J</i> = 8.6 Hz, 2H), 7.50 (d, <i>J</i> = 15.7 Hz, 1H), 12.05 (brs, 1H), 13.40 (brs, 1H). MS (FAB, neg) <i>m</i>/<i>z</i> 554 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>34</sub>H<sub>37</sub>NO<sub>6</sub> (M – H)<sup>−</sup> calcd mass 554.2543, found 554.2532. HPLC purity 97% (method B).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-{1-(Carboxymethyl)-2-methyl-7-[(<i>E</i>)-2-{4-[4-(2,3,6-trifluorophenyl)butoxy]phenyl}vinyl]-1<i>H</i>-indol-3-yl}butanoic Acid (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared from compound <b>43b</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.64–1.84 (m, 6H), 2.22 (t, <i>J</i> = 7.2 Hz, 2H), 2.24–2.30 (s, 3H), 2.67 (t, <i>J</i> = 7.2 Hz, 2H), 2.70–2.80 (m, 2H), 3.97–4.08 (m, 2H), 5.02 (s, 2H), 6.81–7.06 (m, 4H), 7.05–7.21 (m, 2H), 7.28–7.44 (m, 2H), 7.44–7.60 (m, 3H), 12.06 (brs, 1H), 13.10 (brs, 1H). MS (FAB, neg) <i>m</i>/<i>z</i> 578 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>32</sub>F<sub>3</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 578.2154, found 578.2151. HPLC purity 95% (method B).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-{1-(Carboxymethyl)-2-methyl-7-[(<i>E</i>)-2-{4-[4-(2,3,5,6-tetrafluorophenyl)butoxy]phenyl}vinyl]-1<i>H</i>-indol-3-yl}butanoic Acid (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was prepared from compound <b>43b</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.65–1.84 (m, 6H), 2.21 (t, <i>J</i> = 7.2 Hz, 2H), 2.25 (s, 3H), 2.62–2.71 (m, 2H), 2.75–2.85 (m, 2H), 3.97–4.08 (m, 2H), 4.97–5.09 (m, 2H), 6.83–7.04 (m, 4H), 7.14 (d, <i>J</i> = 7.1 Hz, 1H), 7.36–7.41 (m, 1H), 7.44–7.56 (m, 3H), 7.64–7.83 (m, 1H), 12.11 (brs, 1H), 13.07 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85, 22.12, 22.97, 25.16, 25.72, 28.08, 33.00, 47.13, 66.98, 104.33 (m), 110.58, 114.65, 117.13, 118.95, 120.13, 120.64 (m), 122.31, 123.03, 127.59, 128.75, 129.89, 130.24, 133.50, 134.11, 144.18 (m), 145.22 (m), 158.17, 171.19, 174.42. MS (FAB, neg) <i>m</i>/<i>z</i> 596 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>31</sub>F<sub>4</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 596.2060, found 596.2060. HPLC purity 95% (method B).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-{1-(Carboxymethyl)-2-methyl-7-[(<i>E</i>)-2-{4-[4-(2,3,4,5-tetrafluorophenyl)butoxy]phenyl}vinyl]-1<i>H</i>-indol-3-yl}butanoic Acid (<b>13</b>)</h4><div class="NLM_p last">Compound <b>13</b> was prepared from compound <b>43b</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.65–1.85 (m, 6H), 2.21 (t, <i>J</i> = 7.3 Hz, 2H), 2.25 (s, 3H), 2.62–2.76 (m, 4H), 3.90–4.09 (m, 2H), 5.02 (s, 2H), 6.87 (d, <i>J</i> = 15.9 Hz, 1H), 6.89–7.04 (m, 3H), 7.14 (d, <i>J</i> = 7.3 Hz, 1H), 7.33–7.42 (m, 2H), 7.43–7.58 (m, 3H), 12.02 (brs, 1H), 13.01 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 27.23, 27.95, 33.00, 47.12, 67.09, 110.59, 112.09 (m), 114.65, 117.13, 118.95, 120.13, 122.31, 123.02, 125.87 (m), 127.58, 128.76, 129.87, 130.25, 133.49, 134.11, 137.66 (m), 139.74 (m), 145.04 (m), 146.05 (m), 158.19, 171.19, 174.42. MS (FAB, neg) <i>m</i>/<i>z</i> 596 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>31</sub>F<sub>4</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 596.2060, found 596.2060. HPLC purity 95% (method B).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-{1-(Carboxymethyl)-2-methyl-7-[(<i>E</i>)-2-{4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}vinyl]-1<i>H</i>-indol-3-yl}butanoic Acid (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared from compound <b>43b</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60–1.84 (m, 6H), 2.21 (t, <i>J</i> = 7.1 Hz, 2H), 2.25 (s, 3H), 2.61–2.77 (m, 4H), 3.99 (t, <i>J</i> = 5.9 Hz, 2H), 4.99 (s, 2H), 6.82–6.94 (m, 3H), 6.98 (t, <i>J</i> = 7.6 Hz, 1H), 7.14 (d, <i>J</i> = 7.3 Hz, 1H), 7.38 (d, <i>J</i> = 7.3 Hz, 1H), 7.41–7.58 (m, 4H), 12.20 (brs, 1H), 13.10 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85, 21.45, 22.98, 25.28, 25.73, 28.06, 33.01, 47.24, 66.99, 101.31 (m), 110.52, 114.63, 114.95 (m), 117.11, 118.90, 120.07, 122.31, 123.08, 127.58, 128.73, 129.89, 130.17, 133.50, 134.11, 136.38 (m), 148.17(m), 148.93 (m), 154.94 (m), 158.15, 171.22, 174.42. MS (FAB, neg) <i>m</i>/<i>z</i> 596 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>31</sub>F<sub>4</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 596.2060, found 596.2060. HPLC purity 98% (method B).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-{1-(Carboxymethyl)-7-[(<i>E</i>)-2-{4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}vinyl]-2-methyl-1<i>H</i>-indol-3-yl}butanoic Acid (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared from compound <b>43b</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59–1.85 (m, 6H), 2.17 (d, <i>J</i> = 2.2 Hz, 3H), 2.21 (t, <i>J</i> = 7.4 Hz, 2H), 2.25 (s, 3H), 2.60–2.74 (m, 4H), 4.02 (t, <i>J</i> = 6.1 Hz, 2H), 5.01 (s, 2H), 6.81–7.05 (m, 6H), 7.08–7.18 (m, 2H), 7.38 (d, <i>J</i> = 7.5 Hz, 1H), 7.47 (d, <i>J</i> = 8.6 Hz, 2H), 7.49 (d, <i>J</i> = 16.5 Hz, 1H), 12.10 (brs, 1H), 13.20 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85, 10.01, 22.98, 25.72, 26.16, 28.36, 31.97, 33.00, 47.13, 67.25, 110.590, 112.31 (<i>J</i><sub>C–F</sub> = 23.0 Hz), 114.660, 117.130, 118.950, 120.130, 122.200, 122.320, 122.990, 124.61 (<i>J</i><sub>C–F</sub> = 2.8 Hz), 126.67(<i>J</i><sub>C–F</sub> = 9.1 Hz), 127.590, 128.760, 129.830, 130.260, 133.490, 134.100, 143.08 (<i>J</i><sub>C–F</sub> = 4.1 Hz), 158.260, 160.70 (<i>J</i><sub>C–F</sub> = 239.9 Hz), 171.190, 174.420. MS (FAB, neg) <i>m</i>/<i>z</i> 556 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>34</sub>H<sub>36</sub>FNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 556.2499, found 556.2502. HPLC purity 98% (method A).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-{1-(Carboxymethyl)-7-[(<i>E</i>)-2-{4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}vinyl]-2-methyl-1<i>H</i>-indol-3-yl}butanoic Acid (<b>16</b>)</h4><div class="NLM_p last"><b>38b</b> (37 mg, 0.19 mmol), ADDP (98 mg, 0.37 mmol), and PPh<sub>3</sub> (94 mg, 0.37 mmol) were added to a solution of <b>43b</b> (70 mg, 0.16 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL), and the mixture was stirred for 15 h at room temperature. Triphenylphosphine oxide was removed by filtration, and the filtrate was concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>44m</b> (109 mg, quant). A 2 mol/L aqueous solution of sodium hydroxide (1.0 mL) was added to a mixture of <b>44m</b> (98 mg, 0.16 mmol), DME (2.0 mL), and EtOH (2.0 mL), and the mixture was stirred for 2.5 h at 50 °C. The reaction mixture was acidified with 2 mol/L hydrochloric acid and extracted with EtOAc. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was stirred for 30 min in <sup>i</sup>Pr<sub>2</sub>O and filtered to obtain a solid. The resulting solid was dried to give <b>16</b> (82 mg, 92%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.52–1.86 (m, 6H), 2.21 (t, <i>J</i> = 7.3 Hz, 2H), 2.25 (s, 3H), 2.31 (s, 3H), 2.61–2.79 (m, 4H), 4.02 (t, <i>J</i> = 6.2 Hz, 2H), 5.01 (s, 2H), 6.81–7.05 (m, 4H), 7.07–7.19 (m, 3H), 7.22–7.31 (m, 1H), 7.34–7.43 (m, 1H), 7.43–7.59 (m, 3H), 12.20 (brs, 1H), 13.31 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85, 15.50, 22.98, 25.72, 26.21, 28.35, 33.00, 33.06, 47.13, 67.24, 110.58, 114.66, 117.13, 118.95, 120.13, 122.32, 123.00, 126.63, 126.86, 127.59, 127.86, 128.76, 129.84, 130.26, 133.27, 133.50, 133.83, 134.11, 142.74, 158.25, 171.20, 174.42. MS (FAB, neg) <i>m</i>/<i>z</i> 572 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>34</sub>H<sub>36</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 572.2204, found 572.2201. HPLC purity 95% (method A).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Ethyl (7-Bromo-2-methyl-1<i>H</i>-indol-3-yl)acetate (<b>46a</b>)</h4><div class="NLM_p last">Compound <b>46a</b> was prepared from compound <b>45</b> in a manner similar to that described for compound <b>41b</b> (<a class="ref internalNav" href="#sec5_1_13_2" aria-label="Procedure 2">Procedure 2</a>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 2.44 (s, 3H), 3.65 (s, 2H), 4.12 (q, <i>J</i> = 7.2 Hz, 2H), 6.96 (t, <i>J</i> = 7.8 Hz, 1H), 7.25 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H), 7.41–7.50 (m, 1H), 8.01 (s, 1H).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Ethyl 3-(7-Bromo-2-methyl-1<i>H</i>-indol-3-yl)propanoate (<b>46b</b>)</h4><div class="NLM_p last">Compound <b>46b</b> was prepared from compound <b>45</b> in a manner similar to that described for compound <b>41b</b> (<a class="ref internalNav" href="#sec5_1_13_2" aria-label="Procedure 2">Procedure 2</a>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.21 (t, <i>J</i> = 7.2 Hz, 3H), 2.42 (s, 3H), 2.59 (t, <i>J</i> = 6.6 Hz, 2H), 3.01 (t, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 6.95 (t, <i>J</i> = 7.8 Hz, 1H), 7.25 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H), 7.43 (d, <i>J</i> = 7.8 Hz, 1H), 7.92 (brs, 1H).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Diethyl 2,2′-(7-Bromo-2-methyl-1<i>H</i>-indole-1,3-diyl)diacetate (<b>47a</b>)</h4><div class="NLM_p last">Compound <b>47a</b> was prepared from compound <b>46a</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 1.27 (t, <i>J</i> = 7.2 Hz, 3H), 2.33 (s, 3H), 3.68 (s, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.24 (q, <i>J</i> = 7.2 Hz, 2H), 5.29 (s, 2H), 6.92 (t, <i>J</i> = 7.8 Hz, 1H), 7.23–7.31 (m, 1H), 7.47 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Ethyl 3-[7-Bromo-1-(2-ethoxy-2-oxoethyl)-2-methyl-1<i>H</i>-indol-3-yl]propanoate (<b>47b</b>)</h4><div class="NLM_p last">Compound <b>47b</b> was prepared from compound <b>41b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.20–1.32 (m, 6H), 2.31 (s, 3H), 2.57 (t, <i>J</i> = 7.2 Hz, 2H), 3.03 (t, <i>J</i> = 7.5 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.26 (q, <i>J</i> = 7.4 Hz, 2H), 5.27 (s, 2H), 6.92 (dd, <i>J</i> = 7.5, 7.8 Hz, 1H), 7.27 (dd, <i>J</i> = 7.5, 1.0 Hz, 1H), 7.44 (dd, <i>J</i> = 7.8, 1.0, Hz, 1H).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Ethyl 4-[7-Bromo-3-(2-ethoxy-2-oxoethyl)-2-methyl-1<i>H</i>-indol-1-yl]butanoate (<b>47d</b>)</h4><div class="NLM_p last">Compound <b>47d</b> was prepared from compound <b>46a</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H), 1.99–2.14 (m, 2H), 2.40 (t, <i>J</i> = 7.2 Hz, 2H), 2.42 (s, 3H), 3.67 (s, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.14 (q, <i>J</i> = 7.2 Hz, 2H), 4.47–4.58 (m, 2H), 6.91 (t, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.29 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.47 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H).</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Ethyl 4-[7-Bromo-3-(3-ethoxy-3-oxopropyl)-2-methyl-1<i>H</i>-indol-1-yl]butanoate (<b>47e</b>)</h4><div class="NLM_p last">Compound <b>47e</b> was prepared from compound <b>46b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 6.9 Hz, 3H), 1.26 (t, <i>J</i> = 6.8 Hz, 3H), 1.99–2.09 (m, 2H), 2.36–2.41 (m, 2H), 2.39 (s, 3H), 2.55 (t, <i>J</i> = 7.9 Hz, 2H), 3.02 (t, <i>J</i> = 7.9 Hz, 2H), 4.07–4.17 (m, 4H), 4.48–4.53 (m, 2H), 6.90 (dd, <i>J</i> = 7.5, 7.8 Hz, 1H), 7.28 (d, <i>J</i> = 7.5 Hz, 1H), 7.44 (d, <i>J</i> = 7.8 Hz, 1H).</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Diethyl 4,4′-(7-Bromo-2-methyl-1<i>H</i>-indole-1,3-diyl)dibutanoate (<b>47f</b>)</h4><div class="NLM_p last">Compound <b>47f</b> was prepared from compound <b>41b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 1.82–2.12 (m, 4H), 2.29 (t, <i>J</i> = 7.8 Hz, 2H), 2.36 (s, 3H), 2.39 (t, <i>J</i> = 7.5 Hz, 2H), 2.73 (t, <i>J</i> = 7.5 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.13 (q, <i>J</i> = 7.2 Hz, 2H), 4.46–4.55 (m, 2H), 6.88 (t, <i>J</i> = 7.5 Hz, 1H), 7.27 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H), 7.43 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Ethyl 5-[7-Bromo-3-(2-ethoxy-2-oxoethyl)-2-methyl-1<i>H</i>-indol-1-yl]pentanoate (<b>47g</b>)</h4><div class="NLM_p last">Compound <b>47g</b> was prepared from compound <b>46a</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.17–1.29 (m, 6H), 1.65–1.87 (m, 4H), 2.35 (t, <i>J</i> = 7.0 Hz, 2H), 2.39 (s, 3H), 3.66 (s, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.12 (q, <i>J</i> = 7.2 Hz, 2H), 4.39–4.52 (m, 2H), 6.89 (t, <i>J</i> = 7.8, 7.5 Hz, 1H), 7.27 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H), 7.45 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H).</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Ethyl 5-[7-Bromo-3-(3-ethoxy-3-oxopropyl)-2-methyl-1<i>H</i>-indol-1-yl]pentanoate (<b>47h</b>)</h4><div class="NLM_p last">Compound <b>47h</b> was prepared from compound <b>46b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.19–1.28 (m, 6H), 1.69–1.95 (m, 4H), 2.33–2.36 (m, 2H), 2.36 (s, 3H), 2.54 (t, <i>J</i> = 7.8 Hz, 2H), 3.01 (t, <i>J</i> = 7.8 Hz, 2H), 4.05–4.15 (m, 4H), 4.41–4.46 (m, 2H), 6.87 (dd, <i>J</i> = 7.8, 7.5 Hz, 1H), 7.27 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H), 7.41 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H).</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Ethyl 5-[7-Bromo-3-(4-ethoxy-4-oxobutyl)-2-methyl-1<i>H</i>-indol-1-yl]pentanoate (<b>47i</b>)</h4><div class="NLM_p last">Compound <b>47i</b> was prepared from compound <b>41b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.24 (t, <i>J</i> = 7.1 Hz, 3H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 1.70–1.81 (m, 4H), 1.85–1.94 (m, 2H), 2.27–2.40 (m, 4H), 2.34 (s, 3H), 2.73 (t, <i>J</i> = 7.4 Hz, 2H), 4.07–4.16 (m, 4H), 4.42–4.47 (m, 2H), 6.88 (dd, <i>J</i> = 7.8, 7.5 Hz, 1H), 7.27 (dd, <i>J</i> = 7.5, 1.1 Hz, 1H), 7.43 (dd, J = 7.8, 1.1 Hz, 1H).</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Diethyl 2,2′-{7-[(4-Hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indole-1,3-diyl}diacetate (<b>48a</b>)</h4><div class="NLM_p last">Compound <b>48a</b> was prepared from compound <b>47a</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.11 (t, <i>J</i> = 7.2 Hz, 3H), 1.27 (t, <i>J</i> = 7.2 Hz, 3H), 2.32 (s, 3H), 3.73 (s, 2H), 4.12 (q, <i>J</i> = 7.2 Hz, 2H), 4.16 (q, <i>J</i> = 7.2 Hz, 2H), 5.35 (s, 2H), 5.72 (s, 1H), 6.62 (d, <i>J</i> = 8.7 Hz, 2H), 7.06 (t, <i>J</i> = 7.6 Hz, 1H), 7.31 (dd, <i>J</i> = 7.4, 1.2 Hz, 1H), 7.35 (d, <i>J</i> = 8.7 Hz, 2H), 7.50 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H).</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Ethyl 3-{1-(2-Ethoxy-2-oxoethyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-3-yl}propanoate (<b>48b</b>)</h4><div class="NLM_p last">Compound <b>48b</b> was prepared from compound <b>47b</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.12 (t, <i>J</i> = 7.1 Hz, 3H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 2.32 (s, 3H), 2.59 (t, <i>J</i> = 7.5 Hz, 2H), 3.05 (t, <i>J</i> = 7.5 Hz, 2H), 4.11(q, <i>J</i> = 7.1 Hz, 2H), 4.13 (q, <i>J</i> = 7.2 Hz, 2H), 5.12 (s, 1H), 5.43 (s, 2H), 6.81–6.84 (m, 2H), 7.04 (dd, <i>J</i> = 7.8, 7.5 Hz, 1H), 7.31 (dd, <i>J</i> = 7.5, 1.0 Hz, 1H), 7.43–7.46 (m, 2H), 7.49 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H).</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Ethyl 4-{1-(2-Ethoxy-2-oxoethyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-3-yl}butanoate (<b>48c</b>)</h4><div class="NLM_p last">Compound <b>48c</b> was prepared from compound <b>42b</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.12 (t, <i>J</i> = 7.1 Hz, 3H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 1.86–1.98 (m, 2H), 2.29 (s, 3H), 2.28–2.36 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.13 (q, <i>J</i> = 7.2 Hz, 2H), 5.09 (s, 1H), 5.44 (s, 2H), 6.82 (d, <i>J</i> = 8.8 Hz, 2H), 7.03 (dd, <i>J</i> = 7.8, 7.5 Hz, 2H), 7.30 (dd, <i>J</i> = 7.5, 1.1 Hz, 1H), 7.44 (d, <i>J</i> = 8.8 Hz, 2H), 7.49 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Ethyl 4-{3-(2-Ethoxy-2-oxoethyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-1-yl}butanoate (<b>48d</b>)</h4><div class="NLM_p last">Compound <b>48d</b> was prepared from compound <b>47d</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.12 (t, <i>J</i> = 7.2 Hz, 3H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 2.07–2.20 (m, 2H), 2.30 (t, <i>J</i> = 7.4 Hz, 2H), 2.40 (s, 3H), 3.70 (s, 2H), 4.08 (q, <i>J</i> = 7.2 Hz, 2H), 4.14 (q, <i>J</i> = 7.2 Hz, 2H), 4.53–4.64 (m, 2H), 5.50 (s, 1H), 6.71 (d, <i>J</i> = 8.8 Hz, 2H), 7.05 (t, <i>J</i> = 7.8 Hz, 1H), 7.33 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H), 7.38 (d, <i>J</i> = 8.8 Hz, 2H), 7.51 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H).</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Ethyl 4-{3-(3-Ethoxy-3-oxopropyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-1-yl}butanoate (<b>48e</b>)</h4><div class="NLM_p last">Compound <b>48e</b> was prepared from compound <b>47e</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.19–1.25 (m, 6H), 2.12–2.19 (m, 2H), 2.28–2.33 (m, 2H), 2.39 (s, 3H), 2.58 (t, <i>J</i> = 7.7 Hz, 2H), 3.04 (t, <i>J</i> = 7.7 Hz, 2H), 4.05–4.14 (m, 4H), 4.62 (t, <i>J</i> = 7.5 Hz, 2H), 5.35 (s, 1H), 6.81–6.84 (m, 2H), 7.03 (dd, <i>J</i> = 7.8, 7.2 Hz, 1H), 7.32 (d, <i>J</i> = 7.2 Hz, 1H), 7.41–7.44 (m, 2H), 7.49 (d, <i>J</i> = 7.8 Hz, 1H).</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Diethyl 4,4′-{7-[(4-Hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indole-1,3-diyl}dibutanoate (<b>48f</b>)</h4><div class="NLM_p last">Compound <b>48f</b> was prepared from compound <b>47f</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H), 1.82–1.99 (m, 2H), 2.05–2.21 (m, 2H), 2.29–2.35 (m, 7H), 2.75 (t, <i>J</i> = 7.5 Hz, 2H), 4.04–4.14 (m, 4H), 4.62 (t, <i>J</i> = 7.2 Hz, 2H), 5.39 (s, 1H), 6.83 (d, <i>J</i> = 8.7 Hz, 2H), 7.01 (t, <i>J</i> = 7.8 Hz, 1H), 7.30 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.42 (d, <i>J</i> = 8.7 Hz, 2H), 7.48 (dd, <i>J</i> = 7.2, 1.2 Hz, 1H).</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Ethyl 5-{3-(2-Ethoxy-2-oxoethyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-1-yl}pentanoate (<b>48g</b>)</h4><div class="NLM_p last">Compound <b>48g</b> was prepared from compound <b>47g</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.19 (t, <i>J</i> = 7.2 Hz, 3H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H), 1.56–1.70 (m, 2H), 1.74–1.90 (m, 2H), 2.24 (t, <i>J</i> = 7.4 Hz, 2H), 2.37 (s, 3H), 3.71 (s, 2H), 4.06 (q, <i>J</i> = 7.2 Hz, 2H), 4.15 (q, <i>J</i> = 7.2 Hz, 2H), 4.45–4.59 (m, 2H), 5.69 (s, 1H), 6.65 (d, <i>J</i> = 8.8 Hz, 2H), 7.04 (t, <i>J</i> = 7.8 Hz, 1H), 7.29–7.40 (m, 3H), 7.50 (dd, <i>J</i> = 8.7, 1.1 Hz, 1H).</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Ethyl 5-{3-(3-Ethoxy-3-oxopropyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-1-yl}pentanoate (<b>48h</b>)</h4><div class="NLM_p last">Compound <b>48h</b> was prepared from compound <b>47h</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.17–1.24 (m, 6H), 1.64–1.86 (m, 4H), 2.25 (t, <i>J</i> = 7.4 Hz, 2H), 2.37 (s, 3H), 2.57 (t, <i>J</i> = 7.8 Hz, 2H), 3.04 (t, <i>J</i> = 7.8 Hz, 2H), 4.03–4.14 (m, 4H), 4.54 (t, <i>J</i> = 7.7 Hz, 2H), 5.36 (s, 1H), 6.81–6.84 (m, 2H), 7.02 (dd, <i>J</i> = 7.8, 7.7 Hz, 1H), 7.31 (dd, <i>J</i> = 7.7, 0.9 Hz, 1H), 7.41–7.44 (m, 2H), 7.48 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H).</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Ethyl 5-{3-(4-Ethoxy-4-oxobutyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-1-yl}pentanoate (<b>48i</b>)</h4><div class="NLM_p last">Compound <b>48i</b> was prepared from compound <b>47i</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.20 (t, <i>J</i> = 7.1 Hz, 3H), 1.24 (t, <i>J</i> = 7.2 Hz, 3H), 1.65–1.97 (m, 6H), 2.26 (t, <i>J</i> = 7.5 Hz, 2H), 2.31 (t, <i>J</i> = 8.0 Hz, 2H), 2.34 (s, 3H), 2.75 (t, <i>J</i> = 7.5 Hz, 2H), 4.07 (q, <i>J</i> = 7.1 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.58 (t, <i>J</i> = 7.7 Hz, 2H), 5.36 (s, 1H), 6.82–6.85 (m, 2H), 7.01 (dd, <i>J</i> = 8.0, 7.4 Hz, 1H), 7.31 (dd, <i>J</i> = 7.4, 1.1 Hz, 1H), 7.41–7.44 (m, 2H), 7.48 (dd, <i>J</i> = 8.0, 1.1 Hz, 1H).</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 2,2′-[7-({4-[4-(3-Chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indole-1,3-diyl]diacetic Acid (<b>17</b>)</h4><div class="NLM_p last"><b>38ba</b> (65 mg, 0.18 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (109 mg, 0.33 mmol) were added to a solution of <b>48a</b> (70 mg) in DMF (0.5 mL), and the reaction mixture was stirred for 14 h at room temperature. The reaction mixture was filtered and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give the ester derivative <b>49a</b>. A 2 mol/L aqueous solution of sodium hydroxide (0.6 mL) was added to a mixture of <b>49a</b>, DME (1.5 mL), and EtOH (1.5 mL), and the mixture was stirred for 7 h at 50 °C. The reaction mixture was acidified with 2 mol/L hydrochloric acid and extracted with EtOAc. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was stirred for 30 min in <sup>i</sup>Pr<sub>2</sub>O and filtered to obtain a solid. The resulting solid was dried to give <b>17</b> (88 mg, 89%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57–1.85 (m, 4H), 2.28 (s, 3H), 2.31 (s, 3H), 2.65–2.76 (m, 2H), 3.62 (s, 2H), 4.00–4.10 (m, 2H), 5.40 (s, 2H), 6.94–7.04 (m, 3H), 7.08–7.17 (m, 2H), 7.18–7.28 (m, 2H), 7.42–7.54 (m, 3H), 12.15 (brs, 1H), 13.02 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.83, 15.50, 26.16, 28.26, 29.87, 33.04, 45.45, 67.36, 85.83, 92.69, 104.52, 105.18, 114.39, 114.78, 118.85, 126.23, 126.64, 126.86, 127.86, 128.64, 132.52, 133.27, 133.83, 134.09, 135.82, 142.71, 158.81, 170.56, 172.73. MS (FAB, neg) <i>m</i>/<i>z</i> 542 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>32</sub>H<sub>30</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 542.1734, found 542.1725. HPLC purity 97% (method A).</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 3-[1-(Carboxymethyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-3-yl]propanoic Acid (<b>18</b>)</h4><div class="NLM_p last">Compound <b>18</b> was prepared from compound <b>48b</b> and <b>38ba</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59–1.72 (m, 2H), 1.72–1.85 (m, 2H), 2.27 (s, 3H), 2.31 (s, 3H), 2.40–2.47 (m, 2H), 2.67–2.73 (m, 2H), 2.91 (t, <i>J</i> = 7.5 Hz, 2H), 4.05 (t, <i>J</i> = 6.3 Hz, 2H), 5.38 (s, 2H), 7.00 (t, <i>J</i> = 8.0 Hz, 3H), 7.08–7.17 (m, 2H), 7.18–7.23 (m, 1H), 7.23–7.29 (m, 1H), 7.45–7.54 (m, 3H), 12.06 (brs, 1H), 12.91 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.68, 15.50, 19.33, 26.16, 28.26, 33.04, 34.90, 45.36, 67.36, 85.92, 92.65, 104.51, 110.11, 114.42, 114.79, 118.59, 118.73, 126.12, 126.64, 126.87, 127.86, 128.25, 132.50, 133.27, 133.83, 134.23, 134.63, 142.71, 158.80, 170.63, 173.89. MS (FAB, neg) <i>m</i>/<i>z</i> 556 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>32</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 556.1891, found 556.1890. HPLC purity 95% (method B).</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-[1-(Carboxymethyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-3-yl]butanoic Acid (<b>19</b>)</h4><div class="NLM_p last">Compound <b>19</b> was prepared from compound <b>48c</b> and <b>38ba</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.58–1.86 (m, 6H), 2.21 (t, <i>J</i> = 7.2 Hz, 2H), 2.25 (s, 3H), 2.31 (s, 3H), 2.62–2.75 (m, 4H), 3.99–4.09 (m, 2H), 5.31–5.46 (m, 2H), 6.94–7.04 (m, 3H), 7.08–7.16 (m, 2H), 7.20 (d, <i>J</i> = 7.1 Hz, 1H), 7.22–7.29 (m, 1H), 7.44–7.54 (m, 3H), 12.09 (brs, 1H), 12.88 (brs, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 26.16, 28.25, 32.96, 33.03, 45.34, 67.36, 85.94, 92.62, 104.47, 110.73, 114.43, 114.79, 118.59, 118.65, 126.06, 126.64, 126.86, 127.85, 128.57, 132.48, 133.27, 133.83, 134.25, 134.48, 142.71, 158.79, 170.67, 174.38. MS (FAB, neg) <i>m</i>/<i>z</i> 570 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>34</sub>H<sub>34</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 570.2047, found 570.2048. HPLC purity 95% (method B).</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-[3-(Carboxymethyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-1-yl]butanoic Acid (<b>23</b>)</h4><div class="NLM_p last">Compound <b>23</b> was prepared from compound <b>48d</b> and <b>38ba</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57–1.86 (m, 4H), 1.87–2.05 (m, 2H), 2.20 (t, <i>J</i> = 7.4 Hz, 2H), 2.31 (s, 3H), 2.33–2.38 (m, 3H), 2.64–2.79 (m, 2H), 3.61 (s, 2H), 4.05 (t, <i>J</i> = 6.2 Hz, 2H), 4.49–4.62 (m, 2H), 6.93–7.04 (m, 3H), 7.06–7.18 (m, 2H), 7.19–7.28 (m, 2H), 7.41–7.54 (m, 3H), 12.25 (brs, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 570 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>34</sub>H<sub>34</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 570.2047, found 570.2026. HPLC purity 95% (method B).</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-[3-(2-Carboxyethyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-1-yl]butanoic Acid (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was prepared from compound <b>48e</b> and <b>38ba</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59–1.72 (m, 2H), 1.72–1.83 (m, 2H), 1.86–2.02 (m, 2H), 2.13–2.22 (m, 2H), 2.31 (s, 3H), 2.35 (s, 3H), 2.39–2.46 (m, 2H), 2.65–2.77 (m, 2H), 2.84–2.99 (m, 2H), 4.05 (t, <i>J</i> = 6.3 Hz, 2H), 4.47–4.60 (m, 2H), 6.94–7.04 (m, 3H), 7.09–7.18 (m, 2H), 7.19–7.30 (m, 2H), 7.45–7.55 (m, 3H), 12.10 (s, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 584 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>35</sub>H<sub>36</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 584.2204, found 584.2206. HPLC purity 99% (method A).</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 4,4′-[7-({4-[4-(3-Chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indole-1,3-diyl]dibutanoic Acid (<b>25</b>)</h4><div class="NLM_p last">Compound <b>25</b> was prepared from compound <b>48f</b> and <b>38ba</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59–1.87 (m, 6H), 1.88–2.03 (m, 2H), 2.12–2.23 (m, 4H), 2.31 (s, 3 H), 2.33 (s, 3H), 2.61–2.77 (m, 4H), 4.05 (t, <i>J</i> = 6.2 Hz, 2H), 4.54 (t, <i>J</i> = 7.5 Hz, 2H), 6.93–7.03 (m, 3H), 7.07–7.18 (m, 2H), 7.19–7.29 (m, 2H), 7.42–7.58 (m, 3H), 12.05 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.74, 15.49, 22.82, 25.74, 26.14, 26.61, 28.25, 30.48, 33.01, 33.03, 42.57, 67.36, 86.39, 91.64, 104.35, 110.76, 114.44, 114.94, 118.40, 118.70, 126.21, 126.63, 126.85, 127.85, 128.66, 132.42, 133.27, 133.47, 133.83, 134.09, 142.71, 158.82, 173.70, 174.38. MS (FAB, neg) <i>m</i>/<i>z</i> 598 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>36</sub>H<sub>38</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 598.2360, found 598.2371. HPLC purity 98% (method B)</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 5-[3-(Carboxymethyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-1-yl]pentanoic Acid (<b>26</b>)</h4><div class="NLM_p last">Compound <b>26</b> was prepared from compound <b>48g</b> and <b>38ba</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.43–1.58 (m, 2H), 1.58–1.85 (m, 6H), 2.19 (t, <i>J</i> = 7.3 Hz, 2H), 2.31 (s, 3H), 2.35 (s, 3H), 2.64–2.76 (m, 2H), 3.61 (s, 2H), 4.04 (t, <i>J</i> = 6.3 Hz, 2H), 4.45–4.64 (m, 2H), 6.91–7.03 (m, 3H), 7.07–7.18 (m, 2H), 7.19–7.29 (m, 2H), 7.40–7.55 (m, 3H), 12.15 (brs, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 584 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>35</sub>H<sub>36</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 584.2204, found 584.2200. HPLC purity 96% (method B).</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 5-[3-(2-Carboxyethyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-1-yl]pentanoic Acid (<b>27</b>)</h4><div class="NLM_p last">Compound <b>27</b> was prepared from compound <b>48h</b> and <b>38ba</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.41–1.57 (m, 2H), 1.59–1.84 (m, 6H), 2.18 (t, <i>J</i> = 7.2 Hz, 2H), 2.31 (s, 3H), 2.34 (s, 3H), 2.38–2.46 (m, 2H), 2.65–2.76 (m, 2H), 2.90 (t, <i>J</i> = 7.4 Hz, 2H), 4.04 (t, <i>J</i> = 6.2 Hz, 2H), 4.47–4.61 (m, 2H), 6.92–7.02 (m, 3H), 7.07–7.17 (m, 2H), 7.20 (dd, <i>J</i> = 7.3, 0.9 Hz, 1H), 7.23–7.28 (m, 1H), 7.43–7.53 (m, 3H), 11.99 (brs, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 598 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>36</sub>H<sub>38</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 598.2360, found 598.2352. HPLC purity 99% (method B).</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 5-[3-(3-Carboxypropyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-1-yl]pentanoic Acid (<b>28</b>)</h4><div class="NLM_p last">Compound <b>28</b> was prepared from compound <b>48i</b> and <b>38ba</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.43–1.57 (m, 2H), 1.59–1.85 (m, 8H), 2.13–2.24 (m, 4H), 2.31 (s, 3H), 2.33 (s, 3H), 2.62–2.75 (m, 4H), 3.99–4.09 (m, 2H), 4.50–4.60 (m, 2H), 6.93–7.01 (m, 3H), 7.07–7.17 (m, 2H), 7.20 (dd, <i>J</i> = 7.4, 0.8 Hz, 1H), 7.23–7.28 (m, 1H), 7.43–7.52 (m, 3H), 11.96 (brs, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 612 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>37</sub>H<sub>40</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 612.2517, found 612.2516. HPLC purity 99% (method B).</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Ethyl 2-Methyl-2-propanyl 2,2′-(7-bromo-2-methyl-1<i>H</i>-indole-1,3-diyl)diacetate (<b>50a</b>)</h4><div class="NLM_p last">Compound <b>50a</b> was prepared from compound <b>46a</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 1.46 (s, 9H), 2.33 (s, 3H), 3.68 (s, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 5.20 (s, 2H), 6.92 (t, <i>J</i> = 7.8 Hz, 1H), 7.24–7.31 (m, 1H), 7.47 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H).</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Ethyl 3-(7-Bromo-2-methyl-1-{2-[(2-methyl-2-propanyl)oxy]-2-oxoethyl}-1<i>H</i>-indol-3-yl)propanoate (<b>50b</b>)</h4><div class="NLM_p last">Compound <b>50b</b> was prepared from compound <b>46b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 1.45 (s, 9H), 2.30 (s, 3H), 2.51–2.62 (m, 2H), 2.98–3.08 (m, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 5.17 (s, 2H), 6.90 (dd, <i>J</i> = 7.8, 7.6 Hz, 1H), 7.26 (dd, <i>J</i> = 7.6, 1.0 Hz, 1H), 7.43 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H).</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Ethyl 4-(7-Bromo-2-methyl-1-{2-[(2-methyl-2-propanyl)oxy]-2-oxoethyl}-1<i>H</i>-indol-3-yl)butanoate (<b>50c</b>)</h4><div class="NLM_p last">Compound <b>50c</b> was prepared from compound <b>41b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.24 (t, <i>J</i> = 7.2 Hz, 3H), 1.44 (s, 9H), 1.84–1.98 (m, 2H), 2.24–2.34 (m, 5H), 2.74 (t, <i>J</i> = 7.4 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 5.17 (s, 2H), 6.88 (t, <i>J</i> = 7.6 Hz, 1H), 7.24 (dd, <i>J</i> = 7.6, 1.0 Hz, 1H), 7.42 (dd, <i>J</i> = 7.6, 1.0 Hz, 1H).</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> [7-Bromo-3-(2-ethoxy-2-oxoethyl)-2-methyl-1<i>H</i>-indol-1-yl]acetic Acid (<b>51a</b>)</h4><div class="NLM_p last">HCO<sub>2</sub>H (15 mL) was added to a solution of <b>50a</b> (890 mg, 2.17 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), and the reaction mixture was stirred for 14 h at room temperature. The residue was stirred for 30 min in <sup>i</sup>Pr<sub>2</sub>O and filtered to obtain a solid. The resulting solid was dried to give <b>51a</b> (768 mg, 93%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 2.34 (s, 3H), 3.68 (s, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 5.37 (s, 2H), 6.94 (t, <i>J</i> = 7.8 Hz, 1H), 7.29 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H), 7.48 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H).</div></div><div id="sec5_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> [7-Bromo-3-(3-ethoxy-3-oxopropyl)-2-methyl-1<i>H</i>-indol-1-yl]acetic Acid (<b>51b</b>)</h4><div class="NLM_p last">Compound <b>51b</b> was prepared from compound <b>50b</b> in a manner similar to that described for compound <b>51a</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.12 (t, <i>J</i> = 7.2 Hz, 3H), 2.25 (s, 3H), 2.47–2.55 (m, 2H), 2.93 (t, <i>J</i> = 7.2 Hz, 2H), 3.99 (q, <i>J</i> = 7.2 Hz, 2H), 5.23 (s, 2H), 6.90 (t, <i>J</i> = 7.7 Hz, 1H), 7.22 (dd, <i>J</i> = 7.7, 0.9 Hz, 1H), 7.47 (dd, <i>J</i> = 7.7, 0.9 Hz, 1H), 13.01 (s, 1H).</div></div><div id="sec5_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> [7-Bromo-3-(4-ethoxy-4-oxobutyl)-2-methyl-1<i>H</i>-indol-1-yl]acetic Acid (<b>51c</b>)</h4><div class="NLM_p last">Compound <b>51c</b> was prepared from compound <b>50c</b> in a manner similar to that described for compound <b>51a</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.15 (t, <i>J</i> = 7.2 Hz, 3H), 1.65–1.83 (m, 2H), 2.20–2.32 (m, 5H), 2.67 (t, <i>J</i> = 7.5 Hz, 2H), 4.03 (q, <i>J</i> = 7.2 Hz, 2H), 5.24 (s, 2H), 6.90 (t, <i>J</i> = 7.8 Hz, 1H), 7.21 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H), 7.47 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H), 13.01 (s, 1H).</div></div><div id="sec5_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Ethyl 3-[7-Bromo-3-(2-ethoxy-2-oxoethyl)-2-methyl-1<i>H</i>-indol-1-yl]propanoate (<b>53a</b>)</h4><div class="NLM_p last">Triethylamine (0.42 mL, 3.0 mmol) and isobutyl chloroformate (0.25 mL, 2.6 mmol) were added to a solution of <b>51a</b> (708 mg, 2.0 mmol) in THF (10.0 mL) at −10 °C. The reaction mixture was stirred for 3 h at −10 °C. Then CH<sub>2</sub>N<sub>2</sub>/diethyl ether (10 mL) was added to the reaction mixture at −10 °C. The reaction mixture was stirred for 3 h at 0 °C. H<sub>2</sub>O was added to the reaction mixture, and the resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>52a</b>. Triethylamine (0.16 mL, 1.15 mmol) and silver(I) benzoate (30 mg, 0.13 mmol) were added to a solution of <b>52a</b> in EtOH (4.0 mL), and the reaction mixture was stirred for 3 h at 50 °C. The reaction mixture was filtered, the filtrate was poured into water, and the resulting mixture was extracted with EtOAc. The organic layer was washed sequentially with aqueous saturated ammonium chloride solution, water, and saturated brine, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel (<i>n</i>-hexane/EtOAc) to give <b>53a</b> (408 mg, 51%, 2 steps). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 1.25 (t, <i>J</i> = 7.2, 3H), 1.82–1.98 (m, 2H), 2.29 (t, <i>J</i> = 7.2 Hz, 2H), 2.36 (s, 3H), 2.68–2.81 (m, 4H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.15 (q, <i>J</i> = 7.2 Hz, 2H), 4.72–4.84 (m, 2H), 6.90 (t, <i>J</i> = 7.8 Hz, 1H), 7.28 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H), 7.43 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H).</div></div><div id="sec5_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Diethyl 3,3′-(7-Bromo-2-methyl-1<i>H</i>-indole-1,3-diyl)dipropanoate (<b>53b</b>)</h4><div class="NLM_p last">Compound <b>53b</b> was prepared from compound <b>51b</b> in a manner similar to that described for compound <b>53a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 2.38 (s, 3H), 2.49–2.60 (m, 2H), 2.67–2.81 (m, 2H), 2.95–3.06 (m, 2H), 4.09 (q, <i>J</i> = 7.2 Hz, 2H), 4.15 (q, <i>J</i> = 7.2 Hz, 2H), 4.71–4.83 (m, 2H), 6.90 (t, <i>J</i> = 7.8 Hz, 1H), 7.28 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.42 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H).</div></div><div id="sec5_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Ethyl 4-[7-Bromo-1-(3-ethoxy-3-oxopropyl)-2-methyl-1<i>H</i>-indol-3-yl]butanoate (<b>53c</b>)</h4><div class="NLM_p last">Compound <b>53c</b> was prepared from compound <b>51c</b> in a manner similar to that described for compound <b>53a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 1.82–1.98 (m, 2H), 2.29 (t, <i>J</i> = 7.2 Hz, 2H), 2.36 (s, 3H), 2.68–2.81 (m, 4H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.15 (q, <i>J</i> = 7.2 Hz, 2H), 4.72–4.84 (m, 2H), 6.90 (t, <i>J</i> = 7.8 Hz, 1H), 7.28 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H), 7.43 (dd, <i>J</i> = 7.8, 0.9 Hz, 1H).</div></div><div id="sec5_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Ethyl 3-{3-(2-Ethoxy-2-oxoethyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-1-yl}propanoate (<b>54a</b>)</h4><div class="NLM_p last">Compound <b>54a</b> was prepared from compound <b>53a</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.11 (t, <i>J</i> = 7.2 Hz, 3H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H), 2.39 (s, 3H), 2.77–2.89 (m, 2H), 3.70 (s, 2H), 3.99 (q, <i>J</i> = 7.2 Hz, 2H), 4.15 (q, <i>J</i> = 7.2 Hz, 2H), 4.74–4.89 (m, 2H), 5.65–5.77 (m, 1H), 6.60 (d, <i>J</i> = 8.6 Hz, 2H), 7.04 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.28–7.39 (m, 3H), 7.48 (dd, <i>J</i> = 7.8, 1.0 Hz, 1H).</div></div><div id="sec5_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Diethyl 3,3′-{7-[(4-Hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indole-1,3-diyl}dipropanoate (<b>54b</b>)</h4><div class="NLM_p last">Compound <b>54b</b> was prepared from compound <b>53b</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.12 (t, <i>J</i> = 7.2 Hz, 3H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 2.39 (s, 3H), 2.52–2.62 (m, 2H), 2.80–2.89 (m, 2H), 2.98–3.08 (m, 2H), 4.01 (q, <i>J</i> = 7.2 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.83–4.94 (m, 2H), 5.16 (s, 1H), 6.81 (d, <i>J</i> = 8.7 Hz, 2H), 7.04 (dd, <i>J</i> = 7.8, 7.4 Hz, 1H), 7.32 (dd, <i>J</i> = 7.4, 1.1 Hz, 1H), 7.42 (d, <i>J</i> = 8.7 Hz, 2H), 7.48 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H).</div></div><div id="sec5_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Ethyl 4-{1-(3-Ethoxy-3-oxopropyl)-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indol-3-yl}butanoate (<b>54c</b>)</h4><div class="NLM_p last">Compound <b>54c</b> was prepared from compound <b>53c</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.12 (t, <i>J</i> = 7.2 Hz, 3H), 1.24 (t, <i>J</i> = 7.2 Hz, 3H), 1.85–1.99 (m, 2H), 2.30 (t, <i>J</i> = 7.4 Hz, 2H), 2.36 (s, 3H), 2.74 (t, <i>J</i> = 7.4 Hz, 2H), 2.79–2.91 (m, 2H), 4.01 (q, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.82–4.94 (m, 2H), 5.08 (s, 1H), 6.80 (d, <i>J</i> = 8.8 Hz, 2H), 7.02 (t, <i>J</i> = 7.8 Hz, 1H), 7.31 (dd, <i>J</i> = 7.4, 1.1 Hz, 1H), 7.41 (d, <i>J</i> = 8.8 Hz, 2H), 7.47 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H).</div></div><div id="sec5_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 3-[3-(Carboxymethyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-1-yl]propanoic Acid (<b>20</b>)</h4><div class="NLM_p last">Compound <b>20</b> was prepared from compound <b>54a</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.56–1.85 (m, 4H), 2.31 (s, 3H), 2.37 (s, 3H), 2.63–2.80 (m, 4H), 3.60 (s, 2H), 4.04 (t, <i>J</i> = 6.1 Hz, 2H), 4.69–4.86 (m, 2H), 6.95 (d, <i>J</i> = 8.6 Hz, 2H), 7.00 (t, <i>J</i> = 7.7 Hz, 1H), 7.08–7.18 (m, 2H), 7.21–7.30 (m, 2H), 7.41–7.56 (m, 3H), 12.30 (brs, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 556 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>33</sub>H<sub>32</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 556.1891, found 556.1903. HPLC purity 95% (method B).</div></div><div id="sec5_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 3,3′-[7-({4-[4-(3-Chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indole-1,3-diyl]dipropanoic Acid (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> was prepared from compound <b>54b</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.56–1.86 (m, 4H), 2.30 (s, 3H), 2.36 (s, 3H), 2.41 (t, <i>J</i> = 7.5 Hz, 2H), 2.62–2.75 (m, 4H), 2.89 (t, <i>J</i> = 7.5 Hz, 2H), 4.03 (t, <i>J</i> = 6.1 Hz, 2H), 4.66–4.85 (m, 2H), 6.89–7.04 (m, 3H), 7.07–7.17 (m, 2H), 7.20–7.29 (m, 2H), 7.44–7.54 (m, 3H), 12.41 (brs, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 570 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>34</sub>H<sub>34</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 570.2047, found 570.2039. HPLC purity 98% (method B).</div></div><div id="sec5_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-[1-(2-Carboxyethyl)-7-({4-[4-(3-chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indol-3-yl]butanoic Acid (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> was prepared from compound <b>54c</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57–1.86 (m, 6H), 2.19 (t, <i>J</i> = 7.3 Hz, 2H), 2.30 (s, 3H), 2.35 (s, 3H), 2.59–2.77 (m, 6H), 4.04 (t, <i>J</i> = 6.4 Hz, 2H), 4.69–4.83 (m, 2H), 6.90–7.04 (m, 3H), 7.07–7.18 (m, 2H), 7.19–7.29 (m, 2H), 7.44–7.54 (m, 3H), 12.30 (brs, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.63, 15.49, 22.83, 25.78, 26.15, 28.26, 33.02, 33.10, 35.95, 67.33, 86.12, 91.73, 104.33, 110.85, 114.44, 114.73, 118.50, 118.61, 126.26, 126.63, 126.85, 127.85, 128.76, 132.55, 133.21, 133.26, 133.82, 134.04, 142.70, 158.73, 172.43, 174.49. MS (FAB, neg) <i>m</i>/<i>z</i> 584 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>35</sub>H<sub>36</sub>ClNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 584.2204, found 584.2200. HPLC purity 99% (method A).</div></div><div id="sec5_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Ethyl 4-(7-Bromo-4-fluoro-2-methyl-1<i>H</i>-indol-3-yl)butanoate (<b>57a</b>)</h4><div class="NLM_p last">Compound <b>57a</b> was prepared from compound <b>56a</b> in a manner similar to that described for compound <b>41b</b> (<a class="ref internalNav" href="#sec5_1_13_2" aria-label="procedure 2">procedure 2</a>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.2 Hz, 3H), 1.86–2.03 (m, 2H), 2.32 (t, <i>J</i> = 7.4 Hz, 2H), 2.38 (s, 3H), 2.78 (t, <i>J</i> = 7.4 Hz, 2H), 4.08 (q, <i>J</i> = 7.2 Hz, 2H), 6.63 (dd, <i>J</i> = 10.7, 8.4 Hz, 1H), 7.11 (dd, <i>J</i> = 8.4, 4.2 Hz, 1H), 7.96 (s, 1H).</div></div><div id="sec5_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Ethyl 4-(7-Bromo-5-fluoro-2-methyl-1<i>H</i>-indol-3-yl)butanoate (<b>57b</b>)</h4><div class="NLM_p last">Compound <b>57b</b> was prepared from compound <b>56b</b> in a manner similar to that described for compound <b>41b</b> (<a class="ref internalNav" href="#sec5_1_13_2" aria-label="procedure 2">procedure 2</a>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.24 (t, <i>J</i> = 7.2 Hz, 3H), 1.84–1.99 (m, 2H), 2.30 (t, <i>J</i> = 7.3 Hz, 2H), 2.39 (s, 3H), 2.67 (t, <i>J</i> = 7.4 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 7.05 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.11 (dd, <i>J</i> = 9.3, 2.2 Hz, 1H), 7.87 (s, 1H).</div></div><div id="sec5_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Ethyl 4-(7-Bromo-6-fluoro-2-methyl-1<i>H</i>-indol-3-yl)butanoate (<b>57c</b>)</h4><div class="NLM_p last">Compound <b>57c</b> was prepared from compound <b>56c</b> in a manner similar to that described for compound <b>41b</b> (<a class="ref internalNav" href="#sec5_1_13_2" aria-label="procedure 2">procedure 2</a>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 1.85–2.01 (m, 2H), 2.30 (t, <i>J</i> = 7.4 Hz, 2H), 2.38 (s, 3H), 2.70 (t, <i>J</i> = 7.4 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 6.89 (dd, <i>J</i> = 9.4, 8.5 Hz, 1H), 7.33 (dd, <i>J</i> = 8.5, 5.5 Hz, 1H), 7.90 (s, 1H).</div></div><div id="sec5_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Diethyl 4,4′-(7-Bromo-4-fluoro-2-methyl-1<i>H</i>-indole-1,3-diyl)dibutanoate (<b>58a</b>)</h4><div class="NLM_p last">Compound <b>58a</b> was prepared from compound <b>57a</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.21–1.29 (m, 6H), 1.81–2.11 (m, 4H), 2.31 (t, <i>J</i> = 7.2 Hz, 2H), 2.34 (s, 3H), 2.39 (t, <i>J</i> = 7.2 Hz, 2H), 2.81 (t, <i>J</i> = 7.2 Hz, 2H), 4.05–4.17 (m, 4H), 4.49 (t, <i>J</i> = 7.8 Hz, 2H), 6.56 (dd, <i>J</i> = 10.2 Hz, 8.4 Hz, 1H), 7.14 (dd, <i>J</i> = 8.4, 4.8 Hz, 1H).</div></div><div id="sec5_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Diethyl 4,4′-(7-Bromo-5-fluoro-2-methyl-1<i>H</i>-indole-1,3-diyl)dibutanoate (<b>58b</b>)</h4><div class="NLM_p last">Compound <b>58b</b> was prepared from compound <b>57b</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H), 1.79–1.95 (m, 2H), 1.96–2.10 (m, 2H), 2.29 (t, <i>J</i> = 7.4 Hz, 2H), 2.35 (s, 3H), 2.38 (t, <i>J</i> = 7.4 Hz, 2H), 2.68 (t, <i>J</i> = 7.4 Hz, 2H), 4.05–4.20 (m, 4H), 4.40–4.53 (m, 2H), 7.01–7.14 (m, 2H).</div></div><div id="sec5_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Diethyl 4,4′-(7-Bromo-6-fluoro-2-methyl-1<i>H</i>-indole-1,3-diyl)dibutanoate (<b>58c</b>)</h4><div class="NLM_p last">Compound <b>58c</b> was prepared from compound <b>57c</b> in a manner similar to that described for compound <b>42a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.18–1.33 (m, 6H), 1.81–1.95 (m, 2H), 1.97–2.11 (m, 2H), 2.29 (t, <i>J</i> = 7.3 Hz, 2H), 2.34 (s, 3H), 2.40 (t, <i>J</i> = 7.2 Hz, 2H), 2.70 (t, <i>J</i> = 7.5 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.13 (q, <i>J</i> = 7.2 Hz, 2H), 4.42–4.54 (m, 2H), 6.88 (dd, <i>J</i> = 9.2, 8.5 Hz, 1H), 7.32 (dd, <i>J</i> = 8.5, 5.1 Hz, 1H).</div></div><div id="sec5_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Diethyl 4,4′-{4-Fluoro-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indole-1,3-diyl}dibutanoate (<b>59a</b>)</h4><div class="NLM_p last">Compound <b>59a</b> was prepared from compound <b>58a</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.21 (t, <i>J</i> = 7.2 Hz, 3H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 1.82–1.99 (m, 2H), 2.05–2.21 (m, 2H), 2.21–2.38 (m, 7H), 2.81 (t, <i>J</i> = 7.2 Hz, 2H), 4.04–4.13 (m, 4H), 4.61 (t, <i>J</i> = 7.5 Hz, 2H), 5.43 (s, 1H), 6.66 (dd, <i>J</i> = 10.8, 8.4 Hz, 1H), 6.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.21 (dd, <i>J</i> = 8.1, 5.1 Hz, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 2H).</div></div><div id="sec5_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Diethyl 4,4′-{5-Fluoro-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indole-1,3-diyl}dibutanoate (<b>59b</b>)</h4><div class="NLM_p last">Compound <b>59b</b> was prepared from compound <b>58b</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (t, <i>J</i> = 7.2 Hz, 3H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 1.82–1.97 (m, 2H), 2.07–2.20 (m, 2H), 2.26–2.34 (m, 4H), 2.35 (s, 3H), 2.70 (t, <i>J</i> = 7.4 Hz, 2H), 4.08 (q, <i>J</i> = 7.2 Hz, 2H), 4.12 (q, <i>J</i> = 7.2 Hz, 2H), 4.52–4.64 (m, 2H), 5.22–5.32 (m, 1H), 6.84 (d, <i>J</i> = 8.8 Hz, 2H), 7.04 (dd, <i>J</i> = 9.7, 2.6 Hz, 1H), 7.13 (dd, <i>J</i> = 9.2, 2.6 Hz, 1H), 7.43 (d, <i>J</i> = 8.8 Hz, 2H).</div></div><div id="sec5_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Diethyl 4,4′-{6-Fluoro-7-[(4-hydroxyphenyl)ethynyl]-2-methyl-1<i>H</i>-indole-1,3-diyl}dibutanoate (<b>59c</b>)</h4><div class="NLM_p last">Compound <b>59c</b> was prepared from compound <b>58c</b> in a manner similar to that described for compound <b>43a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.15–1.33 (m, 6H), 1.82–1.99 (m, 2H), 2.06–2.22 (m, 2H), 2.23–2.40 (m, 7H), 2.72 (t, <i>J</i> = 7.4 Hz, 2H), 4.09 (q, <i>J</i> = 7.2 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.50–4.66 (m, 2H), 5.40 (s, 1H), 6.77–6.93 (m, 3H), 7.37 (dd, <i>J</i> = 8.6, 5.3 Hz, 1H), 7.45 (d, <i>J</i> = 8.8 Hz, 2H).</div></div><div id="sec5_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 4,4′-[7-({4-[4-(3-Chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-4-fluoro-2-methyl-1<i>H</i>-indole-1,3-diyl]dibutanoic Acid (<b>29</b>)</h4><div class="NLM_p last">Compound <b>29</b> was prepared from compound <b>59a</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57–1.84 (m, 6H), 1.86–2.03 (m, 2H), 2.12–2.23 (m, 4H), 2.30 (s, 3H), 2.32 (s, 3H), 2.65–2.79 (m, 4H), 4.05 (t, <i>J</i> = 6.3 Hz, 2H), 4.55 (t, <i>J</i> = 7.7 Hz, 2H), 6.76 (dd, <i>J</i> = 10.8, 8.2 Hz, 1H), 6.99 (d, <i>J</i> = 9.0 Hz, 2H), 7.07–7.30 (m, 4H), 7.48 (d, <i>J</i> = 9.0 Hz, 2H), 12.08 (brs, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.54, 15.49, 23.95, 26.14, 26.49, 28.25, 30.40, 32.83, 33.03, 42.70, 67.36, 85.49, 91.32, 101.31 (<i>J</i><sub>C–F</sub> = 3.3 Hz), 104.52 (<i>J</i><sub>C–F</sub> = 20.6 Hz), 109.2 (<i>J</i><sub>C–F</sub> = 3.3 Hz), 114.31, 114.93, 116.46 (<i>J</i><sub>C–F</sub> = 19.1 Hz), 126.63, 126.85, 127.05 (<i>J</i><sub>C–F</sub> = 8.3 Hz), 127.85, 132.42, 133.27, 133.83, 134.87, 136.13 (<i>J</i><sub>C–F</sub> = 12.9 Hz), 142.70, 155.98 (<i>J</i><sub>C–F</sub> = 246.8 Hz), 158.85, 173.62, 174.30. MS (FAB, neg) <i>m</i>/<i>z</i> 616 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>36</sub>H<sub>37</sub>ClFNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 616.2266, found 616.2272. HPLC purity 99% (method A).</div></div><div id="sec5_1_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 4,4′-[7-({4-[4-(3-Chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-5-fluoro-2-methyl-1<i>H</i>-indole-1,3-diyl]dibutanoic Acid (<b>30</b>)</h4><div class="NLM_p last">Compound <b>30</b> was prepared from compound <b>59b</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.58–1.85 (m, 6H), 1.86–2.01 (m, 2H), 2.11–2.24 (m, 4H), 2.30 (s, 3H), 2.33 (s, 3H), 2.59–2.76 (m, 4H), 4.05 (t, <i>J</i> = 6.2 Hz, 2H), 4.51 (t, <i>J</i> = 7.6 Hz, 2H), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 7.04 (dd, <i>J</i> = 9.9, 2.6 Hz, 1H), 7.08–7.18 (m, 2H), 7.25 (dd, <i>J</i> = 7.0, 2.4 Hz, 1H), 7.29 (dd, <i>J</i> = 9.3, 2.6 Hz, 1H), 7.50 (d, <i>J</i> = 8.8 Hz, 2H), 12.22 (s, 2 H). MS (FAB, neg) <i>m</i>/<i>z</i> 616 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>36</sub>H<sub>37</sub>ClFNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 616.2266, found 616.2272. HPLC purity 98% (method A).</div></div><div id="sec5_1_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 4,4′-[7-({4-[4-(3-Chloro-2-methylphenyl)butoxy]phenyl}ethynyl)-6-fluoro-2-methyl-1<i>H</i>-indole-1,3-diyl]dibutanoic Acid (<b>31</b>)</h4><div class="NLM_p last">Compound <b>31</b> was prepared from compound <b>59c</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57–1.85 (m, 6H), 1.88–2.01 (m, 2H), 2.14–2.25 (m, 4H), 2.30 (s, 3H), 2.31 (s, 3H), 2.59–2.76 (m, 4H), 4.05 (t, <i>J</i> = 6.2 Hz, 2H), 4.50 (t, <i>J</i> = 7.1 Hz, 2H), 6.94 (dd, <i>J</i> = 10.0, 8.7 Hz, 1H), 7.00 (d, <i>J</i> = 8.8 Hz, 2H), 7.07–7.19 (m, 2H), 7.26 (dd, <i>J</i> = 6.8, 2.2 Hz, 1H), 7.42–7.55 (m, 3H), 12.09 (s, 2H). MS (FAB, neg) <i>m</i>/<i>z</i> 616 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>36</sub>H<sub>37</sub>ClFNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 616.2266, found 616.2272. HPLC purity 98% (method A).</div></div><div id="sec5_1_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 4,4′-[2-Methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1<i>H</i>-indole-1,3-diyl]dibutanoic Acid (<b>32</b>)</h4><div class="NLM_p last">Compound <b>32</b> was prepared from compound <b>48f</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60–1.82 (m, 6 H) 1.86–2.03 (m, 2 H) 2.13–2.25 (m, 4 H) 2.34 (s, 3 H) 2.60–2.78 (m, 4 H) 4.02 (t, <i>J</i> = 5.8 Hz, 2 H) 4.54 (t, <i>J</i> = 7.1 Hz, 2 H) 6.91–7.04 (m, 3 H) 7.21 (d, <i>J</i> = 7.3 Hz, 1 H) 7.38–7.54 (m, 4 H) 12.07 (brs, 2 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.74, 21.43, 22.82, 25.23, 25.74, 26.60, 27.98, 30.47, 33.00, 42.56, 67.12, 86.39, 91.61, 101.33 (m), 104.34, 110.76, 114.49, 114.77, 114.91 (m), 118.40, 118.69, 126.21, 128.66, 132.41, 133.47, 134.08, 136.38 (m), 146.67 (m), 148.93 (m), 154.98, 158.74, 173.69, 174.37. MS (FAB, neg) <i>m</i>/<i>z</i> 622 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>35</sub>H<sub>33</sub>F<sub>4</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 622.2217, found 622.2215. HPLC purity 98% (method A).</div></div><div id="sec5_1_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 4,4′-[4-Fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1<i>H</i>-indole-1,3-diyl]dibutanoic Acid (<b>33</b>)</h4><div class="NLM_p last">Compound <b>33</b> was prepared from compound <b>59a</b> in a manner similar to that described for compound <b>16</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57–1.83 (m, 6H), 1.86–2.03 (m, 2H), 2.12–2.24 (m, 4H), 2.32 (s, 3H), 2.60–2.78 (m, 4H), 3.99 (t, <i>J</i> = 5.8 Hz, 2H), 4.53 (t, <i>J</i> = 7.3 Hz, 2H), 6.73 (dd, <i>J</i> = 10.7, 8.3 Hz, 1H), 6.94 (d, <i>J</i> = 8.8 Hz, 2H), 7.18 (dd, <i>J</i> = 8.3, 5.1 Hz, 1H), 7.34–7.49 (m, 1H), 7.45 (d, <i>J</i> = 8.8 Hz, 2H), 12.07 (s, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.68, 21.54, 24.08, 25.35, 26.59, 28.08, 30.48, 32.98, 42.74, 67.04, 85.38, 91.11, 101.09 (m), 101.13, 104.42 (d, <i>J</i><sub>C–F</sub> = 20.3 Hz), 108.80 (d, <i>J</i><sub>C–F</sub> = 3.0 Hz), 114.13, 114.61, 114.50 (m), 116.21 (d, <i>J</i><sub>C–F</sub> = 19.5 Hz), 126.75 (d, <i>J</i><sub>C–F</sub> = 8.3 Hz), 132.09, 134.53, 135.88 (d, <i>J</i><sub>C–F</sub> = 8.3 Hz), 136.12 (m), 147.81 (m), 148.59 (m), 154.59 (m), 155.60 (m), 158.35, 173.20, 173.88. MS (FAB, neg) <i>m</i>/<i>z</i> 640 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>35</sub>H<sub>32</sub>F<sub>5</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 640.2122, found 640.2101. HPLC purity 99% (method A). Elemental analysis calculated (%) for C<sub>35</sub>H<sub>32</sub>F<sub>5</sub>NO<sub>5</sub>: C 65.52, H 5.03, N 2.18. Found: C 65.42, H 5.19, N 2.03.</div></div><div id="sec5_1_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> 4,4′-[7-({4-[4-(3-Fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indole-1,3-diyl]dibutanoic Acid (<b>34</b>)</h4><div class="NLM_p last">Compound <b>34</b> was prepared from compound <b>48f</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59–1.85 (m, 6H), 1.88–2.02 (m, 2H), 2.13–2.24 (m, 7H), 2.33 (s, 3H), 2.67 (t, <i>J</i> = 7.4 Hz, 4H), 4.05 (t, <i>J</i> = 6.3 Hz, 2H), 4.54 (t, <i>J</i> = 7.4 Hz, 2H), 6.91–7.03 (m, 5H), 7.08–7.17 (m, 1 H), 7.21 (d, <i>J</i> = 6.6 Hz, 1H), 7.43–7.52 (m, 3H), 12.07 (brs, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82, 11.08, 23.85, 26.78, 27.11, 27.64, 29.29, 31.47, 32.96, 33.98, 43.52, 68.19, 87.19, 92.39, 105.07, 111.44, 113.00 (d, <i>J</i><sub>C–F</sub> = 22.5 Hz), 115.12, 115.56, 119.23 (d, <i>J</i><sub>C–F</sub> = 21.8 Hz), 122.92 (d, <i>J</i><sub>C–F</sub> = 14.4 Hz), 125.22 (d, <i>J</i><sub>C–F</sub> = 3.0 Hz), 126.85, 127.30 (d, <i>J</i><sub>C–F</sub> = 9.0 Hz), 129.29, 133.03, 134.06, 134.68, 143.60 (d, <i>J</i><sub>C–F</sub> = 3.8 Hz), 159.33, 159.61, 162.79, 174.21, 174.89. MS (FAB, neg) <i>m</i>/<i>z</i> 582 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>36</sub>H<sub>38</sub>FNO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 582.2656, found 582.2661. HPLC purity >99% (method A).</div></div><div id="sec5_1_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 4,4′-[4-Fluoro-7-(2-{4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1<i>H</i>-indole-1,3-diyl]dibutanoic Acid (<b>35</b>: Gemilukast, ONO-6950)</h4><div class="NLM_p last">Compound <b>35</b> was prepared from compound <b>59a</b> in a manner similar to that described for compound <b>17</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.64–1.71 (m, 2H), 1.74–1.83 (m, 4H), 1.93–2.00 (m 2H), 2.17–2.23 (m, 7H), 2.35 (s, 3H), 2.69 (t, <i>J</i> = 7.5 Hz, 2H), 2.75 (t, <i>J</i> = 7.5 Hz, 2H), 4.07 (t, <i>J</i> = 6.0 Hz, 2H), 4.57 (t, <i>J</i> = 7.5 Hz, 2H), 6.78 (dd, <i>J</i> = 10.5, 8.5 Hz, 1H), 6.96–7.04 (m, 4H), 7.12–7.18 (m, 1H), 7.22 (dd, <i>J</i> = 8.5, 5.0 Hz, 1H), 7.50 (d, <i>J</i> = 9.0 Hz, 2H), 12.09 (brs, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.58, 10.02 (<i>J</i><sub>C–F</sub> = 5.5 Hz), 24.98, 26.13, 26.52, 28.30, 30.42, 31.98 (<i>J</i><sub>C–F</sub> = 2.8 Hz), 32.84, 42.74, 67.39, 85.52, 91.34, 101.32 (<i>J</i><sub>C–F</sub> = 3.8 Hz), 104.56 (<i>J</i><sub>C–F</sub> = 21 Hz), 109.02, 112.37 (<i>J</i><sub>C–F</sub> = 23 Hz), 114.31, 114.95 116.56 (<i>J</i><sub>C–F</sub> = 20 Hz), 122.30 (<i>J</i><sub>C–F</sub> = 16 Hz), 124.65 (<i>J</i><sub>C–F</sub> = 2.8 Hz), 126.72 (<i>J</i><sub>C–F</sub> = 9.1 Hz), 127.08 (<i>J</i><sub>C–F</sub> = 7.8 Hz), 132.47, 134.96 (<i>J</i><sub>C–F</sub> = 0.9 Hz), 136.14 (<i>J</i><sub>C–F</sub> = 13 Hz), 143.08 (<i>J</i><sub>C–F</sub> = 4.1 Hz), 156.00 (<i>J</i><sub>C–F</sub> = 246 Hz), 158.88, 160.72 (<i>J</i><sub>C–F</sub> = 240 Hz), 173.69, 174.37. MS (FAB, neg) <i>m</i>/<i>z</i> 600 (M – H)<sup>−</sup>. HRMS (FAB, neg) C<sub>36</sub>H<sub>37</sub>F<sub>2</sub>NO<sub>5</sub> (M – H)<sup>−</sup> calcd mass 600.2562, found 600.2562. HPLC purity >99% (method A). Elemental analysis calculated (%) for C<sub>36</sub>H<sub>37</sub>F<sub>2</sub>NO<sub>5</sub>: C 71.86, H 6.20, N 2.33. Found: C 71.88, H 6.19, N 2.25.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> In Vitro Assay</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Method 1</h4><div class="NLM_p last">Calcium mobilization assay with compounds <b>1</b>–<b>32</b>: The intracellular calcium mobilization response was measured using the fluorescent Ca<sup>2+</sup> indicator dye Fura 2-AM (Dojindo). CHO-K1 cells stably expressing human CysLT<sub>1</sub>, guinea pig CysLT<sub>1</sub>, or guinea pig CysLT<sub>2</sub> receptors, and the HEK293 cells stably expressing human CysLT<sub>2</sub> receptor were used. Before the assay was performed, these cells were incubated at 37 °C in 5% CO<sub>2</sub> for at least 24 h with the following culture conditions: cells expressing human CysLT<sub>1</sub> receptor (4 × 10<sup>4</sup> cells/well) were cultured with Ham’s F-12 supplemented with 10% vol fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin, and 600 μg/mL Geneticin. cells expressing human CysLT<sub>2</sub> receptor (10 × 10<sup>4</sup> cells/well) were cultured with Dulbecco’s Modified Eagle’s Medium supplemented with 10% vol fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin, and 400 μg/mL geneticin. Cells expressing guinea pig CysLT<sub>1</sub> or CysLT<sub>2</sub> receptors (3 × 10<sup>4</sup> cells/well) were cultured with Ham’s F-12K supplemented with 10% vol fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin, and 500 μg/mL geneticin. After removing the culture medium, loading medium containing 7.5 μM Fura 2-AM, 20 mmol/L HEPES, and 2.5 mmol/L probenecid was added to each well. After a 1 h incubation, loading medium was removed and the cells were incubated at room temperature for 1 h in the assay buffer (Hank’s Balanced Salt Solution containing 20 mM HEPES). The cells were alternately irradiated at two excitation wavelengths (340 and 380 nm) using FDSS-2000 (Hamamatsu Photonics Co., Ltd., Shizuoka, Japan) to measure the ratio of fluorescence intensities (f340/f380) at 500 nm. To evaluate the antagonism of the compounds, they were added 30 min before the addition of the ligand: 100, 100, 10, or 100 nM LTD<sub>4</sub> for human CysLT<sub>1</sub>, human CysLT<sub>2</sub>, guinea pig CysLT<sub>1</sub> or guinea pig CysLT<sub>2</sub> receptors, respectively.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Method 2</h4><div class="NLM_p last">Calcium mobilization assay of compound <b>35</b> (gemilukast): The intracellular calcium response was measured using Fura 2-AM (Dojindo). Briefly, CHO-K1 cells stably expressing human or guinea pig CysLT<sub>1</sub> or CysLT<sub>2</sub> receptors were cultured for at least 24 h (3 × 10<sup>4</sup> cells/well). After removing the culture medium (Ham’s F-12 supplemented with 10% fetal bovine serum and 500 μg/mL geneticin), loading medium containing 5 μM Fura 2-AM was added to each well. After a 1 h incubation, the loading medium was removed and the cells were incubated at room temperature for 1 h in the assay buffer (Hanks’ Balanced Salt Solution containing 20 mM HEPES). The cells were alternately irradiated at two excitation wavelengths (340 and 380 nm) using FDSS-3000 (Hamamatsu Photonics Co., Ltd., Shizuoka, Japan) to measure the ratio of fluorescence intensities (f340/f380) at 500 nm. To evaluate the antagonism of the compounds, they were added 30 min before the addition of the ligand: 100 nM LTD<sub>4</sub> for human CysLT<sub>1</sub> receptor, 0.3 nM LTD<sub>4</sub> for human CysLT<sub>2</sub> receptor, 10 nM LTD<sub>4</sub> for guinea pig CysLT<sub>1</sub> receptor, or 3 nM LTC<sub>4</sub> for guinea pig CysLT<sub>2</sub> receptor.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> Parallel Artificial Membrane Permeability Assay (PAMPA)</h3><div class="NLM_p last">The PAMPA System (Pion) was used. The System Solution Concentrate (Pion) was diluted with water, and DMSO was added to prepare a system solution (in 5% DMSO). NaOH at 0.5 mol/L was added using an automated buffer preparation system to make three different buffers with pH values of 5.0, 6.2, and 7.4. A volume of 150 μL of each buffer was added per well in a UV plate to serve as blanks for UV absorption (190–498 nm). Next, 5 μL of DMSO solution containing the test compounds at 10 mM was added to 1000 μL of the system solution, and this was filtered by suction through a 96-well filter plate (0.2 μm PVDF hydrophilic membrane, Corning) (final compound concentration of 50 μM). A volume of 150 μL of the filtrate was added per well in the UV plate to serve as the reference for UV absorption (190–498 nm). Then, 200 μL of the remaining filtrate was added per well in the donor plate and used as the donor solution. A membrane was prepared by dropping 4 μL of oil (GIT-0 Liquid, Pion) onto the filter of the acceptor plate. A 200 μL aliquot of the acceptor solution (Acceptor Sink Buffer, pH 7.4, Pion) was added to each well in the acceptor plate. The acceptor plate was placed on the donor plate. After a 4 h incubation, 150 μL aliquots were transferred from the donor and acceptor solutions to the UV plate to measure UV absorption (190–498 nm). The membrane permeability coefficient was calculated from the observed values obtained using the PAMPA Evolution Command software.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> Pharmacokinetic Analysis in Rat, Guinea Pig, and Dog</h3><div class="NLM_p last">The pharmacokinetics of compounds were studied following single intravenous and oral administration. The iv and po solution formulations contained wellsolve/H<sub>2</sub>O = 1/9 (Celeste) and sodium hydroxide (2 equiv). All iv and po formulations were given as solutions. Animals were fasted prior to oral dosing in single-dose studies. Oral bioavailability was estimated using noncrossover study designs for the rat, guinea pig, and dog (<i>n</i> = 3). Plasma samples were assayed for compounds using protein precipitation by acetonitrile/ethanol (70/30, v/v), followed by HPLC/MS/MS analysis employing negative-ion Turbo IonSpray ionization. Plasma concentration–time data were analyzed by noncompartmental methods.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> Pharmacokinetic Analysis in Guinea Pig Cassette Dosing</h3><div class="NLM_p last">The pharmacokinetics of compounds were studied following single intravenous and oral administration. The iv and po solution formulations contained wellsolve/H<sub>2</sub>O = 5/95 (Celeste) and sodium hydroxide (1.2 equiv). All iv and po formulations were given as cassette dosing solutions containing five compounds. Animals were fasted prior to oral dosing in single-dose studies. Oral bioavailability was estimated using noncrossover study designs for the guinea pig (<i>n</i> = 3). Plasma samples were assayed for compounds using protein precipitation by acetonitrile/ethanol (70/30, v/v), followed by HPLC/MS/MS analysis employing negative-ion Turbo IonSpray ionization. Plasma concentration–time data were analyzed by noncompartmental methods.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> Measurement of the Concentration in Lung</h3><div class="NLM_p last">The isolated lungs were homogenized in saline. The resulting lung homogenate (0.5 mL) was incubated in 2 mol/L NaOH (0.5 mL) at 60 °C for 3 h, and then diluted 50-fold with PBS. The amount of protein in the sample was spectrophotometrically determined using the BCA Protein Assay Kit (Thermo Scientific). Meanwhile, the amount of compound was measured by HPLC/MS/MS analysis employing negative-ion Turbo InoSpray ionization after protein precipitation with ethanol. The concentrations of compounds in lung tissues were expressed in ng/g protein.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> In Vitro Hepatocyte Metabolic Stability</h3><div class="NLM_p last">The metabolic stability of test compounds (1 μM test concentration) was determined in human cryopreserved hepatocytes (Celsis In Vitro Technologies, Baltimore, USA, pooled donors). Incubations (final incubation volume = 800 μL) were performed at 37 °C under an atmosphere of 95%/5% CO<sub>2</sub>/O<sub>2</sub> using 1 million cells mL<sup>–1</sup> in hepatocyte incubation media (In Vitro Technologies, Baltimore, MD, USA). Then, 150 μL aliquots (cells and media) were taken at zero, 0.5, 1, and 2 h after the start of the incubation and quenched using 300 μL of acetonitrile/ethanol (7/3). The resulting samples were centrifuged at 3000<i>g</i> for 10 min. An aliquot (10 μL) of the supernatant was directly injected onto the LC–MS/MS for analysis. All incubations were performed in duplicate.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> Effects of Compounds on LTD<sub>4</sub> and LTC<sub>4</sub>-Induced Bronchoconstriction in Guinea Pigs</h3><div class="NLM_p last">Ventilation pressure was measured using the method of Konzett and Rössler. Briefly, guinea pigs were anesthetized with intraperitoneal pentobarbital sodium (75 mg/kg). A polyethylene cannula was inserted into the trachea. The other end of the cannula was connected to a volume-limited ventilator (model SN-480-7, Shinano Manufacturing Co., Ltd., Tokyo, Japan), and artificial ventilation was provided at a supply rate of 5 mL/stroke and 70 strokes/min. Another catheter was inserted into the jugular vein, securing the route for administration. The ventilation pressure was measured via a pneumotachometer (M·I·P·S Co., Ltd., Osaka, Japan) connected to a lateral port of the tracheal cannula, using a Win-PULMOS-III system (version 3.6, M·I·P·S Co., Ltd., Osaka, Japan). After the basal ventilation pressure was confirmed to be stabilized, LTD<sub>4</sub> (0.25 μg/kg) or LTC<sub>4</sub> (15 μg/kg) was intravenously administered via the catheter secured in the jugular vein. In the experiment in which LTC<sub>4</sub>-induced bronchoconstriction was examined, <i>S</i>-hexyl GSH (30 mg/kg) was intravenously administered 10 s prior to LTC<sub>4</sub> (15 μg/kg) injection. The ventilation pressure was measured for at least 10 min after LTD<sub>4</sub> or 30 min after LTC<sub>4</sub> injection, and then the trachea was completely blocked to obtain the maximum ventilation pressure. After measurement of the maximum ventilation pressure, artificial ventilation was stopped and the animal was euthanized. The area under the percentage bronchoconstriction curve (AUC) from 0 to 10 min after LTD<sub>4</sub> injection or from 0 to 30 min after LTC<sub>4</sub> injection was calculated.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> Antigen-Induced Contraction in Isolated Human Bronchial Strips</h3><div class="NLM_p last">As described in the previous report,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> bronchi (outer diameter 2–6 mm) were isolated from macroscopic normal portions of the lung tissue and cut into 1.5 mm wide spirals. In the experiments to evaluate of the effects of CysLT antagonists on antigen-induced contraction, the bronchi were passively sensitized by incubation in human atopic serum for 2 h at 37 °C. Bronchial strips (2 cm long, outer diameter 2–4 mm) were then cut and suspended under an isotonic resting tension of 300 mg at 37 °C in a Magnus bath containing Tyrode’s solution gassed with 95% O<sub>2</sub>–5% CO<sub>2</sub>. Before starting the experiments, acetylcholine (5 μM) and then histamine (10 μM) were repeatedly applied to the preparations until almost equal contractions were obtained. When the resting tonus of the histamine-treated smooth muscle stabilized, guinea pig serum albumin at a final concentration of 0.1 mg/mL was added to prevent adsorption of ONO-6950 and montelukast to the inner wall of the Magnus bath. Immediately after the addition of guinea pig serum albumin, ONO-6950 (100 nM), BayCysLT<sub>2</sub>RA (10 nM), montelukast (10 nM), or DMSO (final concentration: 0.1%) were applied, and 30–35 min after the addition, antigen challenge (mite extract from <i>Dermatophagoides farinae</i>, 3 μg/mL) was performed. As previously reported,<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> a cyclooxygenase inhibitor, indomethacin (3 μM), and an antihistamine drug, pyrilamine (1 μM), were applied 10 and 5 min, respectively, before antigen challenge. Data were expressed as the % of 10 μM histamine-induced contraction. Each compound was added at 30 min before the antigen challenge.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i128"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00741">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This information includes the experimental details for data collection, data reduction, and refinement statistics of the X-ray crystallography of <b>35</b> (PDF). Molecular formula strings (XLSX). The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00741" class="ext-link">10.1021/acs.jmedchem.5b00741</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00741/suppl_file/jm5b00741_si_001.pdf">jm5b00741_si_001.pdf (141.73 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00741/suppl_file/jm5b00741_si_002.xlsx">jm5b00741_si_002.xlsx (11.92 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00741" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoshi Itadani</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dbb2afbabfbab5b29bb4b5b4f5b8b4f5b1ab"><span class="__cf_email__" data-cfemail="660f12070207080f26090809480509480c16">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuyuki Ohmoto</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3d56135255505249527d525352135e5213574d"><span class="__cf_email__" data-cfemail="5c37723334313328331c333233723f3372362c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kentaro Yashiro</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshiyuki Aratani</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tetsuya Sekiguchi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atsushi Kinoshita</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hideki Moriguchi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nobukazu Ohta</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shinya Takahashi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akiharu Ishida</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yohei Tajima</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katsuya Hisaichi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masaki Ima</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junya Ueda</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiromu Egashira</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomohiko Sekioka</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michiaki Kadode</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuo Yonetomi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takafumi Nakao</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atsuto Inoue</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroaki Nomura</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tetsuya Kitamine</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manabu Fujita</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takeshi Nabe</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshiyuki Yamaura</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoya Matsumura</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akira Imagawa</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshisuke Nakayama</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Takeuchi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry Research Laboratories, ‡Department of Biology & Pharmacology and §Pharmaceutical
Technology Laboratories, Ono Pharmaceutical
Co., Ltd. 3-1-1 Sakurai,
Shimamoto, Mishima, Osaka 618-8585, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge, Hirakata, Osaka 573-0101, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Kyoto Pharmaceutical University, 5 Nakauchi Misasagi, Yamashina, Kyoto 607-8414, Japan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d868e8904-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i129">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Ms. Tomoko Hirota for the LC/MS and HPLC measurement and Dr. Rie Omi for X-ray crystallographic analysis.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i130" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i130"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i131" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i131"> Abbreviations Used</h2><tr><td class="NLM_term">CysLTs</td><td class="NLM_def"><p class="first last">cysteinyl leukotrienes</p></td></tr><tr><td class="NLM_term">hCysLT<sub>1</sub></td><td class="NLM_def"><p class="first last">human CysLT<sub>1</sub></p></td></tr><tr><td class="NLM_term">hCysLT<sub>2</sub></td><td class="NLM_def"><p class="first last">human CysLT2</p></td></tr><tr><td class="NLM_term">gCysLT1</td><td class="NLM_def"><p class="first last">guinea pig CysLT1</p></td></tr><tr><td class="NLM_term">gCysLT2</td><td class="NLM_def"><p class="first last">guinea pig CysLT2</p></td></tr><tr><td class="NLM_term">LTC<sub>4</sub></td><td class="NLM_def"><p class="first last">leukotriene C4</p></td></tr><tr><td class="NLM_term">LTD4</td><td class="NLM_def"><p class="first last">leukotriene D<sub>4</sub></p></td></tr><tr><td class="NLM_term">LTE<sub>4</sub></td><td class="NLM_def"><p class="first last">leukotriene E<sub>4</sub></p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i132">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1126/science.6301011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1126%2Fscience.6301011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=1983&pages=568-575&author=B.+Samuelsson&title=Leukotrienes%3A+Mediators+of+immediate+hypersensitivity+reactions+and+inflammation&doi=10.1126%2Fscience.6301011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.6301011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6301011%26sid%3Dliteratum%253Aachs%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DLeukotrienes%253A%2520Mediators%2520of%2520immediate%2520hypersensitivity%2520reactions%2520and%2520inflammation%26jtitle%3DScience%26date%3D1983%26volume%3D220%26spage%3D568%26epage%3D575%26doi%3D10.1126%2Fscience.6301011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Cysteinyl leukotriene receptors</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">68–69</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span><span class="refDoi"> DOI: 10.1016/S0090-6980(02)00057-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2FS0090-6980%2802%2900057-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=12432945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvV2nurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68%E2%80%9369&publication_year=2002&pages=587-597&author=J.+F.+Evans&title=Cysteinyl+leukotriene+receptors&doi=10.1016%2FS0090-6980%2802%2900057-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteinyl leukotriene receptors</span></div><div class="casAuthors">Evans, Jilly F.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">68-69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">587-597</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The cysteinyl leukotrienes, leukotriene C4 (LTC4), LTD4, and LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways.  Pharmacol. characterizations identified at least 2 subtypes of cysteinyl leukotriene (CysLT) receptor based on agonist and antagonist potency for biol. responses.  The rank potency of agonist activation for the CysLT1 receptor is LTD4>LTC4>LTE4 and for the CysLT2 receptor is LTC4=LTD4>LTE4.  CysLT1 selective receptor antagonists are efficacious in the treatment of asthma.  No selective CysLT2 receptor antagonists have been described.  Mol. identification of the human and mouse CysLT1 and CysLT2 receptors has confirmed their structure as putative seven transmembrane domain G protein-coupled receptors and largely confirmed the previous pharmacol. characterizations.  The CysLT1 receptor is most highly expressed in spleen, peripheral blood leukocytes including eosinophils, and lung smooth muscle cells and interstitial lung macrophages.  The CysLT2 receptor is most highly expressed in the heart, adrenal medulla, placenta, and peripheral blood leukocytes.  The mol. identification of the mouse CysLT1 and CysLT2 receptors show similar but not identical profiles to the orthologous human receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp919NPGvLxbVg90H21EOLACvtfcHk0libRbowxYhkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvV2nurY%253D&md5=1fb88bf13253e95ee671387e4cb515b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0090-6980%2802%2900057-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-6980%252802%252900057-6%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCysteinyl%2520leukotriene%2520receptors%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2002%26volume%3D68%25E2%2580%259369%26spage%3D587%26epage%3D597%26doi%3D10.1016%2FS0090-6980%2802%2900057-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bäck, M.</span><span> </span><span class="NLM_article-title">Functional characteristics of cysteinyl-leukotriene receptor subtypes</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.1016/S0024-3205(02)01733-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2FS0024-3205%2802%2901733-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=611-622&author=M.+B%C3%A4ck&title=Functional+characteristics+of+cysteinyl-leukotriene+receptor+subtypes&doi=10.1016%2FS0024-3205%2802%2901733-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2802%2901733-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252802%252901733-2%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ck%26aufirst%3DM.%26atitle%3DFunctional%2520characteristics%2520of%2520cysteinyl-leukotriene%2520receptor%2520subtypes%26jtitle%3DLife%2520Sci.%26date%3D2002%26volume%3D71%26spage%3D611%26epage%3D622%26doi%3D10.1016%2FS0024-3205%2802%2901733-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Capra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovati, G. E.</span><span> </span><span class="NLM_article-title">Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1002/med.20071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1002%2Fmed.20071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=16894531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1GjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=469-527&author=V.+Capraauthor=M.+D.+Thompsonauthor=A.+Salaauthor=D.+E.+Coleauthor=G.+Folcoauthor=G.+E.+Rovati&title=Cysteinyl-leukotrienes+and+their+receptors+in+asthma+and+other+inflammatory+diseases%3A+Critical+update+and+emerging+trends&doi=10.1002%2Fmed.20071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends</span></div><div class="casAuthors">Capra, Valerie; Thompson, Miles D.; Sala, Angelo; Cole, David E.; Folco, Giancarlo; Rovati, G. Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-527</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cysteinyl-leukotrienes (cysteinyl-LTs), i.e., LTC4, LTD4, and LTE4, trigger contractile and inflammatory responses through the specific interaction with G protein-coupled receptors (GPCRs) belonging to the purine receptor cluster of the rhodopsin family, and identified as CysLT receptors (CysLTRs).  Cysteinyl-LTs have a clear role in pathophysiol. conditions such as asthma and allergic rhinitis (AR), and have been implicated in other inflammatory conditions including cardiovascular diseases, cancer, atopic dermatitis, and urticaria.  Mol. cloning of human CysLT1R and CysLT2R subtypes has confirmed most of the previous pharmacol. characterization and identified distinct expression patterns only partially overlapping.  Interestingly, recent data provide evidence for the immunomodulation of CysLTR expression, the existence of addnl. receptor subtypes, and of an intracellular pool of CysLTRs that may have roles different from those of plasma membrane receptors.  Furthermore, genetic variants have been identified for the CysLTRs that may interact to confer risk for atopy.  Finally, a crosstalk between the cysteinyl-LT and the purine systems is being delineated.  This review will summarize and attempt to integrate recent data derived from studies on the mol. pharmacol. and pharmacogenetics of CysLTRs, and will consider the therapeutic opportunities arising from the new roles suggested for cysteinyl-LTs and their receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnK6rg8Ia-obVg90H21EOLACvtfcHk0lgYi_J1fr_D9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1GjsL8%253D&md5=2d39d3847f0b3eb465df75c012f78ea2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmed.20071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20071%26sid%3Dliteratum%253Aachs%26aulast%3DCapra%26aufirst%3DV.%26aulast%3DThompson%26aufirst%3DM.%2BD.%26aulast%3DSala%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DD.%2BE.%26aulast%3DFolco%26aufirst%3DG.%26aulast%3DRovati%26aufirst%3DG.%2BE.%26atitle%3DCysteinyl-leukotrienes%2520and%2520their%2520receptors%2520in%2520asthma%2520and%2520other%2520inflammatory%2520diseases%253A%2520Critical%2520update%2520and%2520emerging%2520trends%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2007%26volume%3D27%26spage%3D469%26epage%3D527%26doi%3D10.1002%2Fmed.20071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chateauneuf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooks, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosfield, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caskey, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of the human cysteinyl leukotriene CysLT<sub>1</sub> receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span><span class="refDoi"> DOI: 10.1038/21658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1038%2F21658" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=789-793&author=K.+R.+Lynchauthor=G.+P.+O%27Neillauthor=Q.+Liuauthor=D.+S.+Imauthor=N.+Sawyerauthor=K.+M.+Mettersauthor=N.+Coulombeauthor=M.+Abramovitzauthor=D.+J.+Figueroaauthor=Z.+Zengauthor=B.+M.+Connollyauthor=C.+Baiauthor=C.+P.+Austinauthor=A.+Chateauneufauthor=R.+Stoccoauthor=G.+M.+Greigauthor=S.+Kargmanauthor=S.+B.+Hooksauthor=E.+Hosfieldauthor=D.+L.+Williamsauthor=A.+W.+Ford-Hutchinsonauthor=C.+T.+Caskeyauthor=J.+F.+Evans&title=Characterization+of+the+human+cysteinyl+leukotriene+CysLT1+receptor&doi=10.1038%2F21658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F21658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F21658%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DO%2527Neill%26aufirst%3DG.%2BP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DIm%26aufirst%3DD.%2BS.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DCoulombe%26aufirst%3DN.%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DConnolly%26aufirst%3DB.%2BM.%26aulast%3DBai%26aufirst%3DC.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DChateauneuf%26aufirst%3DA.%26aulast%3DStocco%26aufirst%3DR.%26aulast%3DGreig%26aufirst%3DG.%2BM.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DHooks%26aufirst%3DS.%2BB.%26aulast%3DHosfield%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520human%2520cysteinyl%2520leukotriene%2520CysLT1%2520receptor%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D789%26epage%3D793%26doi%3D10.1038%2F21658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Dowd, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellefeuille, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of the human cysteinyl leukotriene 2 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">30531</span><span class="NLM_x">–</span> <span class="NLM_lpage">30536</span><span class="refDoi"> DOI: 10.1074/jbc.M003490200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1074%2Fjbc.M003490200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10851239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1agt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30531-30536&author=C.+E.+Heiseauthor=B.+F.+O%27Dowdauthor=D.+J.+Figueroaauthor=N.+Sawyerauthor=T.+Nguyenauthor=D.-S.+Imauthor=R.+Stoccoauthor=J.+N.+Bellefeuilleauthor=M.+Abramovitzauthor=R.+Chengauthor=D.+L.+Williamsauthor=Z.+Zengauthor=Q.+Liuauthor=L.+Maauthor=M.+K.+Clementsauthor=N.+Coulombeauthor=Y.+Liuauthor=C.+P.+Austinauthor=S.+R.+Georgeauthor=G.+P.+O%27Neillauthor=K.+M.+Mettersauthor=K.+R.+Lynchauthor=J.+F.+Evans&title=Characterization+of+the+human+cysteinyl+leukotriene+2+receptor&doi=10.1074%2Fjbc.M003490200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human cysteinyl leukotriene 2 receptor</span></div><div class="casAuthors">Heise, Christopher E.; O'Dowd, Brian F.; Figueroa, David J.; Sawyer, Nicole; Nguyen, Tuan; Im, Dong-Soon; Stocco, Rino; Bellefeuille, Julie N.; Abramovitz, Mark; Cheng, Regina; Williams, David L., Jr.; Zeng, Zhizhen; Liu, Qingyun; Ma, Lei; Clements, Michelle K.; Coulombe, Nathalie; Liu, Yuan; Austin, Christopher P.; George, Susan R.; O'Neill, Gary P.; Metters, Kathleen M.; Lynch, Kevin R.; Evans, Jilly F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">30531-30536</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The contractile and inflammatory actions of the cysteinyl leukotrienes (CysLTs), LTC4, LTD4, and LTE4, are thought to be mediated through at least two distinct but related CysLT G protein-coupled receptors.  The human CysLT1 receptor has been recently cloned and characterized.  We describe here the cloning and characterization of the second cysteinyl leukotriene receptor, CysLT2, a 346-amino acid protein with 38% amino acid identity to the CysLT1 receptor.  The recombinant human CysLT2 receptor was expressed in Xenopus oocytes and HEK293T cells and shown to couple to elevation of intracellular calcium when activated by LTC4, LTD4, or LTE4.  Analyses of radiolabeled LTD4 binding to the recombinant CysLT2 receptor demonstrated high affinity binding and a rank order of potency for competition of LTC4 = LTD4 » LTE4.  In contrast to the dual CysLT1/CysLT2 antagonist, BAY u9773, the CysLT1 receptor-selective antagonists MK-571, montelukast, zafirlukast, and pranlukast exhibited low potency in competition for LTD4 binding and as antagonists of CysLT2 receptor signaling.  CysLT2 receptor mRNA was detected in lung macrophages and airway smooth muscle, cardiac Purkinje cells, adrenal medulla cells, peripheral blood leukocytes, and brain, and the receptor gene was mapped to chromosome 13q14, a region linked to atopic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNARzHAjs1wLVg90H21EOLACvtfcHk0lhPd6HPKPu8Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1agt74%253D&md5=a3c128d90e193664c2180e3029d8b96d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003490200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003490200%26sid%3Dliteratum%253Aachs%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DO%2527Dowd%26aufirst%3DB.%2BF.%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DIm%26aufirst%3DD.-S.%26aulast%3DStocco%26aufirst%3DR.%26aulast%3DBellefeuille%26aufirst%3DJ.%2BN.%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DCoulombe%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DO%2527Neill%26aufirst%3DG.%2BP.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520human%2520cysteinyl%2520leukotriene%25202%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D30531%26epage%3D30536%26doi%3D10.1074%2Fjbc.M003490200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Asano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukunaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span> </span><span class="NLM_article-title">Leukotriene C<sub>4</sub> synthase gene A(−444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1097/00008571-200210000-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1097%2F00008571-200210000-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=12360108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVeqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=565-570&author=K.+Asanoauthor=T.+Shiomiauthor=N.+Hasegawaauthor=H.+Nakamuraauthor=H.+Kudoauthor=T.+Matsuzakiauthor=H.+Hakunoauthor=K.+Fukunagaauthor=Y.+Suzukiauthor=M.+Kanazawaauthor=K.+Yamaguchi&title=Leukotriene+C4+synthase+gene+A%28%E2%88%92444%29C+polymorphism+and+clinical+response+to+a+CYS-LT1+antagonist%2C+pranlukast%2C+in+Japanese+patients+with+moderate+asthma&doi=10.1097%2F00008571-200210000-00009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma</span></div><div class="casAuthors">Asano, Koichiro; Shiomi, Tetsuya; Hasegawa, Naoki; Nakamura, Hidetoshi; Kudo, Hiroyasu; Matsuzaki, Tatsu; Hakuno, Haruhiko; Fukunaga, Kouichi; Suzuki, Yusuke; Kanazawa, Minoru; Yamaguchi, Kazuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">565-570</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">CysLT antagonists are effective for a subset of patients with asthma; however, there has been no good way to predict a given patient's response.  The authors examd. the interaction between the clin. response to a cysLT1 antagonist, pranlukast, and DNA sequence variant A(-444)C in leukotriene C4 synthase (LTC4S) gene in Japanese patients with moderate asthma.  The frequency of LTC4S C(-444) allele was 21.6% in the Japanese general population (= 171) and 19.4% in the asthmatic subjects (n = 349).  A 4-wk prospective, open trial of pranlukast (225 mg twice daily) was performed in 50 patients with moderate asthma who had been well controlled with inhaled corticosteroid (beclomethasone 400-800 μg/day or fluticasone 200-400 μg/day).  The C(-444) allele carriers (n = 16) responded better to pranlukast compared to the A(-444) allele homozygotes (n = 31) [14.3±5.3% vs. 3.1±2.4% improvement of forced expiratory vol. in one second (FEV1), P < 0.01], while LTC4S genotype-stratified response to inhaled β-agonist salbutamol (200 μg) was not obsd. (17.5±2.1% vs. 18.7±2.2% improvement of FEV1).  Univariate anal. demonstrated that the better response to pranlukast (more than 10% improvement of FEV1) was correlated with LTC4S genotype (P < 0.01) and pretreatment airway reversibility to salbutamol (P < 0.01), but not with sex, age, atopic status, urinary leukotriene E4 excretion rate, or daily dose of inhaled corticosteroid.  Furthermore, multivariate regression anal. suggested that LTC4S genotype and the bronchodilatory effect of salbutamol were independent variables to predict the clin. response to pranlukast (P < 0.05).  The authors conclude that LTC4S genotype is predictive of the clin. response to a cysLT1 antagonist, pranlukast, in Japanese patients with moderate asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8DNbJ5AM9GrVg90H21EOLACvtfcHk0lhPd6HPKPu8Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVeqtbc%253D&md5=f7b3dd0087e2dae02bdf25e45ce23890</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2F00008571-200210000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008571-200210000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DShiomi%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DH.%26aulast%3DMatsuzaki%26aufirst%3DT.%26aulast%3DHakuno%26aufirst%3DH.%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DKanazawa%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DK.%26atitle%3DLeukotriene%2520C4%2520synthase%2520gene%2520A%2528%25E2%2588%2592444%2529C%2520polymorphism%2520and%2520clinical%2520response%2520to%2520a%2520CYS-LT1%2520antagonist%252C%2520pranlukast%252C%2520in%2520Japanese%2520patients%2520with%2520moderate%2520asthma%26jtitle%3DPharmacogenetics%26date%3D2002%26volume%3D12%26spage%3D565%26epage%3D570%26doi%3D10.1097%2F00008571-200210000-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Weiler, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randolph, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearlman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rundell, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storms, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessing-Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicklas, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portnoy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nsouli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieken, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, N.</span><span> </span><span class="NLM_article-title">Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter</span> <span class="citation_source-journal">Ann. Allergy, Asthma, Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">S1</span><span class="NLM_x">–</span> <span class="NLM_lpage">S47</span><span class="refDoi"> DOI: 10.1016/j.anai.2010.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.anai.2010.09.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2010&pages=S1-S47&author=J.+M.+Weilerauthor=S.+D.+Andersonauthor=C.+Randolphauthor=S.+Boniniauthor=T.+J.+Craigauthor=D.+S.+Pearlmanauthor=K.+W.+Rundellauthor=W.+S.+Silversauthor=W.+W.+Stormsauthor=D.+I.+Bernsteinauthor=J.+Blessing-Mooreauthor=L.+Coxauthor=D.+A.+Khanauthor=D.+M.+Langauthor=R.+A.+Nicklasauthor=J.+Oppenheimerauthor=J.+M.+Portnoyauthor=D.+E.+Schullerauthor=S.+L.+Spectorauthor=S.+A.+Tillesauthor=D.+Wallaceauthor=W.+Hendersonauthor=L.+Schwartzauthor=D.+Kaufmanauthor=T.+Nsouliauthor=L.+Schiekenauthor=N.+Rosario&title=Pathogenesis%2C+prevalence%2C+diagnosis%2C+and+management+of+exercise-induced+bronchoconstriction%3A+a+practice+parameter&doi=10.1016%2Fj.anai.2010.09.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.anai.2010.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.anai.2010.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DWeiler%26aufirst%3DJ.%2BM.%26aulast%3DAnderson%26aufirst%3DS.%2BD.%26aulast%3DRandolph%26aufirst%3DC.%26aulast%3DBonini%26aufirst%3DS.%26aulast%3DCraig%26aufirst%3DT.%2BJ.%26aulast%3DPearlman%26aufirst%3DD.%2BS.%26aulast%3DRundell%26aufirst%3DK.%2BW.%26aulast%3DSilvers%26aufirst%3DW.%2BS.%26aulast%3DStorms%26aufirst%3DW.%2BW.%26aulast%3DBernstein%26aufirst%3DD.%2BI.%26aulast%3DBlessing-Moore%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DL.%26aulast%3DKhan%26aufirst%3DD.%2BA.%26aulast%3DLang%26aufirst%3DD.%2BM.%26aulast%3DNicklas%26aufirst%3DR.%2BA.%26aulast%3DOppenheimer%26aufirst%3DJ.%26aulast%3DPortnoy%26aufirst%3DJ.%2BM.%26aulast%3DSchuller%26aufirst%3DD.%2BE.%26aulast%3DSpector%26aufirst%3DS.%2BL.%26aulast%3DTilles%26aufirst%3DS.%2BA.%26aulast%3DWallace%26aufirst%3DD.%26aulast%3DHenderson%26aufirst%3DW.%26aulast%3DSchwartz%26aufirst%3DL.%26aulast%3DKaufman%26aufirst%3DD.%26aulast%3DNsouli%26aufirst%3DT.%26aulast%3DSchieken%26aufirst%3DL.%26aulast%3DRosario%26aufirst%3DN.%26atitle%3DPathogenesis%252C%2520prevalence%252C%2520diagnosis%252C%2520and%2520management%2520of%2520exercise-induced%2520bronchoconstriction%253A%2520a%2520practice%2520parameter%26jtitle%3DAnn.%2520Allergy%252C%2520Asthma%252C%2520Immunol.%26date%3D2010%26volume%3D105%26spage%3DS1%26epage%3DS47%26doi%3D10.1016%2Fj.anai.2010.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, S.</span><span> </span><span class="NLM_article-title">Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F<sub>1α</sub></span> <span class="citation_source-journal">Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1034/j.1398-9995.1999.00011.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1034%2Fj.1398-9995.1999.00011.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=489-494&author=H.+Tanakaauthor=T.+Saitohauthor=K.+Kurokawaauthor=S.+Teramotoauthor=N.+Miyazakiauthor=S.+Kanekoauthor=M.+Hashimotoauthor=S.+Abe&title=Leukotriene+%28LT%29-receptor+antagonist+is+more+effective+in+asthmatic+patients+with+a+low+baseline+ratio+of+urinary+LTE4+to+2%2C3-dinor-6-keto-prostaglandin+%28PG%29F1%CE%B1&doi=10.1034%2Fj.1398-9995.1999.00011.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1034%2Fj.1398-9995.1999.00011.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1398-9995.1999.00011.x%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSaitoh%26aufirst%3DT.%26aulast%3DKurokawa%26aufirst%3DK.%26aulast%3DTeramoto%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DN.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DAbe%26aufirst%3DS.%26atitle%3DLeukotriene%2520%2528LT%2529-receptor%2520antagonist%2520is%2520more%2520effective%2520in%2520asthmatic%2520patients%2520with%2520a%2520low%2520baseline%2520ratio%2520of%2520urinary%2520LTE4%2520to%25202%252C3-dinor-6-keto-prostaglandin%2520%2528PG%2529F1%25CE%25B1%26jtitle%3DAllergy%26date%3D1999%26volume%3D54%26spage%3D489%26epage%3D494%26doi%3D10.1034%2Fj.1398-9995.1999.00011.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borish, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baramki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1046/j.1365-2222.2003.01786.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1046%2Fj.1365-2222.2003.01786.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14519144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVCjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=1380-1388&author=D.+J.+Figueroaauthor=L.+Borishauthor=D.+Baramkiauthor=G.+Philipauthor=C.+P.+Austinauthor=J.+F.+Evans&title=Expression+of+cysteinyl+leukotriene+synthetic+and+signalling+proteins+in+inflammatory+cells+in+active+seasonal+allergic+rhinitis&doi=10.1046%2Fj.1365-2222.2003.01786.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis</span></div><div class="casAuthors">Figueroa, D. J.; Borish, L.; Baramki, D.; Philip, G.; Austin, C. P.; Evans, J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Allergy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1380-1388</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Cysteinyl leukotrienes (CysLTs) are bioactive lipids that have been shown to contribute to allergic and inflammatory diseases.  Eosinophils and mast cells have the capacity to produce large amts. of CysLTs after allergic or non-allergic stimulation.  Mol. identification of both the synthetic and signaling proteins in the CysLT pathway allows the investigation of expression of the CysLT enzymes and receptors in active allergic rhinitis.  The authors examd. the expression of the proteins involved in the synthesis of CysLTs and the cysteinyl leukotriene-1 (CysLT1) and cysteinyl leukotriene-2 (CysLT2) receptors in inflammatory cells from patients with active seasonal allergic rhinitis.  Nasal lavage samples were obtained from patients during active seasonal allergic rhinitis.  Specific cellular immunocytochem. techniques were used to detect the cysteinyl leukotriene synthetic proteins, namely 5-lipoxygenase (5-LO), 5-lipoxygenase-activating protein (FLAP), and leukotriene C4 synthase (LTC4S).  In situ hybridization and immunocytochem. techniques were used to identify the mRNA and proteins for the CysLT1 and CysLT2 receptors.  5-LO, FLAP, and LTC4S, and the CysLT1 and CysLT2 receptors were expressed in the majority of eosinophils and in subsets of mast cells and mononuclear cells.  5-LO, FLAP, and the CysLT1 receptor, but not LTC4S or the CysLT2 receptor, were expressed in a subset of nasal neutrophils.  The study thus demonstrates the presence of CysLT pathway proteins in key allergic and inflammatory cells from the upper airway of patients with active seasonal allergic rhinitis.  These data highlight the potential of CysLT-modifying agents to treat both upper and lower airway symptoms in patients suffering from allergic rhinitis and asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm-YdA-xBKwbVg90H21EOLACvtfcHk0liCnxRvwSGRTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVCjt7w%253D&md5=d0957d7e8082e022542f234ed7e77f3c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2222.2003.01786.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2222.2003.01786.x%26sid%3Dliteratum%253Aachs%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DBorish%26aufirst%3DL.%26aulast%3DBaramki%26aufirst%3DD.%26aulast%3DPhilip%26aufirst%3DG.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DExpression%2520of%2520cysteinyl%2520leukotriene%2520synthetic%2520and%2520signalling%2520proteins%2520in%2520inflammatory%2520cells%2520in%2520active%2520seasonal%2520allergic%2520rhinitis%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2003%26volume%3D33%26spage%3D1380%26epage%3D1388%26doi%3D10.1046%2Fj.1365-2222.2003.01786.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, K.</span><span> </span><span class="NLM_article-title">Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1714</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span><span class="refDoi"> DOI: 10.1046/j.1365-2222.2001.01184.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1046%2Fj.1365-2222.2001.01184.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=11696047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=1714-1723&author=H.+Mitaauthor=M.+Hasegawaauthor=H.+Saitoauthor=K.+Akiyama&title=Levels+of+cysteinyl+leukotriene+receptor+mRNA+in+human+peripheral+leucocytes%3A+significantly+higher+expression+of+cysteinyl+leukotriene+receptor+2+mRNA+in+eosinophils&doi=10.1046%2Fj.1365-2222.2001.01184.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils</span></div><div class="casAuthors">Mita, H.; Hasegawa, M.; Saito, H.; Akiyama, K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Allergy</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1714-1723</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Background: Cysteinyl leukotrienes (CysLTs) have been implicated as important contributors in the pathophysiol. of asthma and their biol. effects are mediated by at least two distinct G-protein-coupled receptors.  CDNA sequences of cysteinyl leukotriene receptor 1 (CysLTR1) and cysteinyl leukotriene receptor 2 (CysLTR2) have recently been elucidated.  Objectives: Our aim is to explore gene expression and the comparative expression of CysLTR1 mRNA and CysLTR2 mRNA in human peripheral blood leukocytes.  Methods: Gene expression of CysLTR1 and CysLTR2 mRNAs in human peripheral blood eosinophils, neutrophils, monocytes and T lymphocytes has been measured by competitive reverse transcription-polymerase chain reactions using RNA or DNA competitors.  Results: (a) When cellular levels of CysLTR1 mRNA were normalized to those of G3PDH mRNA, the relative concn. of CysLTR1 mRNA in eosinophils (43.8 ± 37.2, n = 29) was significantly higher than that in neutrophils (18.7 ± 23.3, n = 11), monocytes (0.93 ± 1.1, n = 10) and T lymphocytes (3.4 ± 2.4, n = 11).  (b) When measured using each DNA competitor, mRNAs for both types of CysLTR coexisted in each type of leukocyte.  The ratio of CysLTR1 mRNA to CysLTR2 mRNA was significantly lower in eosinophils (0.65 ± 0.42, n = 12) than in neutrophils (6.9 ± 4.9, n = 12), monocytes (1.8 ± 0.9, n = 10) and T lymphocytes (4.5 ± 5.7, n = 10).  (c) Human umbilical vein endothelial cells expressed CysLTR2 mRNA, but not CysLTR1 mRNA.  Conclusion: These studies reveal that CysLTR1 mRNA and, in particular, CysLTR2 mRNA are abundantly expressed at high levels in eosinophils, raising the possibility that CysLTR2 may have an important physiol. role in eosinophils and a CysLTR2 antagonist may be a good target for preventing signal transduction by CysLTs in eosinophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhdxw-4oCXpLVg90H21EOLACvtfcHk0liCnxRvwSGRTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslGitA%253D%253D&md5=4fc5144e7dbc95a482104ec27a22452c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2222.2001.01184.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2222.2001.01184.x%26sid%3Dliteratum%253Aachs%26aulast%3DMita%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DK.%26atitle%3DLevels%2520of%2520cysteinyl%2520leukotriene%2520receptor%2520mRNA%2520in%2520human%2520peripheral%2520leucocytes%253A%2520significantly%2520higher%2520expression%2520of%2520cysteinyl%2520leukotriene%2520receptor%25202%2520mRNA%2520in%2520eosinophils%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2001%26volume%3D31%26spage%3D1714%26epage%3D1723%26doi%3D10.1046%2Fj.1365-2222.2001.01184.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mellor, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodge, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austen, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, J. A.</span><span> </span><span class="NLM_article-title">Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">11589</span><span class="NLM_x">–</span> <span class="NLM_lpage">11593</span><span class="refDoi"> DOI: 10.1073/pnas.2034927100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1073%2Fpnas.2034927100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=11589-11593&author=E.+A.+Mellorauthor=N.+Frankauthor=D.+Solerauthor=M.+R.+Hodgeauthor=J.+M.+Loraauthor=K.+F.+Austenauthor=J.+A.+Boyce&title=Expression+of+the+type+2+receptor+for+cysteinyl+leukotrienes+%28CysLT2R%29+by+human+mast+cells%3A+Functional+distinction+from+CysLT1R&doi=10.1073%2Fpnas.2034927100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2034927100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2034927100%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DE.%2BA.%26aulast%3DFrank%26aufirst%3DN.%26aulast%3DSoler%26aufirst%3DD.%26aulast%3DHodge%26aufirst%3DM.%2BR.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DAusten%26aufirst%3DK.%2BF.%26aulast%3DBoyce%26aufirst%3DJ.%2BA.%26atitle%3DExpression%2520of%2520the%2520type%25202%2520receptor%2520for%2520cysteinyl%2520leukotrienes%2520%2528CysLT2R%2529%2520by%2520human%2520mast%2520cells%253A%2520Functional%2520distinction%2520from%2520CysLT1R%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D11589%26epage%3D11593%26doi%3D10.1073%2Fpnas.2034927100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gauvreau, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plitt, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baatjes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGlashan, D. W.</span><span> </span><span class="NLM_article-title">Expression of functional cysteinyl leukotriene receptors by human basophils</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1016/j.jaci.2005.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.jaci.2005.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=15990778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVWnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2005&pages=80-87&author=G.+M.+Gauvreauauthor=J.+R.+Plittauthor=A.+Baatjesauthor=D.+W.+MacGlashan&title=Expression+of+functional+cysteinyl+leukotriene+receptors+by+human+basophils&doi=10.1016%2Fj.jaci.2005.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of functional cysteinyl leukotriene receptors by human basophils</span></div><div class="casAuthors">Gauvreau, Gail M.; Plitt, Jim R.; Baatjes, Adrian; MacGlashan, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-87</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Synthesis of leukotriene (LT) C4 by basophils and mast cells is an important component of IgE-mediated inflammation, resulting in increased levels of the cysteinyl leukotrienes (cysLTs) LTC4, LTD4, and LTE4.  Receptors for cysLTs are expressed on a variety of peripheral blood leukocytes, but of interest, they are also expressed on cells that synthesize LTC4, such as eosinophils and mast cells.  Here, the authors examd. human basophils for expression and function of cysLT receptor type 1 (cysLT1) and cysLT receptor type 2 (cysLT2).  Basophils were purified from human blood and analyzed by RT-PCR, Western blotting, and flow cytometry for receptor expression.  Basophils were also examd. for functional responses to LTD4, including cytosolic calcium flux, histamine release, viability, and chemotaxis.  The authors found that basophils express mRNA for cysLT1 and cysLT2.  CysLT1 and cysLT2 were also detectable by flow cytometry, but only cysLT2 was detectable by Western blotting with available antibodies.  Increases in cytosolic calcium induced by LTD4-stimulated basophils were inhibited by the cysLT1 receptor antagonist zafirlukast, confirming the presence of functional cysLT1 receptors on basophils.  There was no effect of LTD4 on histamine release; however, LTD4 decreased CD95 (Fas) expression on basophils in several-day cultures.  Thus, basophils express the cysLT receptors cysLT1 and cysLT2, and some functional responses to LTD4 can be obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5uSggnbqf97Vg90H21EOLACvtfcHk0ljHt6VapprHgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVWnsLk%253D&md5=16f2db9bac7aabf338f80796896a3b8f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2005.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2005.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DGauvreau%26aufirst%3DG.%2BM.%26aulast%3DPlitt%26aufirst%3DJ.%2BR.%26aulast%3DBaatjes%26aufirst%3DA.%26aulast%3DMacGlashan%26aufirst%3DD.%2BW.%26atitle%3DExpression%2520of%2520functional%2520cysteinyl%2520leukotriene%2520receptors%2520by%2520human%2520basophils%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2005%26volume%3D116%26spage%3D80%26epage%3D87%26doi%3D10.1016%2Fj.jaci.2005.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sjöström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmblad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeggström, J. Z.</span><span> </span><span class="NLM_article-title">Dominant expression of the CysLT<sub>2</sub> receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">37e</span><span class="NLM_x">–</span> <span class="NLM_lpage">41e</span><span class="refDoi"> DOI: 10.1161/01.ATV.0000082689.46538.DF</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1161%2F01.ATV.0000082689.46538.DF" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=37e-41e&author=M.+Sj%C3%B6str%C3%B6mauthor=A.-S.+Johanssonauthor=O.+Schr%C3%B6derauthor=H.+Qiuauthor=J.+Palmbladauthor=J.+Z.+Haeggstr%C3%B6m&title=Dominant+expression+of+the+CysLT2+receptor+accounts+for+calcium+signaling+by+cysteinyl+leukotrienes+in+human+umbilical+vein+endothelial+cells&doi=10.1161%2F01.ATV.0000082689.46538.DF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000082689.46538.DF&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000082689.46538.DF%26sid%3Dliteratum%253Aachs%26aulast%3DSj%25C3%25B6str%25C3%25B6m%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DA.-S.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DO.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DPalmblad%26aufirst%3DJ.%26aulast%3DHaeggstr%25C3%25B6m%26aufirst%3DJ.%2BZ.%26atitle%3DDominant%2520expression%2520of%2520the%2520CysLT2%2520receptor%2520accounts%2520for%2520calcium%2520signaling%2520by%2520cysteinyl%2520leukotrienes%2520in%2520human%2520umbilical%2520vein%2520endothelial%2520cells%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D37e%26epage%3D41e%26doi%3D10.1161%2F01.ATV.0000082689.46538.DF" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Montuschi, P.</span><span> </span><span class="NLM_article-title">Role of leukotrienes and leukotriene modifiers in asthma</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1792</span><span class="NLM_x">–</span> <span class="NLM_lpage">1811</span><span class="refDoi"> DOI: 10.3390/ph3061792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.3390%2Fph3061792" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=1792-1811&author=P.+Montuschi&title=Role+of+leukotrienes+and+leukotriene+modifiers+in+asthma&doi=10.3390%2Fph3061792"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3390%2Fph3061792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3061792%26sid%3Dliteratum%253Aachs%26aulast%3DMontuschi%26aufirst%3DP.%26atitle%3DRole%2520of%2520leukotrienes%2520and%2520leukotriene%2520modifiers%2520in%2520asthma%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26spage%3D1792%26epage%3D1811%26doi%3D10.3390%2Fph3061792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Dahlén, S. E.</span><span> </span><span class="NLM_article-title">Treatment of asthma with antileukotrienes: First line or last resort therapy?</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">533</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2005.12.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.ejphar.2005.12.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=16510137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVKgsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2006&pages=40-56&author=S.+E.+Dahl%C3%A9n&title=Treatment+of+asthma+with+antileukotrienes%3A+First+line+or+last+resort+therapy%3F&doi=10.1016%2Fj.ejphar.2005.12.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of asthma with antileukotrienes: First line or last resort therapy?</span></div><div class="casAuthors">Dahlen, Sven-Erik</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">40-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Twenty five years after the structure elucidation of slow reacting substance of anaphylaxis, antileukotrienes are established as a new therapeutic modality in asthma.  The chapter reviews the biochem. and pharmacol. of leukotrienes and antileukotrienes with particular focus on the different usage of antileukotrienes for treatment of asthma and rhinitis in Europe and the US.  Further research needs and new areas for leukotriene involvement in respiratory diseases are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjbWuBm2YIO7Vg90H21EOLACvtfcHk0lj6m5uDZeu9cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVKgsL8%253D&md5=4cf7641bd1ab493b5a31558f210e7cea</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.12.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.12.070%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.%2BE.%26atitle%3DTreatment%2520of%2520asthma%2520with%2520antileukotrienes%253A%2520First%2520line%2520or%2520last%2520resort%2520therapy%253F%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D533%26spage%3D40%26epage%3D56%26doi%3D10.1016%2Fj.ejphar.2005.12.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kumlin, M.</span><span> </span><span class="NLM_article-title">Measurement of leukotrienes in humans</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">S102</span><span class="NLM_x">–</span> <span class="NLM_lpage">S106</span><span class="refDoi"> DOI: 10.1164/ajrccm.161.supplement_1.ltta-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1164%2Fajrccm.161.supplement_1.ltta-20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2000&pages=S102-S106&author=M.+Kumlin&title=Measurement+of+leukotrienes+in+humans&doi=10.1164%2Fajrccm.161.supplement_1.ltta-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.161.supplement_1.ltta-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.161.supplement_1.ltta-20%26sid%3Dliteratum%253Aachs%26aulast%3DKumlin%26aufirst%3DM.%26atitle%3DMeasurement%2520of%2520leukotrienes%2520in%2520humans%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2000%26volume%3D161%26spage%3DS102%26epage%3DS106%26doi%3D10.1164%2Fajrccm.161.supplement_1.ltta-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Higashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawagishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osame, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, K.</span><span> </span><span class="NLM_article-title">Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1016/j.jaci.2003.10.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.jaci.2003.10.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14767442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtV2gur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=277-283&author=N.+Higashiauthor=M.+Taniguchiauthor=H.+Mitaauthor=Y.+Kawagishiauthor=T.+Ishiiauthor=A.+Higashiauthor=M.+Osameauthor=K.+Akiyama&title=Clinical+features+of+asthmatic+patients+with+increased+urinary+leukotriene+E4+excretion+%28hyperleukotrienuria%29%3A+Involvement+of+chronic+hyperplastic+rhinosinusitis+with+nasal+polyposis&doi=10.1016%2Fj.jaci.2003.10.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria) Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis</span></div><div class="casAuthors">Higashi, Noritaka; Taniguchi, Masami; Mita, Haruhisa; Kawagishi, Yukio; Ishii, Toyota; Higashi, Ai; Osame, Mitsuhiro; Akiyama, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The urinary leukotriene E4 (U-LTE4) concn. is significantly increased in patients with aspirin-intolerant asthma (AIA).  However, the relationship between the clinicopathogenetic factors of asthma and the U-LTE4 concn. remains undetd.  We sought to examine the clin. features of asthmatic patients with increased excretion levels of U-LTE4 (hyperleukotrienuria).  We measured the U-LTE4 concns. in 137 asthmatic patients (including 64 patients with AIA) who were in clin. stable condition.  A U-LTE4 concn. of 150 pg/mg creatinine or greater (mean U-LTE4 + 3 SDs of normal healthy control subjects) was indicative of hyperleukotrienuria.  The basal concn. of U-LTE4 was significantly higher in the patients with AIA than in those with aspirin-tolerant asthma (ATA; median, 227.2 vs 90.3 pg/mg creatinine; P < .01).  Compared with normal leukotrienuria in the patients with AIA, hyperleukotrienuria in the patients with AIA was assocd. with older age and decrease in pulmonary function.  On the other hand, compared with normal leukotrienuria in the patients with ATA, hyperleukotrienuria in the patients with ATA was assocd. with severe asthma and chronic hyperplastic rhinosinusitis with nasal polyposis (CHRS/NP), which are well-known symptoms of the aspirin triad, as well as hypereosinophilia and anosmia.  The patients with ATA with CHRS/NP excreted U-LTE4 at significantly high concns.  There were significant decreases in the U-LTE4 concns. before and after the sinus surgery in both the AIA and ATA groups (P < .05).  Cysteinyl leukotrienes are not strictly assocd. with aspirin intolerance itself but rather with clin. features, such as CHRS/NP, that are similar to those seen in AIA.  CHRS/NP might be involved in cysteinyl leukotriene overprodn. in asthmatic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozYdEM8FQ7LVg90H21EOLACvtfcHk0lj6m5uDZeu9cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtV2gur8%253D&md5=57e5650deb96caecdc1f424a8d2ebda0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2003.10.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2003.10.068%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DN.%26aulast%3DTaniguchi%26aufirst%3DM.%26aulast%3DMita%26aufirst%3DH.%26aulast%3DKawagishi%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DHigashi%26aufirst%3DA.%26aulast%3DOsame%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DK.%26atitle%3DClinical%2520features%2520of%2520asthmatic%2520patients%2520with%2520increased%2520urinary%2520leukotriene%2520E4%2520excretion%2520%2528hyperleukotrienuria%2529%253A%2520Involvement%2520of%2520chronic%2520hyperplastic%2520rhinosinusitis%2520with%2520nasal%2520polyposis%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2004%26volume%3D113%26spage%3D277%26epage%3D283%26doi%3D10.1016%2Fj.jaci.2003.10.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Abraham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antó, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bel, E. H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellsagud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahién, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahién, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dews, Ń.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djukanovic, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkerts, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratziou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holgate, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanniess, F.</span><span> </span><span class="NLM_article-title">The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1183/09031936.03.00261903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1183%2F09031936.03.00261903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14516137" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=470-477&author=B.+Abrahamauthor=J.+M.+Ant%C3%B3author=E.+Barreiroauthor=E.+H.+D.+Belauthor=J.+Bousquetauthor=J.+Castellsagudauthor=P.+Chanezauthor=B.+Dahi%C3%A9nauthor=S.+E.+Dahi%C3%A9nauthor=%C5%83.+Dewsauthor=R.+Djukanovicauthor=L.+M.+Fabbriauthor=G.+Folkertsauthor=M.+Gagaauthor=C.+Gratziouauthor=S.+T.+Holgateauthor=P.+H.+Howarthauthor=S.+L.+Johnstonauthor=F.+Kanniess&title=The+ENFUMOSA+cross-sectional+European+multicentre+study+of+the+clinical+phenotype+of+chronic+severe+asthma&doi=10.1183%2F09031936.03.00261903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1183%2F09031936.03.00261903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.03.00261903%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DB.%26aulast%3DAnt%25C3%25B3%26aufirst%3DJ.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%26aulast%3DBel%26aufirst%3DE.%2BH.%2BD.%26aulast%3DBousquet%26aufirst%3DJ.%26aulast%3DCastellsagud%26aufirst%3DJ.%26aulast%3DChanez%26aufirst%3DP.%26aulast%3DDahi%25C3%25A9n%26aufirst%3DB.%26aulast%3DDahi%25C3%25A9n%26aufirst%3DS.%2BE.%26aulast%3DDews%26aufirst%3D%25C5%2583.%26aulast%3DDjukanovic%26aufirst%3DR.%26aulast%3DFabbri%26aufirst%3DL.%2BM.%26aulast%3DFolkerts%26aufirst%3DG.%26aulast%3DGaga%26aufirst%3DM.%26aulast%3DGratziou%26aufirst%3DC.%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DHowarth%26aufirst%3DP.%2BH.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DKanniess%26aufirst%3DF.%26atitle%3DThe%2520ENFUMOSA%2520cross-sectional%2520European%2520multicentre%2520study%2520of%2520the%2520clinical%2520phenotype%2520of%2520chronic%2520severe%2520asthma%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2003%26volume%3D22%26spage%3D470%26epage%3D477%26doi%3D10.1183%2F09031936.03.00261903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Green, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malice, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzi, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, T. F.</span><span> </span><span class="NLM_article-title">Increase in urinary leukotriene LTE<sub>4</sub> levels in acute asthma: correlation with airflow limitation</span> <span class="citation_source-journal">Thorax</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1136/thorax.2003.006825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1136%2Fthorax.2003.006825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=100-104&author=S.+A.+Greenauthor=M.+P.+Maliceauthor=W.+Tanakaauthor=C.+A.+Tozziauthor=T.+F.+Reiss&title=Increase+in+urinary+leukotriene+LTE4+levels+in+acute+asthma%3A+correlation+with+airflow+limitation&doi=10.1136%2Fthorax.2003.006825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1136%2Fthorax.2003.006825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthorax.2003.006825%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DS.%2BA.%26aulast%3DMalice%26aufirst%3DM.%2BP.%26aulast%3DTanaka%26aufirst%3DW.%26aulast%3DTozzi%26aufirst%3DC.%2BA.%26aulast%3DReiss%26aufirst%3DT.%2BF.%26atitle%3DIncrease%2520in%2520urinary%2520leukotriene%2520LTE4%2520levels%2520in%2520acute%2520asthma%253A%2520correlation%2520with%2520airflow%2520limitation%26jtitle%3DThorax%26date%3D2004%26volume%3D59%26spage%3D100%26epage%3D104%26doi%3D10.1136%2Fthorax.2003.006825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wunder, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kast, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hütter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ergüden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Härter, M.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene2 (CysLT<sub>2</sub>) receptor</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00730.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1111%2Fj.1476-5381.2010.00730.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=20423349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslyqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=399-409&author=F.+Wunderauthor=H.+Tinelauthor=R.+Kastauthor=A.+Geertsauthor=E.+M.+Beckerauthor=P.+Kolkhofauthor=J.+H%C3%BCtterauthor=J.+Erg%C3%BCdenauthor=M.+H%C3%A4rter&title=Pharmacological+characterization+of+the+first+potent+and+selective+antagonist+at+the+cysteinyl+leukotriene2+%28CysLT2%29+receptor&doi=10.1111%2Fj.1476-5381.2010.00730.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor</span></div><div class="casAuthors">Wunder, F.; Tinel, H.; Kast, R.; Geerts, A.; Becker, E. M.; Kolkhof, P.; Huetter, J.; Ergueden, J.; Haerter, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">399-409</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cysteinyl leukotrienes (CysLTs) have been implicated in the pathophysiol. of inflammatory and cardiovascular disorders.  Their actions are mediated by CysLT1 and CysLT2 receptors.  Here we report the discovery of 3-({[(1S,3S)-3-carboxycyclohexyl]amino}carbonyl)-4-(3-{4-[4-(cyclo-hexyloxy)butoxy]phenyl}propoxy) benzoic acid (HAMI3379), the first potent and selective CysLT2 receptor antagonist.  Pharmacol. characterization of HAMI3379 was performed using stably transfected CysLT1 and CysLT2 receptor cell lines, and isolated, Langendorff-perfused, guinea pig hearts.  In a CysLT2 receptor reporter cell line, HAMI3379 antagonized leukotriene D4- (LTD4-) and leukotriene C4- (LTC4-) induced intracellular calcium mobilization with IC50 values of 3.8 nM and 4.4 nM resp.  In contrast, HAMI3379 exhibited very low potency on a recombinant CysLT1 receptor cell line (IC50 > 10 000 nM).  In addn., HAMI3379 did not exhibit any agonistic activity on both CysLT receptor cell lines.  In binding studies using membranes from the CysLT2 and CysLT1 receptor cell lines, HAMI3379 inhibited [3H]-LTD4 binding with IC50 values of 38 nM and >10 000 nM resp.  In isolated Langendorff-perfused guinea pig hearts HAMI3379 concn.-dependently inhibited and reversed the LTC4-induced perfusion pressure increase and contractility decrease.  The selective CysLT1 receptor antagonist zafirlukast was found to be inactive in this exptl. setting.  HAMI3379 was identified as a potent and selective CysLT2 receptor antagonist, which was devoid of CysLT receptor agonism.  Using this compd., we showed that the cardiac effects of CysLTs are predominantly mediated by the CysLT2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPXKwyaOtBz7Vg90H21EOLACvtfcHk0lgTGGujQfYEDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslyqsb4%253D&md5=c603b4f0c541500e5c78ef3f0898949e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00730.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00730.x%26sid%3Dliteratum%253Aachs%26aulast%3DWunder%26aufirst%3DF.%26aulast%3DTinel%26aufirst%3DH.%26aulast%3DKast%26aufirst%3DR.%26aulast%3DGeerts%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DE.%2BM.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DH%25C3%25BCtter%26aufirst%3DJ.%26aulast%3DErg%25C3%25BCden%26aufirst%3DJ.%26aulast%3DH%25C3%25A4rter%26aufirst%3DM.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520first%2520potent%2520and%2520selective%2520antagonist%2520at%2520the%2520cysteinyl%2520leukotriene2%2520%2528CysLT2%2529%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26spage%3D399%26epage%3D409%26doi%3D10.1111%2Fj.1476-5381.2010.00730.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ni, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantyne, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barajas-Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Amand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C. D.</span><span> </span><span class="NLM_article-title">A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1124/jpet.111.186031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1124%2Fjpet.111.186031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=21903747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=768-778&author=N.+C.+Niauthor=D.+Yanauthor=L.+L.+Ballantyneauthor=A.+Barajas-Espinosaauthor=T.+St.+Amandauthor=D.+A.+Prattauthor=C.+D.+Funk&title=A+selective+cysteinyl+leukotriene+receptor+2+antagonist+blocks+myocardial+ischemia%2Freperfusion+injury+and+vascular+permeability+in+mice&doi=10.1124%2Fjpet.111.186031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice</span></div><div class="casAuthors">Ni, Nathan C.; Yan, Dong; Ballantyne, Laurel L.; Barajas-Espinosa, Alma; St. Amand, Tim; Pratt, Derek A.; Funk, Colin D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">768-778</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cysteinyl leukotrienes (CysLTs) are potent inflammatory mediators that predominantly exert their effects by binding to cysteinyl leukotriene receptors of the G protein-coupled receptor family.  CysLT receptor 2 (CysLT2R), expressed in endothelial cells of some vascular beds, has been implicated in a variety of cardiovascular functions.  Endothelium-specific overexpression of human CysLT2R in transgenic mice (hEC-CysLT2R) greatly increases myocardial infarction damage.  Investigation of this receptor, however, has been hindered by the lack of selective pharmacol. antagonists.  Here, we describe the characterization of 3-(((3-carboxycyclohexyl)amino)car-bonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)-propoxy)benzoic acid (BayCysLT2) and explore the selective effects of this compd. in attenuating myocardial ischemia/reperfusion damage and vascular leakage.  Using a recently developed β-galactosidase-β-arrestin complementation assay for CysLT2R activity, we detd. BayCysLT2 to be ∼20-fold more potent than the nonselective dual CysLT receptor 1 (CysLT1R)/CysLT2R antagonist 4-(((1R,2E,4E,6Z,9Z)-1-((1S)-4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraen-1-yl)thio)benzoic acid (Bay-u9773) (IC50 274 nM vs. 4.6 μM, resp.).  Intracellular calcium mobilization in response to cysteinyl leukotriene administration showed that BayCysLT2 was >500-fold more selective for CysLT2R compared with CysLT1R.  I.p. injection of BayCysLT2 in mice significantly attenuated leukotriene D4-induced Evans blue dye leakage in the murine ear vasculature.  BayCysLT2 administration either before or after ischemia/reperfusion attenuated the aforementioned increased myocardial infarction damage in hEC-CysLT2R mice.  Finally, decreased neutrophil infiltration and leukocyte adhesion mol. mRNA expression were obsd. in mice treated with antagonist compared with untreated controls.  In conclusion, we present the characterization of a potent and selective antagonist for CysLT2R that is useful for discerning biol. activities of this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj8FNIMQvhPLVg90H21EOLACvtfcHk0ljUp_GzzeY_QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSks70%253D&md5=79c59e2a08ad2ac6d36b629f2760d323</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.186031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.186031%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DN.%2BC.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DBallantyne%26aufirst%3DL.%2BL.%26aulast%3DBarajas-Espinosa%26aufirst%3DA.%26aulast%3DSt.%2BAmand%26aufirst%3DT.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26aulast%3DFunk%26aufirst%3DC.%2BD.%26atitle%3DA%2520selective%2520cysteinyl%2520leukotriene%2520receptor%25202%2520antagonist%2520blocks%2520myocardial%2520ischemia%252Freperfusion%2520injury%2520and%2520vascular%2520permeability%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D768%26epage%3D778%26doi%3D10.1124%2Fjpet.111.186031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nothacker, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Molecular Cloning and Characterization of a Second Human Cysteinyl Leukotriene Receptor: Discovery of a Subtype Selective Agonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span><span class="refDoi"> DOI: 10.1124/mol.58.6.1601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1124%2Fmol.58.6.1601" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1601-1608&author=H.-P.+Nothackerauthor=Z.+Wangauthor=Y.+Zhuauthor=R.+K.+Reinscheidauthor=S.+H.+S.+Linauthor=O.+Civelli&title=Molecular+Cloning+and+Characterization+of+a+Second+Human+Cysteinyl+Leukotriene+Receptor%3A+Discovery+of+a+Subtype+Selective+Agonist&doi=10.1124%2Fmol.58.6.1601"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fmol.58.6.1601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.58.6.1601%26sid%3Dliteratum%253Aachs%26aulast%3DNothacker%26aufirst%3DH.-P.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DLin%26aufirst%3DS.%2BH.%2BS.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DMolecular%2520Cloning%2520and%2520Characterization%2520of%2520a%2520Second%2520Human%2520Cysteinyl%2520Leukotriene%2520Receptor%253A%2520Discovery%2520of%2520a%2520Subtype%2520Selective%2520Agonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1601%26epage%3D1608%26doi%3D10.1124%2Fmol.58.6.1601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Bäck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlén, S. E.</span><span> </span><span class="NLM_article-title">The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/S0014-2999(96)00700-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2FS0014-2999%2896%2900700-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=8982726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A280%3ADyaK2s7jsleruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=1996&pages=107-113&author=M.+B%C3%A4ckauthor=E.+W.+Jonssonauthor=S.+E.+Dahl%C3%A9n&title=The+cysteinyl-leukotriene+receptor+antagonist+BAY+u9773+is+a+competitive+antagonist+of+leukotriene+C4+in+the+guinea-pig+ileum&doi=10.1016%2FS0014-2999%2896%2900700-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum</span></div><div class="casAuthors">Back M; Jonsson E W; Dahlen S E</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-13</span>
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Two main classes of receptors exist for leukotrienes C4, D4 and E4, collectively named cysteinyl-leukotrienes (CysLTs).  The CysLT1 receptor is blocked by currently available leukotriene antagonists, and the CysLT2 receptor is defined by the absence of selective antagonists.  The contractile response to leukotriene C4 in guinea-pig ileum longitudinal muscle is resistant to CysLT1 receptor antagonists.  However, the leukotriene E4 analogue BAY u9773 (6(R)-(4'-carboxyphenylthio)-5(S)-hydroxy-7(E),9(E),11(Z), 14(Z)-eicosatetraenoic acid) has recently been reported to inhibit CysLT2 responses.  Therefore BAY u9773 was evaluated for antagonism of the effect of leukotriene C4 in the guinea-pig ileum longitudinal muscle.  We found that BAY u9773 (0.3-10 microM) did not contract the preparation, but produced a concentration-dependent rightward shift in the concentration-response relation for leukotriene C4.  Schild plot analysis yielded a slope which was not significantly different from unity and a pA2 value of 6.1.  The inhibition of leukotriene C4 by BAY u9773 was not altered by antagonism of CysLT1 receptors by ICI 198,615 {[1-[[2-methoxy-4-[[(phenylsulfonyl)amino]carbonyl]-phenyl] methyl]-1H-indazol-6-yl]carbamic acid cyclopentyl ester}(100 nM).  The CysLT1 receptor agonist, leukotriene E4 (1 microM), contracted the preparation but did not inhibit the contraction induced by leukotriene C4.  Taken together, the antagonism exerted by BAY u9773 appeared unrelated to actions on CysLT1 receptors.  In conclusion, BAY u9773 was a useful selective competitive antagonist of leukotriene C4, and the findings support the classification of the receptors for leukotriene C4 in the guinea-pig ileum as CysLT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXvxsacXhd8eLt9HypzAgQfW6udTcc2eYMXWO5TLwTlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7jsleruw%253D%253D&md5=a7738288bd555245f3d11e3443a818a0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900700-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900700-5%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ck%26aufirst%3DM.%26aulast%3DJonsson%26aufirst%3DE.%2BW.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.%2BE.%26atitle%3DThe%2520cysteinyl-leukotriene%2520receptor%2520antagonist%2520BAY%2520u9773%2520is%2520a%2520competitive%2520antagonist%2520of%2520leukotriene%2520C4%2520in%2520the%2520guinea-pig%2520ileum%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D317%26spage%3D107%26epage%3D113%26doi%3D10.1016%2FS0014-2999%2896%2900700-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Akai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, Y.</span><span> </span><span class="NLM_article-title">Preparation of Benzo[<i>b</i>]furans having five-membered heterocycles at the 2-position and 2-(4-alkylcarbamoylbuta-1,3-dienyl)benzo[<i>b</i>]furans, and their cysteinyl leukotriene receptor (CysLT<sub>1</sub>, CysLT<sub>2</sub>) inhibitory activity</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span><span class="refDoi"> DOI: 10.1248/cpb.c12-00560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1248%2Fcpb.c12-00560" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=1461-1467&author=Y.+Akaiauthor=Y.+Tabuchiauthor=K.+Andoauthor=A.+Itoauthor=Y.+Sakataauthor=I.+Kawasakiauthor=T.+Ohishiauthor=M.+Yamashitaauthor=S.+Ohtaauthor=K.+Nishideauthor=Y.+Ohishi&title=Preparation+of+Benzo%5Bb%5Dfurans+having+five-membered+heterocycles+at+the+2-position+and+2-%284-alkylcarbamoylbuta-1%2C3-dienyl%29benzo%5Bb%5Dfurans%2C+and+their+cysteinyl+leukotriene+receptor+%28CysLT1%2C+CysLT2%29+inhibitory+activity&doi=10.1248%2Fcpb.c12-00560"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c12-00560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c12-00560%26sid%3Dliteratum%253Aachs%26aulast%3DAkai%26aufirst%3DY.%26aulast%3DTabuchi%26aufirst%3DY.%26aulast%3DAndo%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DSakata%26aufirst%3DY.%26aulast%3DKawasaki%26aufirst%3DI.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DNishide%26aufirst%3DK.%26aulast%3DOhishi%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520Benzo%255Bb%255Dfurans%2520having%2520five-membered%2520heterocycles%2520at%2520the%25202-position%2520and%25202-%25284-alkylcarbamoylbuta-1%252C3-dienyl%2529benzo%255Bb%255Dfurans%252C%2520and%2520their%2520cysteinyl%2520leukotriene%2520receptor%2520%2528CysLT1%252C%2520CysLT2%2529%2520inhibitory%2520activity%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2012%26volume%3D60%26spage%3D1461%26epage%3D1467%26doi%3D10.1248%2Fcpb.c12-00560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Tsuji, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, Y.</span><span> </span><span class="NLM_article-title">Preparation of 3-acetoacetylaminobenzo[<i>b</i>]furan derivatives with cysteinyl leukotriene receptor 2 antagonistic activity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">3139</span><span class="NLM_x">–</span> <span class="NLM_lpage">3141</span><span class="refDoi"> DOI: 10.1039/b307468d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1039%2Fb307468d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14527142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntV2nurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=3139-3141&author=E.+Tsujiauthor=K.+Andoauthor=J.+Kunitomoauthor=M.+Yamashitaauthor=S.+Ohtaauthor=S.+Kohnoauthor=Y.+Ohishi&title=Preparation+of+3-acetoacetylaminobenzo%5Bb%5Dfuran+derivatives+with+cysteinyl+leukotriene+receptor+2+antagonistic+activity&doi=10.1039%2Fb307468d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 3-acetoacetylaminobenzo[b]furan derivatives with cysteinyl leukotriene receptor 2 antagonistic activity</span></div><div class="casAuthors">Tsuji, Eriko; Ando, Kumiko; Kunitomo, Jun-ichi; Yamashita, Masayuki; Ohta, Shunsaku; Kohno, Shigekatsu; Ohishi, Yoshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3139-3141</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Novel 3-acetoacetylaminobenzo[b]furan derivs. with a modified triene system at the 3-position were prepd. through acylation of the 3-aminobenzo[b]furans with 5-methylisoxazole-4-carboxylic acid chloride followed by basic cleavage of the isoxazole ring and several of these compds. showed moderate cysteinyl leukotriene receptor 2 antagonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSGa4DhPygi7Vg90H21EOLACvtfcHk0lgZIL2OqOdfSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntV2nurw%253D&md5=7f3974ea50dd52bdf482e4afb242ce32</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2Fb307468d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb307468d%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DE.%26aulast%3DAndo%26aufirst%3DK.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DKohno%26aufirst%3DS.%26aulast%3DOhishi%26aufirst%3DY.%26atitle%3DPreparation%2520of%25203-acetoacetylaminobenzo%255Bb%255Dfuran%2520derivatives%2520with%2520cysteinyl%2520leukotriene%2520receptor%25202%2520antagonistic%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D3139%26epage%3D3141%26doi%3D10.1039%2Fb307468d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ando, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, Y.</span><span> </span><span class="NLM_article-title">Syntheses of 3-acetoacetylaminobenzo[<i>b</i>]furan derivatives having cysteinyl leukotriene 2 receptor antagonistic activity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1039/b312682j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1039%2Fb312682j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=625-635&author=K.+Andoauthor=E.+Tsujiauthor=Y.+Andoauthor=N.+Kuwataauthor=J.+Kunitomoauthor=M.+Yamashitaauthor=S.+Ohtaauthor=S.+Kohnoauthor=Y.+Ohishi&title=Syntheses+of+3-acetoacetylaminobenzo%5Bb%5Dfuran+derivatives+having+cysteinyl+leukotriene+2+receptor+antagonistic+activity&doi=10.1039%2Fb312682j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fb312682j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb312682j%26sid%3Dliteratum%253Aachs%26aulast%3DAndo%26aufirst%3DK.%26aulast%3DTsuji%26aufirst%3DE.%26aulast%3DAndo%26aufirst%3DY.%26aulast%3DKuwata%26aufirst%3DN.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DKohno%26aufirst%3DS.%26aulast%3DOhishi%26aufirst%3DY.%26atitle%3DSyntheses%2520of%25203-acetoacetylaminobenzo%255Bb%255Dfuran%2520derivatives%2520having%2520cysteinyl%2520leukotriene%25202%2520receptor%2520antagonistic%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2004%26volume%3D2%26spage%3D625%26epage%3D635%26doi%3D10.1039%2Fb312682j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Itadani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span> </span><span class="NLM_article-title">Discovery of highly potent dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span><span class="refDoi"> DOI: 10.1021/ml500298y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500298y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1230-1234&author=S.+Itadaniauthor=S.+Takahashiauthor=M.+Imaauthor=T.+Sekiguchiauthor=M.+Fujitaauthor=Y.+Nakayamaauthor=J.+Takeuchi&title=Discovery+of+highly+potent+dual+CysLT1+and+CysLT2+antagonist&doi=10.1021%2Fml500298y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fml500298y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500298y%26sid%3Dliteratum%253Aachs%26aulast%3DItadani%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DIma%26aufirst%3DM.%26aulast%3DSekiguchi%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520dual%2520CysLT1%2520and%2520CysLT2%2520antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1230%26epage%3D1234%26doi%3D10.1021%2Fml500298y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Itadani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aratani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egashira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonetomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span> </span><span class="NLM_article-title">Discovery of a potent, orally available dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist with dicarboxylic acid</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2079</span><span class="NLM_x">–</span> <span class="NLM_lpage">2097</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.bmc.2015.03.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2079-2097&author=S.+Itadaniauthor=S.+Takahashiauthor=M.+Imaauthor=T.+Sekiguchiauthor=Y.+Arataniauthor=H.+Egashiraauthor=N.+Matsumuraauthor=A.+Inoueauthor=Y.+Yonetomiauthor=M.+Fujitaauthor=Y.+Nakayamaauthor=J.+Takeuchi&title=Discovery+of+a+potent%2C+orally+available+dual+CysLT1+and+CysLT2+antagonist+with+dicarboxylic+acid&doi=10.1016%2Fj.bmc.2015.03.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DItadani%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DIma%26aufirst%3DM.%26aulast%3DSekiguchi%26aufirst%3DT.%26aulast%3DAratani%26aufirst%3DY.%26aulast%3DEgashira%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DYonetomi%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520orally%2520available%2520dual%2520CysLT1%2520and%2520CysLT2%2520antagonist%2520with%2520dicarboxylic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2079%26epage%3D2097%26doi%3D10.1016%2Fj.bmc.2015.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Smith, H. W.</span><span> </span><span class="NLM_article-title">Observation on the flora of the alimentary tract of animals and factors affecting its composition</span> <span class="citation_source-journal">J. Pathol. Bacteriol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1002/path.1700890112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1002%2Fpath.1700890112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14263502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A280%3ADyaF2M%252FmvVSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1965&pages=95-122&author=H.+W.+Smith&title=Observation+on+the+flora+of+the+alimentary+tract+of+animals+and+factors+affecting+its+composition&doi=10.1002%2Fpath.1700890112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">OBSERVATIONS ON THE FLORA OF THE ALIMENTARY TRACT OF ANIMALS AND FACTORS AFFECTING ITS COMPOSITION</span></div><div class="casAuthors">SMITH H W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pathology and bacteriology</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-122</span>
        ISSN:<span class="NLM_cas:issn">0368-3494</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyyZWw8WFtoUGy1nwu7K2mfW6udTcc2eYl1UQ3PJJt_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2M%252FmvVSgtQ%253D%253D&md5=af24fdc98570d299f15c9cdada0e3636</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fpath.1700890112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1700890112%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DH.%2BW.%26atitle%3DObservation%2520on%2520the%2520flora%2520of%2520the%2520alimentary%2520tract%2520of%2520animals%2520and%2520factors%2520affecting%2520its%2520composition%26jtitle%3DJ.%2520Pathol.%2520Bacteriol.%26date%3D1965%26volume%3D89%26spage%3D95%26epage%3D122%26doi%3D10.1002%2Fpath.1700890112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lindahl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungell, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lennernäs, H.</span><span> </span><span class="NLM_article-title">Characterization of fluids from the stomach and proximal jejunum in men and women</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1023/A:1012107801889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1023%2FA%3A1012107801889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=9144738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADyaK2sXjtVWrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=497-502&author=A.+Lindahlauthor=A.-L.+Ungellauthor=L.+Knutsonauthor=H.+Lennern%C3%A4s&title=Characterization+of+fluids+from+the+stomach+and+proximal+jejunum+in+men+and+women&doi=10.1023%2FA%3A1012107801889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of fluids from the stomach and proximal jejunum in men and women</span></div><div class="casAuthors">Lindahl, Anders; Ungell, Anna-Lena; Knutson, Lars; Lennernaes, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">497-502</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">The fluids available for drug dissoln. in the human upper gastrointestinal tract were investigated during the fasted state, and variations and potential gender differences regarding the physicochem. properties of these fluids were examd.  Healthy men and women were intubated, and fluids from the stomach and upper jejunum were collected sep.  Bulk pH, osmolality, electrolytes and total concns. of bile acids and proteins were assessed.  To study intraindividual variations, the individuals were studied on more than one occasion.  The stomach and upper jejunal fluids varied significantly in all the entities measured, except the total concn. of proteins.  The intraindividual variability was pronounced in some of the individuals, both in the stomach and the upper jejunum.  No gender differences were obsd.  This study demonstrates the complex nature of the fluids available for drug dissoln. in the stomach and the upper small intestine in humans.  The results can be used when designing a more physiol. in vitro dissoln. media representative of the fasted state.  When designing such a medium, it is suggested that gender differences not be taken into account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkWYadeuAwLLVg90H21EOLACvtfcHk0li3tvEtcnK9Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtVWrsbk%253D&md5=39741d8e8f26b74f179ac0410ca4bee8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1012107801889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1012107801889%26sid%3Dliteratum%253Aachs%26aulast%3DLindahl%26aufirst%3DA.%26aulast%3DUngell%26aufirst%3DA.-L.%26aulast%3DKnutson%26aufirst%3DL.%26aulast%3DLennern%25C3%25A4s%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520fluids%2520from%2520the%2520stomach%2520and%2520proximal%2520jejunum%2520in%2520men%2520and%2520women%26jtitle%3DPharm.%2520Res.%26date%3D1997%26volume%3D14%26spage%3D497%26epage%3D502%26doi%3D10.1023%2FA%3A1012107801889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lakshminarayana, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravindran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiricek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjundappa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayyar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurumurthy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span> </span><span class="NLM_article-title">Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e105222</span><span class="refDoi"> DOI: 10.1371/journal.pone.0105222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1371%2Fjournal.pone.0105222" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105222&author=S.+B.+Lakshminarayanaauthor=H.+I.+M.+Boshoffauthor=J.+Cherianauthor=S.+Ravindranauthor=A.+Gohauthor=J.+Jiricekauthor=M.+Nanjundappaauthor=A.+Nayyarauthor=M.+Gurumurthyauthor=R.+Singhauthor=T.+Dickauthor=F.+Blascoauthor=C.+E.+Barryauthor=P.+C.+Hoauthor=U.+H.+Manjunatha&title=Pharmacokinetics-Pharmacodynamics+Analysis+of+Bicyclic+4-Nitroimidazole+Analogs+in+a+Murine+Model+of+Tuberculosis&doi=10.1371%2Fjournal.pone.0105222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105222%26sid%3Dliteratum%253Aachs%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DRavindran%26aufirst%3DS.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DNanjundappa%26aufirst%3DM.%26aulast%3DNayyar%26aufirst%3DA.%26aulast%3DGurumurthy%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26atitle%3DPharmacokinetics-Pharmacodynamics%2520Analysis%2520of%2520Bicyclic%25204-Nitroimidazole%2520Analogs%2520in%2520a%2520Murine%2520Model%2520of%2520Tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105222%26doi%3D10.1371%2Fjournal.pone.0105222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>Singulair; <span class="NLM_series">Center for Drug Evaluation and Research Application Number 20-829</span>; <span class="NLM_publisher-name">Center for Drug Evaluationa and Research, U.S. Food and Drug Administration</span>,<span class="NLM_x"> </span><span class="NLM_year">1998</span><span class="NLM_x">; </span><a href="http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020829s000_Singular_Pharma.pdf" class="extLink">http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020829s000_Singular_Pharma.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Singulair%3B+Center+for+Drug+Evaluation+and+Research+Application+Number+20-829%3B+Center+for+Drug+Evaluationa+and+Research%2C+U.S.+Food+and+Drug+Administration%2C+1998%3B+http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F98%2F020829s000_Singular_Pharma.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DSingulair%26pub%3DCenter%2520for%2520Drug%2520Evaluationa%2520and%2520Research%252C%2520U.S.%2520Food%2520and%2520Drug%2520Administration%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkison, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, J.W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppugalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björnsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavé, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulin, P.</span><span> </span><span class="NLM_article-title">PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4090</span><span class="NLM_x">–</span> <span class="NLM_lpage">4110</span><span class="refDoi"> DOI: 10.1002/jps.22552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1002%2Fjps.22552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=21541938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVylurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4090-4110&author=B.+J.+Ringauthor=J.+Y.+Chienauthor=K.+K.+Adkisonauthor=H.+M.+Jonesauthor=M.+Rowlandauthor=R.+D.+Jonesauthor=J.W.+T.+Yatesauthor=M.+S.+Kuauthor=C.+R.+Gibsonauthor=H.+Heauthor=R.+Vuppugallaauthor=P.+Maratheauthor=V.+Fischerauthor=S.+Duttaauthor=V.+K.+Sinhaauthor=T.+Bj%C3%B6rnssonauthor=T.+Lav%C3%A9author=P.+Poulin&title=PhRMA+CPCDC+initiative+on+predictive+models+of+human+pharmacokinetics%2C+part+3%3A+comparative+assessement+of+prediction+methods+of+human+clearance&doi=10.1002%2Fjps.22552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">PhRMA CPCDC initiative on predictive models of human pharmacokinetics, Part 3: Comparative assessment of prediction methods of human clearance</span></div><div class="casAuthors">Ring, Barbara J.; Chien, Jenny Y.; Adkison, Kimberly K.; Jones, Hannah M.; Rowland, Malcolm; Jones, Rhys Do; Yates, James W. T.; Ku, M. Sherry; Gibson, Christopher R.; He, Handan; Vuppugalla, Ragini; Marathe, Punit; Fischer, Volker; Dutta, Sandeep; Sinha, Vikash K.; Bjoernsson, Thorir; Lave, Thierry; Poulin, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4090-4110</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The objective of this study was to evaluate the performance of various allometric and in vitro-in vivo extrapolation (IVIVE) methodologies with and without plasma protein binding corrections for the prediction of human i.v. clearance (CL).  The objective was also to evaluate the IVIVE prediction methods with animal data.  Methodologies were selected from the literature.  Pharmaceutical Research and Manufacturers of America member companies contributed blinded datasets from preclin. and clin. studies for 108 compds., among which 19 drugs had i.v. clin. pharmacokinetics data and were used in the anal.  In vivo and in vitro preclin. data were used to predict CL by 29 different methods.  For many compds., in vivo data from only two species (generally rat and dog) were available and/or the required in vitro data were missing, which meant some methods could not be properly evaluated.  In addn., 66 methods of predicting oral (p.o.) area under the curve (AUCp.o.) were evaluated for 107 compds. using rational combinations of i.v. CL and bioavailability (F), and direct scaling of obsd. p.o. CL from preclin. species.  Various statistical and outlier techniques were employed to assess the predictability of each method.  Across methods, the max. success rate in predicting human CL for the 19 drugs was 100%, 94%, and 78% of the compds. with predictions falling within 10-fold, threefold, and twofold error, resp., of the obsd. CL.  In general, in vivo methods performed slightly better than IVIVE methods (at least in terms of measures of correlation and global concordance), with the fu intercept method and two-species-based allometry (rat-dog) being the best performing methods.  IVIVE methods using microsomes (incorporating both plasma and microsomal binding) and hepatocytes (not incorporating binding) resulted in 75% and 78%, resp., of the predictions falling within twofold error.  IVIVE methods using other combinations of binding assumptions were much less accurate.  The results for prediction of AUCp.o. were consistent with i.v. CL.  However, the greatest challenge to successful prediction of human p.o. CL is the est. of F in human.  Overall, the results of this initiative confirmed predictive performance of common methodologies used to predict human CL. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 100:4090-4110, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppzhGQYZ2u-7Vg90H21EOLACvtfcHk0lhfCPl_lEE5eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVylurrK&md5=5892df5a4c1c57bc65a2d5307882f6ad</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.22552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22552%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DChien%26aufirst%3DJ.%2BY.%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DRowland%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DR.%2BD.%26aulast%3DYates%26aufirst%3DJ.W.%2BT.%26aulast%3DKu%26aufirst%3DM.%2BS.%26aulast%3DGibson%26aufirst%3DC.%2BR.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DVuppugalla%26aufirst%3DR.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DDutta%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DV.%2BK.%26aulast%3DBj%25C3%25B6rnsson%26aufirst%3DT.%26aulast%3DLav%25C3%25A9%26aufirst%3DT.%26aulast%3DPoulin%26aufirst%3DP.%26atitle%3DPhRMA%2520CPCDC%2520initiative%2520on%2520predictive%2520models%2520of%2520human%2520pharmacokinetics%252C%2520part%25203%253A%2520comparative%2520assessement%2520of%2520prediction%2520methods%2520of%2520human%2520clearance%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4090%26epage%3D4110%26doi%3D10.1002%2Fjps.22552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argikar, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennehy, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunduz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liric Rajlic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1177/0091270012440282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1177%2F0091270012440282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=23436263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ynsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=178-191&author=F.+Lombardoauthor=N.+J.+Watersauthor=U.+A.+Argikarauthor=M.+K.+Dennehyauthor=J.+Zhanauthor=M.+Gunduzauthor=S.+P.+Harrimanauthor=G.+Berelliniauthor=I.+Liric+Rajlicauthor=R.+S.+Obach&title=Comprehensive+assessment+of+human+pharmacokinetic+prediction+based+on+in+vivo+animal+pharmacokinetic+data%2C+part+2%3A+clearance&doi=10.1177%2F0091270012440282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance</span></div><div class="casAuthors">Lombardo, Franco; Waters, Nigel J.; Argikar, Upendra A.; Dennehy, Michelle K.; Zhan, Jenny; Gunduz, Mithat; Harriman, Shawn P.; Berellini, Giuliano; Rajlic, Ivana Liric; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-191</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A comprehensive anal. on the prediction of human clearance based on i.v. pharmacokinetic data from rat, dog, and monkey for approx. 400 compds. was undertaken.  This data set has been carefully compiled from literature reports and expanded with some inhouse detns. for plasma protein binding and rat clearance.  To the authors' knowledge, this is the largest publicly available data set.  The present examn. offers a comparison of 37 different methods for prediction of human clearance across compds. of diverse physicochem. properties.  Furthermore, this work demonstrates the application of each prediction method to each charge class of the compds., thus presenting an addnl. dimension to prediction of human pharmacokinetics.  In general, the observations suggest that methods employing monkey clearance values and a method incorporating differences in plasma protein binding between rat and human yield the best overall predictions as suggested by approx. 60% compds. within 2-fold geometric mean-fold error.  Other single-species scaling or proportionality methods incorporating the fraction unbound in the corresponding preclin. species for prediction of free clearance in human were generally unsuccessful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD0VWrLLqed7Vg90H21EOLACvtfcHk0lhfCPl_lEE5eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ynsL%252FK&md5=a87b8d0a0025910b592a3e757fb35d54</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1177%2F0091270012440282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270012440282%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DDennehy%26aufirst%3DM.%2BK.%26aulast%3DZhan%26aufirst%3DJ.%26aulast%3DGunduz%26aufirst%3DM.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DLiric%2BRajlic%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DComprehensive%2520assessment%2520of%2520human%2520pharmacokinetic%2520prediction%2520based%2520on%2520in%2520vivo%2520animal%2520pharmacokinetic%2520data%252C%2520part%25202%253A%2520clearance%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D53%26spage%3D178%26epage%3D191%26doi%3D10.1177%2F0091270012440282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Orning, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarström, S.</span><span> </span><span class="NLM_article-title">Inhibition of leukotriene C and leukotriene D biosynthesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8026</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=8023-8026&author=L.+Orningauthor=S.+Hammarstr%C3%B6m&title=Inhibition+of+leukotriene+C+and+leukotriene+D+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrning%26aufirst%3DL.%26aulast%3DHammarstr%25C3%25B6m%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520leukotriene%2520C%2520and%2520leukotriene%2520D%2520biosynthesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D8023%26epage%3D8026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umemoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span> </span><span class="NLM_article-title">Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT<sub>2</sub>) mediates cell proliferation and intracellular calcium mobilization by LTC<sub>4</sub> and LTD4</span> <span class="citation_source-journal">BMB Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.5483/BMBRep.2008.41.2.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.5483%2FBMBRep.2008.41.2.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=18315950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVeisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=139-145&author=Y.+Itoauthor=M.+Hiranoauthor=N.+Umemotoauthor=L.+Zangauthor=Z.+Wangauthor=T.+Okaauthor=Y.+Shimadaauthor=Y.+Nishimuraauthor=I.+Kurokawaauthor=H.+Mizutaniauthor=T.+Tanaka&title=Guinea+pig+cysteinyl+leukotriene+receptor+2+%28gpCysLT2%29+mediates+cell+proliferation+and+intracellular+calcium+mobilization+by+LTC4+and+LTD4&doi=10.5483%2FBMBRep.2008.41.2.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4</span></div><div class="casAuthors">Ito, Yoshiyuki; Hirano, Minoru; Umemoto, Noriko; Zang, Liqing; Wang, Zhipeng; Oka, Takehiko; Shimada, Yasuhito; Nishimura, Yuhei; Kurokawa, Ichiro; Mizutani, Hitoshi; Tanaka, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">BMB Reports</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-145</span>CODEN:
                <span class="NLM_cas:coden">BRMEC2</span>;
        ISSN:<span class="NLM_cas:issn">1976-6696</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We cloned and pharmacol. characterized the guinea pig cysteinyl leukotriene (CysLT) 2 receptor (gpCysLT2).  GpCysLT2 consists of 317 amino acids with 75.3%, 75.2%, 73.3% identity to those of humans, mice and rats, resp.  The gpCysLT2 gene is highly expressed in the lung, moderately in eosinophils, skin, spleen, stomach, colon, and modestly in the small intestine.  CysLTs accelerated the proliferation of gpCysLT2-expressing HEK293.  Leukotriene C4 (LTC4) and leukotriene D4 (LTD4) enhanced the cell proliferation higher than Bay-u 9773, a CysLT2 selective partial agonist and a nonselective antagonist for CysLT receptors.  Bay-u 9773 did not antagonize the cell proliferation by LTC4 and LTD4.  Despite the equipotency of the mitogenic effect among these chems., calcium mobilization (CM) levels were variable (LTC4 > LTD4 > > Bay-u 9773), and Bay-u 9773 antagonized the CM by LTC4.  Moreover, the Gi/o inhibitor pertussis toxin perfectly inhibited agonist-induced cell proliferation.  These results reveal that cell proliferation via CysLT2 signaling was mediated by Gi/o signaling but independent of calcium mobilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl5c7MZJDfzLVg90H21EOLACvtfcHk0lh05XgHeckqaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVeisbY%253D&md5=47cadd02d10442f2da9c7b166a8f9de5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.5483%2FBMBRep.2008.41.2.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5483%252FBMBRep.2008.41.2.139%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DY.%26aulast%3DHirano%26aufirst%3DM.%26aulast%3DUmemoto%26aufirst%3DN.%26aulast%3DZang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DKurokawa%26aufirst%3DI.%26aulast%3DMizutani%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26atitle%3DGuinea%2520pig%2520cysteinyl%2520leukotriene%2520receptor%25202%2520%2528gpCysLT2%2529%2520mediates%2520cell%2520proliferation%2520and%2520intracellular%2520calcium%2520mobilization%2520by%2520LTC4%2520and%2520LTD4%26jtitle%3DBMB%2520Rep.%26date%3D2008%26volume%3D41%26spage%3D139%26epage%3D145%26doi%3D10.5483%2FBMBRep.2008.41.2.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Yonetomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadode, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, K.</span><span> </span><span class="NLM_article-title">Leukotriene C<sub>4</sub> induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexylglutathione-treated guinea pigs</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">754</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.ejphar.2015.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=25704617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1artbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=754&publication_year=2015&pages=98-104&author=Y.+Yonetomiauthor=T.+Sekiokaauthor=M.+Kadodeauthor=T.+Kitamineauthor=A.+Kamiyaauthor=N.+Matsumuraauthor=M.+Fujitaauthor=K.+Kawabata&title=Leukotriene+C4+induces+bronchoconstriction+and+airway+vascular+hyperpermeability+via+the+cysteinyl+leukotriene+receptor+2+in+S-hexylglutathione-treated+guinea+pigs&doi=10.1016%2Fj.ejphar.2015.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs</span></div><div class="casAuthors">Yonetomi, Yasuo; Sekioka, Tomohiko; Kadode, Michiaki; Kitamine, Tetsuya; Kamiya, Akihiro; Matsumura, Naoya; Fujita, Manabu; Kawabata, Kazuhito</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">754</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-104</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cysteinyl leukotrienes act through G-protein-coupled receptors termed cysteinyl leukotriene 1 (CysLT1) and cysteinyl leukotriene 2 (CysLT2) receptors.  However, little is known about the pathophysiol. role of CysLT2 receptors in asthma.  To elucidate the possible involvement of CysLT2 receptors in bronchoconstriction and airway vascular hyperpermeability, we have established a novel guinea pig model of asthma.  In vitro study confirmed that CHO-K1 cells, expressing guinea pig CysLT2 and CysLT1 receptors are selectively stimulated by LTC4 and LTD4, resp.  However, when LTC4 was i.v. injected to guinea pigs, the resulting bronchoconstriction was fully abrogated by montelukast, a CysLT1 receptor antagonist, indicating rapid metab. of LTC4 to LTD4 in the lung.  We found that treatment with S-hexyl glutathione (S-hexyl GSH), an inhibitor of gamma-glutamyl transpeptidase, significantly increased LTC4 content and LTC4/(LTD4 plus LTE4) ratio in the lung.  Under these circumstances, LTC4-induced bronchoconstriction became resistant to montelukast, but sensitive to Compd. A, a CysLT2 receptor antagonist, depending on the dose of S-hexyl GSH.  Combination with montelukast and Compd. A completely abrogated this spasmogenic response.  Addnl., we confirmed that LTC4 elicits airway vascular hyperpermeability via CysLT2 receptors in the presence of high dose of S-hexyl GSH as evidenced by complete inhibition of LTC4-induced hyperpermeability by Compd. A, but not montelukast.  These results suggest that CysLT2 receptors mediate bronchoconstriction and airway vascular hyperpermeability in guinea pigs and that the animal model used in this study may be useful to elucidate the functional role of CysLT2 receptors in various diseases, including asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMaPpteksLt7Vg90H21EOLACvtfcHk0lh05XgHeckqaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1artbw%253D&md5=0745caffdf18ca0963b4a8a7326418d4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DYonetomi%26aufirst%3DY.%26aulast%3DSekioka%26aufirst%3DT.%26aulast%3DKadode%26aufirst%3DM.%26aulast%3DKitamine%26aufirst%3DT.%26aulast%3DKamiya%26aufirst%3DA.%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DKawabata%26aufirst%3DK.%26atitle%3DLeukotriene%2520C4%2520induces%2520bronchoconstriction%2520and%2520airway%2520vascular%2520hyperpermeability%2520via%2520the%2520cysteinyl%2520leukotriene%2520receptor%25202%2520in%2520S-hexylglutathione-treated%2520guinea%2520pigs%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D754%26spage%3D98%26epage%3D104%26doi%3D10.1016%2Fj.ejphar.2015.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Harter, M.; Erguden, J.; Wunder, F.; Tinel, H.; Kobberling, J.; Becker, E.-M.; Munter, K.; Schlemmer, K.-H.; Kast, R.; Kolkhof, P.; Karig, G.; Barfacker, L.; Hubsch, W.; Schuhmacher, J.; Zuleger, S.; Concepcion, A.; Shimizu, H.</span><span> </span><span class="NLM_article-title">Isophthalic acid derivatives</span>. US20060154912,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">, </span>(Example 31).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Harter&author=J.+Erguden&author=F.+Wunder&author=H.+Tinel&author=J.+Kobberling&author=E.-M.+Becker&author=K.+Munter&author=K.-H.+Schlemmer&author=R.+Kast&author=P.+Kolkhof&author=G.+Karig&author=L.+Barfacker&author=W.+Hubsch&author=J.+Schuhmacher&author=S.+Zuleger&author=A.+Concepcion&author=H.+Shimizu&title=Isophthalic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarter%26aufirst%3DM.%26atitle%3DIsophthalic%2520acid%2520derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sekioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadode, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabe, T.</span><span> </span><span class="NLM_article-title">Expression of CysLT<sub>2</sub> receptors in asthma lung, and their possible role in bronchoconstriction</span> <span class="citation_source-journal">Allergol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1016/j.alit.2015.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.alit.2015.04.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=T.+Sekiokaauthor=M.+Kadodeauthor=M.+Fujiiauthor=K.+Kawabataauthor=T.+Abeauthor=M.+Horibaauthor=S.+Kohnoauthor=T.+Nabe&title=Expression+of+CysLT2+receptors+in+asthma+lung%2C+and+their+possible+role+in+bronchoconstriction&doi=10.1016%2Fj.alit.2015.04.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.alit.2015.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.alit.2015.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DSekioka%26aufirst%3DT.%26aulast%3DKadode%26aufirst%3DM.%26aulast%3DFujii%26aufirst%3DM.%26aulast%3DKawabata%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DT.%26aulast%3DHoriba%26aufirst%3DM.%26aulast%3DKohno%26aufirst%3DS.%26aulast%3DNabe%26aufirst%3DT.%26atitle%3DExpression%2520of%2520CysLT2%2520receptors%2520in%2520asthma%2520lung%252C%2520and%2520their%2520possible%2520role%2520in%2520bronchoconstriction%26jtitle%3DAllergol.%2520Int.%26date%3D2015%26doi%3D10.1016%2Fj.alit.2015.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Watanabe-Kohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohata, K.</span><span> </span><span class="NLM_article-title">Significant role of peptide leukotrienes (p-LTs) in the antigen-induced contractions of human and guinea pig lung parenchymas and bronchi or tracheas in vitro</span> <span class="citation_source-journal">Jpn. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1254/jjp.60.209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1254%2Fjjp.60.209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1283422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADyaK3sXnvFansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1992&pages=209-216&author=S.+Watanabe-Kohnoauthor=K.+Yasuiauthor=T.+Nabeauthor=H.+Yamamuraauthor=M.+Horibaauthor=K.+Ohata&title=Significant+role+of+peptide+leukotrienes+%28p-LTs%29+in+the+antigen-induced+contractions+of+human+and+guinea+pig+lung+parenchymas+and+bronchi+or+tracheas+in+vitro&doi=10.1254%2Fjjp.60.209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Significant role of peptide leukotrienes (p-LTs) in the antigen-induced contractions of human and guinea pig lung parenchymas and bronchi or tracheas in vitro</span></div><div class="casAuthors">Watanabe-Kohno, Shigekatsu; Yasui, Kiyoshi; Nabe, Takeshi; Yamamura, Hideki; Horiba, Michiaki; Ohata, Katsuya</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-16</span>CODEN:
                <span class="NLM_cas:coden">JJPAAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-5198</span>.
    </div><div class="casAbstract">Chem. mediators responsible for the antigen-induced contractions of isolated, passively sensitized human and guinea pig lung parenchymas and bronchi or tracheas were evaluated by several antagonists and enzyme inhibitors, with emphasis on the effects of the potent and selective peptide leukotriene (p-LT) antagonist MCI-826.  All of these prepns. showed long-lasting contractions in response to an antigen challenge which lasted for >60 min.  In either the human lung parenchyma and bronchus or guinea pig lung parenchyma, pretreatment with 10-6 g/mL (2.4 × 10-6M) MCI-826 significantly inhibited the late phase at 10-60 min after the challenge of the contraction following slight suppression of the early phase.  The early phase contractions of these prepns. were moderately antagonized by 10-6 g/mL mepyramine, but the late phases were not influenced or were even enhanced.  The combination treatment of MCI-826 with mepyramine addnl. and markedly inhibited both phases of these prepns.  On the other hand, although mepyramine apparently inhibited the early phase of the guinea pig tracheal contraction but not the late phase, no synergistic inhibitions of the contraction were obsd. when it was combined with MCI-826.  The p-LT antagonist FPL 55712, atropine and indomethacin at 10-6 g/mL either slightly inhibited or enhanced the contractions of human lung parenchymas, guinea pig tracheas and lung parenchymas, but the effects were not significant.  Thus, p-LTs largely contribute to induction of the anaphylactic contractions of human lung parenchymas as well as human bronchi and guinea pig lung parenchymas but not guinea pig tracheas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqveD41JDzzC7Vg90H21EOLACvtfcHk0liTSALnoUNPxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXnvFansw%253D%253D&md5=64308f1eeb7ac969792c33f10f325f62</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1254%2Fjjp.60.209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjjp.60.209%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe-Kohno%26aufirst%3DS.%26aulast%3DYasui%26aufirst%3DK.%26aulast%3DNabe%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DH.%26aulast%3DHoriba%26aufirst%3DM.%26aulast%3DOhata%26aufirst%3DK.%26atitle%3DSignificant%2520role%2520of%2520peptide%2520leukotrienes%2520%2528p-LTs%2529%2520in%2520the%2520antigen-induced%2520contractions%2520of%2520human%2520and%2520guinea%2520pig%2520lung%2520parenchymas%2520and%2520bronchi%2520or%2520tracheas%2520in%2520vitro%26jtitle%3DJpn.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D60%26spage%3D209%26epage%3D216%26doi%3D10.1254%2Fjjp.60.209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Buckner, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedyna, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krell, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saban, R.</span><span> </span><span class="NLM_article-title">An examination of the influence of the epithelium on contractile responses to peptideleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=2153812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFalurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1990&pages=77-85&author=C.+K.+Bucknerauthor=J.+S.+Fedynaauthor=J.+L.+Robertsonauthor=J.+A.+Willauthor=D.+M.+Englandauthor=R.+D.+Krellauthor=R.+Saban&title=An+examination+of+the+influence+of+the+epithelium+on+contractile+responses+to+peptideleukotrienes+and+blockade+by+ICI+204%2C219+in+isolated+guinea+pig+trachea+and+human+intralobar+airways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways</span></div><div class="casAuthors">Buckner, C. K.; Fedyna, J. S.; Robertson, J. L.; Will, J. A.; England, D. M.; Krell, R. D.; Saban, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-85</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The influence of the epithelium on inhibition by the leukotriene antagonist ICI 204,219 of contractile responses to peptide leukotriene agonists was examd. in guinea pig tracheal and human bronchial rings.  The -log molar KB values for ICI 204,219 were independent of the epithelium in both tissues.  Even though uninfluenced by the epithelium, the -log molar KB values for ICI 204,219 were about 10-fold smaller in human airways than in guinea pig trachea.  Removal of the epithelium from guinea pig trachea resulted in small lefward shifts of the concn.-response curves to LTC4 and LTD4 and rightward shifts of the concn.-response curves to LTE4 when examd. in the presence of indomethacin.  The lipoxygenase inhibitors nordihydroguaiaretic acid, BW 755C, Rev 5901 and AA861 antagonized responses to LTE4 in the presence, but not in the absence, of epithelium.  In human airways, epithelium removal resulted in a small leftward shift of the concn.-response curve to LTD4, whereas responses to LTC4 and LTE4 were unaltered.  This effect was not obsd. in the presence of indomethacin, relating it to reduced release of cyclooxygenase products.  Apparently, the contractile responses of guinea pig trachea to LTE4 are modulated by LTE4-induced release of 5-lipoxygenase product(s) only when the epithelium is present.  Regardless of the mechanisms, the epithelium-dependent effects of leukotriene agonists do not appear responsible for the difference in potency of ICI 204,219 obsd. between the two species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9z_IJZJdalbVg90H21EOLACvtfcHk0ljgQegVhjCurw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFalurc%253D&md5=b1389585b7791f20546e9c9a9f1a1733</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuckner%26aufirst%3DC.%2BK.%26aulast%3DFedyna%26aufirst%3DJ.%2BS.%26aulast%3DRobertson%26aufirst%3DJ.%2BL.%26aulast%3DWill%26aufirst%3DJ.%2BA.%26aulast%3DEngland%26aufirst%3DD.%2BM.%26aulast%3DKrell%26aufirst%3DR.%2BD.%26aulast%3DSaban%26aufirst%3DR.%26atitle%3DAn%2520examination%2520of%2520the%2520influence%2520of%2520the%2520epithelium%2520on%2520contractile%2520responses%2520to%2520peptideleukotrienes%2520and%2520blockade%2520by%2520ICI%2520204%252C219%2520in%2520isolated%2520guinea%2520pig%2520trachea%2520and%2520human%2520intralobar%2520airways%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1990%26volume%3D252%26spage%3D77%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giossi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, A.</span><span> </span><span class="NLM_article-title">Comparative analysis of isolated human bronchi contraction and biosynthesis of cysteinyl leukotrienes using a direct 5-lipoxygenase inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span><span class="refDoi"> DOI: 10.1016/S0006-2952(97)00055-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2FS0006-2952%2897%2900055-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=437-442&author=M.+Bollaauthor=P.+Carusoauthor=M.+Giossiauthor=G.+Folcoauthor=M.+Civelliauthor=A.+Sala&title=Comparative+analysis+of+isolated+human+bronchi+contraction+and+biosynthesis+of+cysteinyl+leukotrienes+using+a+direct+5-lipoxygenase+inhibitor&doi=10.1016%2FS0006-2952%2897%2900055-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2897%2900055-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252897%252900055-5%26sid%3Dliteratum%253Aachs%26aulast%3DBolla%26aufirst%3DM.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DGiossi%26aufirst%3DM.%26aulast%3DFolco%26aufirst%3DG.%26aulast%3DCivelli%26aufirst%3DM.%26aulast%3DSala%26aufirst%3DA.%26atitle%3DComparative%2520analysis%2520of%2520isolated%2520human%2520bronchi%2520contraction%2520and%2520biosynthesis%2520of%2520cysteinyl%2520leukotrienes%2520using%2520a%2520direct%25205-lipoxygenase%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D54%26spage%3D437%26epage%3D442%26doi%3D10.1016%2FS0006-2952%2897%2900055-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylene Group, Friend or Foe in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5625-5663. <a href="https://doi.org/10.1021/acs.jmedchem.9b01617" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01617%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcetylene%252BGroup%25252C%252BFriend%252Bor%252BFoe%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29092019%26date%3D19022020%26date%3D07022020%26volume%3D63%26issue%3D11%26spage%3D5625%26epage%3D5663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Magnus Munck af Rosenschöld, Petra Johannesson, Antonios Nikitidis, Christian Tyrchan, Hui-Fang Chang, Robert Rönn, Dave Chapman, Victoria Ullah, Grigorios Nikitidis, Pernilla Glader, Helena Käck, Britta Bonn, Fredrik Wågberg, Eva Björkstrand, Ulf Andersson, Linda Swedin, Mattias Rohman, Theresa Andreasson, Eva Lamm Bergström, Fanyi Jiang, Xiao-Hong Zhou, Anders J. Lundqvist, Anna Malmberg, Margareta Ek, Euan Gordon, Anna Pettersen, Lena Ripa, <span class="NLM_string-name hlFld-ContribAuthor">Andrew M. Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 7769-7787. <a href="https://doi.org/10.1021/acs.jmedchem.9b00555" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00555%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BOral%252BLeukotriene%252BC4%252BSynthase%252BInhibitor%252B%2525281S%25252C2S%252529-2-%252528%25257B5-%25255B%2525285-Chloro-2%25252C4-difluorophenyl%252529%2525282-fluoro-2-methylpropyl%252529amino%25255D-3-methoxypyrazin-2-yl%25257Dcarbonyl%252529cyclopropanecarboxylic%252BAcid%252B%252528AZD9898%252529%252Bas%252Ba%252BNew%252BTreatment%252Bfor%252BAsthma%26aulast%3DMunck%2Baf%2BRosensch%25C3%25B6ld%26aufirst%3DMagnus%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30032019%26date%3D30082019%26date%3D15082019%26volume%3D62%26issue%3D17%26spage%3D7769%26epage%3D7787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">H. Ali Döndaş, María de
Gracia Retamosa, <span class="NLM_string-name hlFld-ContribAuthor">José M. Sansano</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Development in Palladium-Catalyzed Domino Reactions: Access to Materials and Biologically Important Carbo- and Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2019,</strong> <em>38 </em>
                                    (9)
                                     , 1828-1867. <a href="https://doi.org/10.1021/acs.organomet.9b00110" title="DOI URL">https://doi.org/10.1021/acs.organomet.9b00110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.9b00110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.9b00110%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DRecent%252BDevelopment%252Bin%252BPalladium-Catalyzed%252BDomino%252BReactions%25253A%252BAccess%252Bto%252BMaterials%252Band%252BBiologically%252BImportant%252BCarbo-%252Band%252BHeterocycles%26aulast%3DD%25C3%25B6nda%25C5%259F%26aufirst%3DH.%2BAli%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17022019%26date%3D12042019%26volume%3D38%26issue%3D9%26spage%3D1828%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Solé</span>, <span class="hlFld-ContribAuthor ">Ferran  Pérez-Janer</span>, <span class="hlFld-ContribAuthor ">Ester  Zulaica</span>, <span class="hlFld-ContribAuthor ">Javier F.  Guastavino</span>, and <span class="hlFld-ContribAuthor ">Israel  Fernández</span>  . </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed α-Arylation of Sulfones in a Three-Component Synthesis of 3-[2-(Phenyl/methylsulfonyl)ethyl]indoles. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2016,</strong> <em>6 </em>
                                    (3)
                                     , 1691-1700. <a href="https://doi.org/10.1021/acscatal.6b00027" title="DOI URL">https://doi.org/10.1021/acscatal.6b00027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.6b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.6b00027%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DPd-Catalyzed%252B%2525CE%2525B1-Arylation%252Bof%252BSulfones%252Bin%252Ba%252BThree-Component%252BSynthesis%252Bof%252B3-%25255B2-%252528Phenyl%25252Fmethylsulfonyl%252529ethyl%25255Dindoles%26aulast%3DSol%25C3%25A9%26aufirst%3DDaniel%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D05012016%26date%3D28012016%26date%3D09022016%26date%3D04032016%26date%3D01022016%26volume%3D6%26issue%3D3%26spage%3D1691%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lou  Saier</span>, <span class="hlFld-ContribAuthor ">Olivier  Peyruchaud</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging role of cysteinyl LTs in cancer. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>88 </em><a href="https://doi.org/10.1111/bph.15402" title="DOI URL">https://doi.org/10.1111/bph.15402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15402%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DEmerging%252Brole%252Bof%252Bcysteinyl%252BLTs%252Bin%252Bcancer%26aulast%3DSaier%26aufirst%3DLou%26date%3D2021%26date%3D2021%26volume%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongzhao  Wang</span>, <span class="hlFld-ContribAuthor ">Zijian  Qin</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>69 </em><a href="https://doi.org/10.1007/s11030-020-10165-4" title="DOI URL">https://doi.org/10.1007/s11030-020-10165-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10165-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DClassification%252Bmodels%252Band%252BSAR%252Banalysis%252Bon%252BCysLT1%252Breceptor%252Bantagonists%252Busing%252Bmachine%252Blearning%252Balgorithms%26aulast%3DWang%26aufirst%3DHongzhao%26date%3D2021%26date%3D2021%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madhuranayaki  Thulasingam</span>, <span class="hlFld-ContribAuthor ">Jesper Z.  Haeggström</span>. </span><span class="cited-content_cbyCitation_article-title">Integral Membrane Enzymes in Eicosanoid Metabolism: Structures, Mechanisms and Inhibitor Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2020,</strong> <em>432 </em>
                                    (18)
                                     , 4999-5022. <a href="https://doi.org/10.1016/j.jmb.2020.07.020" title="DOI URL">https://doi.org/10.1016/j.jmb.2020.07.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2020.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2020.07.020%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DIntegral%252BMembrane%252BEnzymes%252Bin%252BEicosanoid%252BMetabolism%25253A%252BStructures%25252C%252BMechanisms%252Band%252BInhibitor%252BDesign%26aulast%3DThulasingam%26aufirst%3DMadhuranayaki%26date%3D2020%26volume%3D432%26issue%3D18%26spage%3D4999%26epage%3D5022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anastasiia  Gusach</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Luginina</span>, <span class="hlFld-ContribAuthor ">Egor  Marin</span>, <span class="hlFld-ContribAuthor ">Rebecca L.  Brouillette</span>, <span class="hlFld-ContribAuthor ">Élie  Besserer-Offroy</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Longpré</span>, <span class="hlFld-ContribAuthor ">Andrii  Ishchenko</span>, <span class="hlFld-ContribAuthor ">Petr  Popov</span>, <span class="hlFld-ContribAuthor ">Nilkanth  Patel</span>, <span class="hlFld-ContribAuthor ">Taku  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Toru  Maruyama</span>, <span class="hlFld-ContribAuthor ">Benjamin  Stauch</span>, <span class="hlFld-ContribAuthor ">Margarita  Ergasheva</span>, <span class="hlFld-ContribAuthor ">Daria  Romanovskaia</span>, <span class="hlFld-ContribAuthor ">Anastasiia  Stepko</span>, <span class="hlFld-ContribAuthor ">Kirill  Kovalev</span>, <span class="hlFld-ContribAuthor ">Mikhail  Shevtsov</span>, <span class="hlFld-ContribAuthor ">Valentin  Gordeliy</span>, <span class="hlFld-ContribAuthor ">Gye Won  Han</span>, <span class="hlFld-ContribAuthor ">Vsevolod  Katritch</span>, <span class="hlFld-ContribAuthor ">Valentin  Borshchevskiy</span>, <span class="hlFld-ContribAuthor ">Philippe  Sarret</span>, <span class="hlFld-ContribAuthor ">Alexey  Mishin</span>, <span class="hlFld-ContribAuthor ">Vadim  Cherezov</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-13348-2" title="DOI URL">https://doi.org/10.1038/s41467-019-13348-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-13348-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-13348-2%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructural%252Bbasis%252Bof%252Bligand%252Bselectivity%252Band%252Bdisease%252Bmutations%252Bin%252Bcysteinyl%252Bleukotriene%252Breceptors%26aulast%3DGusach%26aufirst%3DAnastasiia%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emiliya V.  Nosova</span>, <span class="hlFld-ContribAuthor ">Galina N.  Lipunova</span>, <span class="hlFld-ContribAuthor ">Valery N.  Charushin</span>, <span class="hlFld-ContribAuthor ">Oleg N.  Chupakhin</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine-containing indoles: Synthesis and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2018,</strong> <em>212 </em>, 51-106. <a href="https://doi.org/10.1016/j.jfluchem.2018.05.012" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2018.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2018.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2018.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DFluorine-containing%252Bindoles%25253A%252BSynthesis%252Band%252Bbiological%252Bactivity%26aulast%3DNosova%26aufirst%3DEmiliya%2BV.%26date%3D2018%26volume%3D212%26spage%3D51%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masaya  Matsuda</span>, <span class="hlFld-ContribAuthor ">Yuki  Tabuchi</span>, <span class="hlFld-ContribAuthor ">Kazuma  Nishimura</span>, <span class="hlFld-ContribAuthor ">Yuri  Nakamura</span>, <span class="hlFld-ContribAuthor ">Tomohiko  Sekioka</span>, <span class="hlFld-ContribAuthor ">Michiaki  Kadode</span>, <span class="hlFld-ContribAuthor ">Kazuhito  Kawabata</span>, <span class="hlFld-ContribAuthor ">Takeshi  Nabe</span>. </span><span class="cited-content_cbyCitation_article-title">Increased expression of CysLT 2 receptors in the lung of asthmatic mice and role in allergic responses. </span><span class="cited-content_cbyCitation_journal-name">Prostaglandins, Leukotrienes and Essential Fatty Acids</span><span> <strong>2018,</strong> <em>131 </em>, 24-31. <a href="https://doi.org/10.1016/j.plefa.2018.03.007" title="DOI URL">https://doi.org/10.1016/j.plefa.2018.03.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.plefa.2018.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.plefa.2018.03.007%26sid%3Dliteratum%253Aachs%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520and%2520Essential%2520Fatty%2520Acids%26atitle%3DIncreased%252Bexpression%252Bof%252BCysLT%252B2%252Breceptors%252Bin%252Bthe%252Blung%252Bof%252Basthmatic%252Bmice%252Band%252Brole%252Bin%252Ballergic%252Bresponses%26aulast%3DMatsuda%26aufirst%3DMasaya%26date%3D2018%26volume%3D131%26spage%3D24%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomohiko  Sekioka</span>, <span class="hlFld-ContribAuthor ">Michiaki  Kadode</span>, <span class="hlFld-ContribAuthor ">Noriko  Osakada</span>, <span class="hlFld-ContribAuthor ">Manabu  Fujita</span>, <span class="hlFld-ContribAuthor ">Naoya  Matsumura</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Yamaura</span>, <span class="hlFld-ContribAuthor ">Shinji  Nakade</span>, <span class="hlFld-ContribAuthor ">Takeshi  Nabe</span>, <span class="hlFld-ContribAuthor ">Kazuhito  Kawabata</span>. </span><span class="cited-content_cbyCitation_article-title">A new CysLT1 and CysLT2 receptors-mediated anaphylaxis guinea pig model. </span><span class="cited-content_cbyCitation_journal-name">Prostaglandins, Leukotrienes and Essential Fatty Acids</span><span> <strong>2017,</strong> <em>119 </em>, 18-24. <a href="https://doi.org/10.1016/j.plefa.2017.03.002" title="DOI URL">https://doi.org/10.1016/j.plefa.2017.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.plefa.2017.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.plefa.2017.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520and%2520Essential%2520Fatty%2520Acids%26atitle%3DA%252Bnew%252BCysLT1%252Band%252BCysLT2%252Breceptors-mediated%252Banaphylaxis%252Bguinea%252Bpig%252Bmodel%26aulast%3DSekioka%26aufirst%3DTomohiko%26date%3D2017%26volume%3D119%26spage%3D18%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. M.  Gauvreau</span>, <span class="hlFld-ContribAuthor ">L.-P.  Boulet</span>, <span class="hlFld-ContribAuthor ">J. M.  FitzGerald</span>, <span class="hlFld-ContribAuthor ">D. W.  Cockcroft</span>, <span class="hlFld-ContribAuthor ">B. E.  Davis</span>, <span class="hlFld-ContribAuthor ">R.  Leigh</span>, <span class="hlFld-ContribAuthor ">M.  Tanaka</span>, <span class="hlFld-ContribAuthor ">J. A.  Fourre</span>, <span class="hlFld-ContribAuthor ">M.  Tanaka</span>, <span class="hlFld-ContribAuthor ">T.  Nabata</span>, <span class="hlFld-ContribAuthor ">P. M.  O'Byrne</span>. </span><span class="cited-content_cbyCitation_article-title">A dual CysLT
              1/2
              antagonist attenuates allergen-induced airway responses in subjects with mild allergic asthma. </span><span class="cited-content_cbyCitation_journal-name">Allergy</span><span> <strong>2016,</strong> <em>71 </em>
                                    (12)
                                     , 1721-1727. <a href="https://doi.org/10.1111/all.12987" title="DOI URL">https://doi.org/10.1111/all.12987</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/all.12987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fall.12987%26sid%3Dliteratum%253Aachs%26jtitle%3DAllergy%26atitle%3DA%252Bdual%252BCysLT%252B1%25252F2%252Bantagonist%252Battenuates%252Ballergen-induced%252Bairway%252Bresponses%252Bin%252Bsubjects%252Bwith%252Bmild%252Ballergic%252Basthma%26aulast%3DGauvreau%26aufirst%3DG.%2BM.%26date%3D2016%26date%3D2016%26volume%3D71%26issue%3D12%26spage%3D1721%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CysLT<sub>1</sub>-selective antagonists. IC<sub>50</sub> values were quoted from refs <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">5</a> (CysLT<sub>1</sub> antagonist activities) and <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">6</a> (CysLT<sub>2</sub> antagonist activities).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CysLT<sub>2</sub>-selective antagonists. IC<sub>50</sub> values were quoted from refs <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a> (HAMI3378) and <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a> (BayCysLT<sub>2</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration of <b>16</b> in plasma or lung tissue of guinea pigs. The value are expressed as the mean ± SD (<i>n</i> = 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plasma and lung tissue concentrations of <b>35</b> in guinea pigs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Efficacy of <b>35</b> in an asthmatic model mediated via CysLT<sub>2</sub> in guinea pigs. (<i>a</i>) ML (montelukast) was orally administered at 0.1 mg/kg. Each column represents the means ± SE of 5–10 animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>35</b> on antigen-induced constriction of isolated human bronchi. (<i>a</i>) Concentration of both montelukast and BayCysLT<sub>2</sub>RA was 10 nmol/L (<i>n</i> = 4). (<i>b</i>) Concentration of <b>35</b> was 100 nmol/L (<i>n</i> = 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Side Chains <b>38a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-butyn-1-ol, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Ph<sub>3</sub>P, CuI, Et<sub>3</sub>N, rt–80 °C, 33–99%; (b) H<sub>2</sub> gas, 10% Pd–C(wet), EtOH, rt, 52–95%; (c) <i>p</i>-toluenesulfonyl chloride, Et<sub>3</sub>N, Me<sub>3</sub>N·HCl, toluene, rt, 80–95%.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Compounds <b>4</b>–<b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AlCl<sub>3</sub>, ethyl succinyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 83%–34%; (b) NaBH<sub>4</sub>, BF<sub>3</sub>·OEt<sub>2</sub>, THF, 0 °C, 54%–76%; (c) ethyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C, 99%–86%; (d) 4-acetoxystyrene, palladium(II)acetate, tri<i>o</i>-tolylphoshine, Et<sub>3</sub>N, dioxane, 100 °C; (e) K<sub>2</sub>CO<sub>3</sub>, THF, EtOH, 50 °C, 89–96% (2 steps); (f) 4-phenyl-1-butanol, 4-(2-methoxyphenyl)-1-butanol, 4-(3-chlorophenyl)-1-butanol, or <b>38a</b>–<b>g</b>, ADDP, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g) NaOHaq, EtOH–DME, rt-50 °C, 51–97% (2 steps).</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(4-phenoxybutoxy)-4-vinylbenzene, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>tert</i>-Bu<sub>3</sub>P, Cy<sub>2</sub>NMe, 1,4-dioxane, 100 °C; (b) NaOHaq, EtOH–DME, rt–50 °C, 92% (2 steps).</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of Compounds <b>17</b>–<b>19</b> and <b>23</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, EtOH, 4-oxopentanoic acid (<i>n</i> = 1), 5-oxohexanoic acid (<i>n</i> = 2), or 6-oxoheptanoic acid (<i>n</i> = 3), 100 °C, 58–60%; (b) Br-(CH<sub>2</sub>)<sub>m</sub>-CO<sub>2</sub>Et (<i>m</i> = 1–4) Cs<sub>2</sub>CO<sub>3</sub>, rt–50 °C, 58–99%; (c) 4-ethynylphenyl acetate, Pd(<i>tert</i>-Bu<sub>3</sub>P)<sub>2</sub>, <sup>i</sup>Pr<sub>2</sub>NH, CH<sub>3</sub>CN, rt; (d) K<sub>2</sub>CO<sub>3</sub>, DME–EtOH, rt, 62–78% (2 steps); (e) <b>38ba</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (f) NaOHaq, EtOH–DME, rt–50 °C, 67–97% (2 steps).</p></p></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Compounds <b>20</b>–<b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-methyl-2-propanyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, 45 °C, 100%; (b) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, rt, 91–100%; (c) isobutyl chloroformate, triethylamine, THF then CH<sub>2</sub>N<sub>2</sub>/diethyl ether, −10 °C to 0 °C; (d) silver(I) benzoate, triethylamine, EtOH, rt–50 °C, 44–52% (2 steps); (e) 4-ethynylphenyl acetate, Pd(P<i>t</i>-Bu<sub>3</sub>)<sub>2</sub>, <sup>i</sup>Pr<sub>2</sub>NH, CH<sub>3</sub>CN, rt; (f) K<sub>2</sub>CO<sub>3</sub>, DME–EtOH, rt–50 °C, 35–84% for 2 steps; (g) <b>38ba</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (h) NaOHaq, DME–EtOH, rt–50 °C, 86–95%.</p></p></figure><figure data-id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Syntheses of Compounds <b>29</b>–<b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, EtOH, 6-oxoheptanoic acid 100 °C, 35–75%; (b) ethyl 4-bromobutanoate, Cs<sub>2</sub>CO<sub>3</sub>, 55 °C, 95–97%; (c) 4-ethynylphenyl acetate, Pd(<i>tert</i>-Bu<sub>3</sub>P)<sub>2</sub>, <sup>i</sup>Pr<sub>2</sub>NH, CH<sub>3</sub>CN, rt; (d) K<sub>2</sub>CO<sub>3</sub>, DME–EtOH, rt, 77–95% (2 steps); (e) <b>38aa</b> or <b>38ba</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, or <b>38a</b> or <b>38e</b>, ADDP, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) NaOHaq, EtOH–DME, rt–50 °C, 72–98% (2 steps).</p></p></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/medium/jm-2015-00741z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. ORTEP drawing of compound <b>35</b> (ONO-6950, gemilukast). Data and refinement statistics are summarized in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00741/20150807/images/large/jm-2015-00741z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00741&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i132">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25043" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25043" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1126/science.6301011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1126%2Fscience.6301011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=1983&pages=568-575&author=B.+Samuelsson&title=Leukotrienes%3A+Mediators+of+immediate+hypersensitivity+reactions+and+inflammation&doi=10.1126%2Fscience.6301011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.6301011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6301011%26sid%3Dliteratum%253Aachs%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DLeukotrienes%253A%2520Mediators%2520of%2520immediate%2520hypersensitivity%2520reactions%2520and%2520inflammation%26jtitle%3DScience%26date%3D1983%26volume%3D220%26spage%3D568%26epage%3D575%26doi%3D10.1126%2Fscience.6301011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Cysteinyl leukotriene receptors</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">68–69</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span><span class="refDoi"> DOI: 10.1016/S0090-6980(02)00057-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2FS0090-6980%2802%2900057-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=12432945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvV2nurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68%E2%80%9369&publication_year=2002&pages=587-597&author=J.+F.+Evans&title=Cysteinyl+leukotriene+receptors&doi=10.1016%2FS0090-6980%2802%2900057-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteinyl leukotriene receptors</span></div><div class="casAuthors">Evans, Jilly F.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">68-69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">587-597</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The cysteinyl leukotrienes, leukotriene C4 (LTC4), LTD4, and LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways.  Pharmacol. characterizations identified at least 2 subtypes of cysteinyl leukotriene (CysLT) receptor based on agonist and antagonist potency for biol. responses.  The rank potency of agonist activation for the CysLT1 receptor is LTD4>LTC4>LTE4 and for the CysLT2 receptor is LTC4=LTD4>LTE4.  CysLT1 selective receptor antagonists are efficacious in the treatment of asthma.  No selective CysLT2 receptor antagonists have been described.  Mol. identification of the human and mouse CysLT1 and CysLT2 receptors has confirmed their structure as putative seven transmembrane domain G protein-coupled receptors and largely confirmed the previous pharmacol. characterizations.  The CysLT1 receptor is most highly expressed in spleen, peripheral blood leukocytes including eosinophils, and lung smooth muscle cells and interstitial lung macrophages.  The CysLT2 receptor is most highly expressed in the heart, adrenal medulla, placenta, and peripheral blood leukocytes.  The mol. identification of the mouse CysLT1 and CysLT2 receptors show similar but not identical profiles to the orthologous human receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp919NPGvLxbVg90H21EOLACvtfcHk0lgTMqYMmTazqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvV2nurY%253D&md5=1fb88bf13253e95ee671387e4cb515b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0090-6980%2802%2900057-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-6980%252802%252900057-6%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCysteinyl%2520leukotriene%2520receptors%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2002%26volume%3D68%25E2%2580%259369%26spage%3D587%26epage%3D597%26doi%3D10.1016%2FS0090-6980%2802%2900057-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bäck, M.</span><span> </span><span class="NLM_article-title">Functional characteristics of cysteinyl-leukotriene receptor subtypes</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.1016/S0024-3205(02)01733-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2FS0024-3205%2802%2901733-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=611-622&author=M.+B%C3%A4ck&title=Functional+characteristics+of+cysteinyl-leukotriene+receptor+subtypes&doi=10.1016%2FS0024-3205%2802%2901733-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2802%2901733-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252802%252901733-2%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ck%26aufirst%3DM.%26atitle%3DFunctional%2520characteristics%2520of%2520cysteinyl-leukotriene%2520receptor%2520subtypes%26jtitle%3DLife%2520Sci.%26date%3D2002%26volume%3D71%26spage%3D611%26epage%3D622%26doi%3D10.1016%2FS0024-3205%2802%2901733-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Capra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovati, G. E.</span><span> </span><span class="NLM_article-title">Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1002/med.20071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1002%2Fmed.20071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=16894531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1GjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=469-527&author=V.+Capraauthor=M.+D.+Thompsonauthor=A.+Salaauthor=D.+E.+Coleauthor=G.+Folcoauthor=G.+E.+Rovati&title=Cysteinyl-leukotrienes+and+their+receptors+in+asthma+and+other+inflammatory+diseases%3A+Critical+update+and+emerging+trends&doi=10.1002%2Fmed.20071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends</span></div><div class="casAuthors">Capra, Valerie; Thompson, Miles D.; Sala, Angelo; Cole, David E.; Folco, Giancarlo; Rovati, G. Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-527</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cysteinyl-leukotrienes (cysteinyl-LTs), i.e., LTC4, LTD4, and LTE4, trigger contractile and inflammatory responses through the specific interaction with G protein-coupled receptors (GPCRs) belonging to the purine receptor cluster of the rhodopsin family, and identified as CysLT receptors (CysLTRs).  Cysteinyl-LTs have a clear role in pathophysiol. conditions such as asthma and allergic rhinitis (AR), and have been implicated in other inflammatory conditions including cardiovascular diseases, cancer, atopic dermatitis, and urticaria.  Mol. cloning of human CysLT1R and CysLT2R subtypes has confirmed most of the previous pharmacol. characterization and identified distinct expression patterns only partially overlapping.  Interestingly, recent data provide evidence for the immunomodulation of CysLTR expression, the existence of addnl. receptor subtypes, and of an intracellular pool of CysLTRs that may have roles different from those of plasma membrane receptors.  Furthermore, genetic variants have been identified for the CysLTRs that may interact to confer risk for atopy.  Finally, a crosstalk between the cysteinyl-LT and the purine systems is being delineated.  This review will summarize and attempt to integrate recent data derived from studies on the mol. pharmacol. and pharmacogenetics of CysLTRs, and will consider the therapeutic opportunities arising from the new roles suggested for cysteinyl-LTs and their receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnK6rg8Ia-obVg90H21EOLACvtfcHk0lgTMqYMmTazqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1GjsL8%253D&md5=2d39d3847f0b3eb465df75c012f78ea2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmed.20071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20071%26sid%3Dliteratum%253Aachs%26aulast%3DCapra%26aufirst%3DV.%26aulast%3DThompson%26aufirst%3DM.%2BD.%26aulast%3DSala%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DD.%2BE.%26aulast%3DFolco%26aufirst%3DG.%26aulast%3DRovati%26aufirst%3DG.%2BE.%26atitle%3DCysteinyl-leukotrienes%2520and%2520their%2520receptors%2520in%2520asthma%2520and%2520other%2520inflammatory%2520diseases%253A%2520Critical%2520update%2520and%2520emerging%2520trends%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2007%26volume%3D27%26spage%3D469%26epage%3D527%26doi%3D10.1002%2Fmed.20071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chateauneuf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooks, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosfield, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caskey, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of the human cysteinyl leukotriene CysLT<sub>1</sub> receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span><span class="refDoi"> DOI: 10.1038/21658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1038%2F21658" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=789-793&author=K.+R.+Lynchauthor=G.+P.+O%27Neillauthor=Q.+Liuauthor=D.+S.+Imauthor=N.+Sawyerauthor=K.+M.+Mettersauthor=N.+Coulombeauthor=M.+Abramovitzauthor=D.+J.+Figueroaauthor=Z.+Zengauthor=B.+M.+Connollyauthor=C.+Baiauthor=C.+P.+Austinauthor=A.+Chateauneufauthor=R.+Stoccoauthor=G.+M.+Greigauthor=S.+Kargmanauthor=S.+B.+Hooksauthor=E.+Hosfieldauthor=D.+L.+Williamsauthor=A.+W.+Ford-Hutchinsonauthor=C.+T.+Caskeyauthor=J.+F.+Evans&title=Characterization+of+the+human+cysteinyl+leukotriene+CysLT1+receptor&doi=10.1038%2F21658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F21658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F21658%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DO%2527Neill%26aufirst%3DG.%2BP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DIm%26aufirst%3DD.%2BS.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DCoulombe%26aufirst%3DN.%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DConnolly%26aufirst%3DB.%2BM.%26aulast%3DBai%26aufirst%3DC.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DChateauneuf%26aufirst%3DA.%26aulast%3DStocco%26aufirst%3DR.%26aulast%3DGreig%26aufirst%3DG.%2BM.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DHooks%26aufirst%3DS.%2BB.%26aulast%3DHosfield%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520human%2520cysteinyl%2520leukotriene%2520CysLT1%2520receptor%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D789%26epage%3D793%26doi%3D10.1038%2F21658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Dowd, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellefeuille, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Characterization of the human cysteinyl leukotriene 2 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">30531</span><span class="NLM_x">–</span> <span class="NLM_lpage">30536</span><span class="refDoi"> DOI: 10.1074/jbc.M003490200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1074%2Fjbc.M003490200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10851239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1agt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30531-30536&author=C.+E.+Heiseauthor=B.+F.+O%27Dowdauthor=D.+J.+Figueroaauthor=N.+Sawyerauthor=T.+Nguyenauthor=D.-S.+Imauthor=R.+Stoccoauthor=J.+N.+Bellefeuilleauthor=M.+Abramovitzauthor=R.+Chengauthor=D.+L.+Williamsauthor=Z.+Zengauthor=Q.+Liuauthor=L.+Maauthor=M.+K.+Clementsauthor=N.+Coulombeauthor=Y.+Liuauthor=C.+P.+Austinauthor=S.+R.+Georgeauthor=G.+P.+O%27Neillauthor=K.+M.+Mettersauthor=K.+R.+Lynchauthor=J.+F.+Evans&title=Characterization+of+the+human+cysteinyl+leukotriene+2+receptor&doi=10.1074%2Fjbc.M003490200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human cysteinyl leukotriene 2 receptor</span></div><div class="casAuthors">Heise, Christopher E.; O'Dowd, Brian F.; Figueroa, David J.; Sawyer, Nicole; Nguyen, Tuan; Im, Dong-Soon; Stocco, Rino; Bellefeuille, Julie N.; Abramovitz, Mark; Cheng, Regina; Williams, David L., Jr.; Zeng, Zhizhen; Liu, Qingyun; Ma, Lei; Clements, Michelle K.; Coulombe, Nathalie; Liu, Yuan; Austin, Christopher P.; George, Susan R.; O'Neill, Gary P.; Metters, Kathleen M.; Lynch, Kevin R.; Evans, Jilly F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">30531-30536</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The contractile and inflammatory actions of the cysteinyl leukotrienes (CysLTs), LTC4, LTD4, and LTE4, are thought to be mediated through at least two distinct but related CysLT G protein-coupled receptors.  The human CysLT1 receptor has been recently cloned and characterized.  We describe here the cloning and characterization of the second cysteinyl leukotriene receptor, CysLT2, a 346-amino acid protein with 38% amino acid identity to the CysLT1 receptor.  The recombinant human CysLT2 receptor was expressed in Xenopus oocytes and HEK293T cells and shown to couple to elevation of intracellular calcium when activated by LTC4, LTD4, or LTE4.  Analyses of radiolabeled LTD4 binding to the recombinant CysLT2 receptor demonstrated high affinity binding and a rank order of potency for competition of LTC4 = LTD4 » LTE4.  In contrast to the dual CysLT1/CysLT2 antagonist, BAY u9773, the CysLT1 receptor-selective antagonists MK-571, montelukast, zafirlukast, and pranlukast exhibited low potency in competition for LTD4 binding and as antagonists of CysLT2 receptor signaling.  CysLT2 receptor mRNA was detected in lung macrophages and airway smooth muscle, cardiac Purkinje cells, adrenal medulla cells, peripheral blood leukocytes, and brain, and the receptor gene was mapped to chromosome 13q14, a region linked to atopic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNARzHAjs1wLVg90H21EOLACvtfcHk0lhs53Qf0xB3DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1agt74%253D&md5=a3c128d90e193664c2180e3029d8b96d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003490200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003490200%26sid%3Dliteratum%253Aachs%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DO%2527Dowd%26aufirst%3DB.%2BF.%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DIm%26aufirst%3DD.-S.%26aulast%3DStocco%26aufirst%3DR.%26aulast%3DBellefeuille%26aufirst%3DJ.%2BN.%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DCoulombe%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DO%2527Neill%26aufirst%3DG.%2BP.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520human%2520cysteinyl%2520leukotriene%25202%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D30531%26epage%3D30536%26doi%3D10.1074%2Fjbc.M003490200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Asano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukunaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span> </span><span class="NLM_article-title">Leukotriene C<sub>4</sub> synthase gene A(−444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1097/00008571-200210000-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1097%2F00008571-200210000-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=12360108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVeqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=565-570&author=K.+Asanoauthor=T.+Shiomiauthor=N.+Hasegawaauthor=H.+Nakamuraauthor=H.+Kudoauthor=T.+Matsuzakiauthor=H.+Hakunoauthor=K.+Fukunagaauthor=Y.+Suzukiauthor=M.+Kanazawaauthor=K.+Yamaguchi&title=Leukotriene+C4+synthase+gene+A%28%E2%88%92444%29C+polymorphism+and+clinical+response+to+a+CYS-LT1+antagonist%2C+pranlukast%2C+in+Japanese+patients+with+moderate+asthma&doi=10.1097%2F00008571-200210000-00009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma</span></div><div class="casAuthors">Asano, Koichiro; Shiomi, Tetsuya; Hasegawa, Naoki; Nakamura, Hidetoshi; Kudo, Hiroyasu; Matsuzaki, Tatsu; Hakuno, Haruhiko; Fukunaga, Kouichi; Suzuki, Yusuke; Kanazawa, Minoru; Yamaguchi, Kazuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">565-570</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">CysLT antagonists are effective for a subset of patients with asthma; however, there has been no good way to predict a given patient's response.  The authors examd. the interaction between the clin. response to a cysLT1 antagonist, pranlukast, and DNA sequence variant A(-444)C in leukotriene C4 synthase (LTC4S) gene in Japanese patients with moderate asthma.  The frequency of LTC4S C(-444) allele was 21.6% in the Japanese general population (= 171) and 19.4% in the asthmatic subjects (n = 349).  A 4-wk prospective, open trial of pranlukast (225 mg twice daily) was performed in 50 patients with moderate asthma who had been well controlled with inhaled corticosteroid (beclomethasone 400-800 μg/day or fluticasone 200-400 μg/day).  The C(-444) allele carriers (n = 16) responded better to pranlukast compared to the A(-444) allele homozygotes (n = 31) [14.3±5.3% vs. 3.1±2.4% improvement of forced expiratory vol. in one second (FEV1), P < 0.01], while LTC4S genotype-stratified response to inhaled β-agonist salbutamol (200 μg) was not obsd. (17.5±2.1% vs. 18.7±2.2% improvement of FEV1).  Univariate anal. demonstrated that the better response to pranlukast (more than 10% improvement of FEV1) was correlated with LTC4S genotype (P < 0.01) and pretreatment airway reversibility to salbutamol (P < 0.01), but not with sex, age, atopic status, urinary leukotriene E4 excretion rate, or daily dose of inhaled corticosteroid.  Furthermore, multivariate regression anal. suggested that LTC4S genotype and the bronchodilatory effect of salbutamol were independent variables to predict the clin. response to pranlukast (P < 0.05).  The authors conclude that LTC4S genotype is predictive of the clin. response to a cysLT1 antagonist, pranlukast, in Japanese patients with moderate asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8DNbJ5AM9GrVg90H21EOLACvtfcHk0lhs53Qf0xB3DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVeqtbc%253D&md5=f7b3dd0087e2dae02bdf25e45ce23890</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2F00008571-200210000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008571-200210000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DShiomi%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DH.%26aulast%3DMatsuzaki%26aufirst%3DT.%26aulast%3DHakuno%26aufirst%3DH.%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DKanazawa%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DK.%26atitle%3DLeukotriene%2520C4%2520synthase%2520gene%2520A%2528%25E2%2588%2592444%2529C%2520polymorphism%2520and%2520clinical%2520response%2520to%2520a%2520CYS-LT1%2520antagonist%252C%2520pranlukast%252C%2520in%2520Japanese%2520patients%2520with%2520moderate%2520asthma%26jtitle%3DPharmacogenetics%26date%3D2002%26volume%3D12%26spage%3D565%26epage%3D570%26doi%3D10.1097%2F00008571-200210000-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Weiler, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randolph, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearlman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rundell, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storms, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessing-Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicklas, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portnoy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nsouli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieken, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, N.</span><span> </span><span class="NLM_article-title">Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter</span> <span class="citation_source-journal">Ann. Allergy, Asthma, Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">S1</span><span class="NLM_x">–</span> <span class="NLM_lpage">S47</span><span class="refDoi"> DOI: 10.1016/j.anai.2010.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.anai.2010.09.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2010&pages=S1-S47&author=J.+M.+Weilerauthor=S.+D.+Andersonauthor=C.+Randolphauthor=S.+Boniniauthor=T.+J.+Craigauthor=D.+S.+Pearlmanauthor=K.+W.+Rundellauthor=W.+S.+Silversauthor=W.+W.+Stormsauthor=D.+I.+Bernsteinauthor=J.+Blessing-Mooreauthor=L.+Coxauthor=D.+A.+Khanauthor=D.+M.+Langauthor=R.+A.+Nicklasauthor=J.+Oppenheimerauthor=J.+M.+Portnoyauthor=D.+E.+Schullerauthor=S.+L.+Spectorauthor=S.+A.+Tillesauthor=D.+Wallaceauthor=W.+Hendersonauthor=L.+Schwartzauthor=D.+Kaufmanauthor=T.+Nsouliauthor=L.+Schiekenauthor=N.+Rosario&title=Pathogenesis%2C+prevalence%2C+diagnosis%2C+and+management+of+exercise-induced+bronchoconstriction%3A+a+practice+parameter&doi=10.1016%2Fj.anai.2010.09.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.anai.2010.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.anai.2010.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DWeiler%26aufirst%3DJ.%2BM.%26aulast%3DAnderson%26aufirst%3DS.%2BD.%26aulast%3DRandolph%26aufirst%3DC.%26aulast%3DBonini%26aufirst%3DS.%26aulast%3DCraig%26aufirst%3DT.%2BJ.%26aulast%3DPearlman%26aufirst%3DD.%2BS.%26aulast%3DRundell%26aufirst%3DK.%2BW.%26aulast%3DSilvers%26aufirst%3DW.%2BS.%26aulast%3DStorms%26aufirst%3DW.%2BW.%26aulast%3DBernstein%26aufirst%3DD.%2BI.%26aulast%3DBlessing-Moore%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DL.%26aulast%3DKhan%26aufirst%3DD.%2BA.%26aulast%3DLang%26aufirst%3DD.%2BM.%26aulast%3DNicklas%26aufirst%3DR.%2BA.%26aulast%3DOppenheimer%26aufirst%3DJ.%26aulast%3DPortnoy%26aufirst%3DJ.%2BM.%26aulast%3DSchuller%26aufirst%3DD.%2BE.%26aulast%3DSpector%26aufirst%3DS.%2BL.%26aulast%3DTilles%26aufirst%3DS.%2BA.%26aulast%3DWallace%26aufirst%3DD.%26aulast%3DHenderson%26aufirst%3DW.%26aulast%3DSchwartz%26aufirst%3DL.%26aulast%3DKaufman%26aufirst%3DD.%26aulast%3DNsouli%26aufirst%3DT.%26aulast%3DSchieken%26aufirst%3DL.%26aulast%3DRosario%26aufirst%3DN.%26atitle%3DPathogenesis%252C%2520prevalence%252C%2520diagnosis%252C%2520and%2520management%2520of%2520exercise-induced%2520bronchoconstriction%253A%2520a%2520practice%2520parameter%26jtitle%3DAnn.%2520Allergy%252C%2520Asthma%252C%2520Immunol.%26date%3D2010%26volume%3D105%26spage%3DS1%26epage%3DS47%26doi%3D10.1016%2Fj.anai.2010.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, S.</span><span> </span><span class="NLM_article-title">Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F<sub>1α</sub></span> <span class="citation_source-journal">Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1034/j.1398-9995.1999.00011.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1034%2Fj.1398-9995.1999.00011.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=489-494&author=H.+Tanakaauthor=T.+Saitohauthor=K.+Kurokawaauthor=S.+Teramotoauthor=N.+Miyazakiauthor=S.+Kanekoauthor=M.+Hashimotoauthor=S.+Abe&title=Leukotriene+%28LT%29-receptor+antagonist+is+more+effective+in+asthmatic+patients+with+a+low+baseline+ratio+of+urinary+LTE4+to+2%2C3-dinor-6-keto-prostaglandin+%28PG%29F1%CE%B1&doi=10.1034%2Fj.1398-9995.1999.00011.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1034%2Fj.1398-9995.1999.00011.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1398-9995.1999.00011.x%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSaitoh%26aufirst%3DT.%26aulast%3DKurokawa%26aufirst%3DK.%26aulast%3DTeramoto%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DN.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DAbe%26aufirst%3DS.%26atitle%3DLeukotriene%2520%2528LT%2529-receptor%2520antagonist%2520is%2520more%2520effective%2520in%2520asthmatic%2520patients%2520with%2520a%2520low%2520baseline%2520ratio%2520of%2520urinary%2520LTE4%2520to%25202%252C3-dinor-6-keto-prostaglandin%2520%2528PG%2529F1%25CE%25B1%26jtitle%3DAllergy%26date%3D1999%26volume%3D54%26spage%3D489%26epage%3D494%26doi%3D10.1034%2Fj.1398-9995.1999.00011.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Figueroa, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borish, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baramki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1046/j.1365-2222.2003.01786.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1046%2Fj.1365-2222.2003.01786.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14519144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVCjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=1380-1388&author=D.+J.+Figueroaauthor=L.+Borishauthor=D.+Baramkiauthor=G.+Philipauthor=C.+P.+Austinauthor=J.+F.+Evans&title=Expression+of+cysteinyl+leukotriene+synthetic+and+signalling+proteins+in+inflammatory+cells+in+active+seasonal+allergic+rhinitis&doi=10.1046%2Fj.1365-2222.2003.01786.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis</span></div><div class="casAuthors">Figueroa, D. J.; Borish, L.; Baramki, D.; Philip, G.; Austin, C. P.; Evans, J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Allergy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1380-1388</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Cysteinyl leukotrienes (CysLTs) are bioactive lipids that have been shown to contribute to allergic and inflammatory diseases.  Eosinophils and mast cells have the capacity to produce large amts. of CysLTs after allergic or non-allergic stimulation.  Mol. identification of both the synthetic and signaling proteins in the CysLT pathway allows the investigation of expression of the CysLT enzymes and receptors in active allergic rhinitis.  The authors examd. the expression of the proteins involved in the synthesis of CysLTs and the cysteinyl leukotriene-1 (CysLT1) and cysteinyl leukotriene-2 (CysLT2) receptors in inflammatory cells from patients with active seasonal allergic rhinitis.  Nasal lavage samples were obtained from patients during active seasonal allergic rhinitis.  Specific cellular immunocytochem. techniques were used to detect the cysteinyl leukotriene synthetic proteins, namely 5-lipoxygenase (5-LO), 5-lipoxygenase-activating protein (FLAP), and leukotriene C4 synthase (LTC4S).  In situ hybridization and immunocytochem. techniques were used to identify the mRNA and proteins for the CysLT1 and CysLT2 receptors.  5-LO, FLAP, and LTC4S, and the CysLT1 and CysLT2 receptors were expressed in the majority of eosinophils and in subsets of mast cells and mononuclear cells.  5-LO, FLAP, and the CysLT1 receptor, but not LTC4S or the CysLT2 receptor, were expressed in a subset of nasal neutrophils.  The study thus demonstrates the presence of CysLT pathway proteins in key allergic and inflammatory cells from the upper airway of patients with active seasonal allergic rhinitis.  These data highlight the potential of CysLT-modifying agents to treat both upper and lower airway symptoms in patients suffering from allergic rhinitis and asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm-YdA-xBKwbVg90H21EOLACvtfcHk0lg04L5YepdL-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVCjt7w%253D&md5=d0957d7e8082e022542f234ed7e77f3c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2222.2003.01786.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2222.2003.01786.x%26sid%3Dliteratum%253Aachs%26aulast%3DFigueroa%26aufirst%3DD.%2BJ.%26aulast%3DBorish%26aufirst%3DL.%26aulast%3DBaramki%26aufirst%3DD.%26aulast%3DPhilip%26aufirst%3DG.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3DExpression%2520of%2520cysteinyl%2520leukotriene%2520synthetic%2520and%2520signalling%2520proteins%2520in%2520inflammatory%2520cells%2520in%2520active%2520seasonal%2520allergic%2520rhinitis%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2003%26volume%3D33%26spage%3D1380%26epage%3D1388%26doi%3D10.1046%2Fj.1365-2222.2003.01786.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, K.</span><span> </span><span class="NLM_article-title">Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1714</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span><span class="refDoi"> DOI: 10.1046/j.1365-2222.2001.01184.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1046%2Fj.1365-2222.2001.01184.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=11696047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=1714-1723&author=H.+Mitaauthor=M.+Hasegawaauthor=H.+Saitoauthor=K.+Akiyama&title=Levels+of+cysteinyl+leukotriene+receptor+mRNA+in+human+peripheral+leucocytes%3A+significantly+higher+expression+of+cysteinyl+leukotriene+receptor+2+mRNA+in+eosinophils&doi=10.1046%2Fj.1365-2222.2001.01184.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils</span></div><div class="casAuthors">Mita, H.; Hasegawa, M.; Saito, H.; Akiyama, K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Allergy</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1714-1723</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Background: Cysteinyl leukotrienes (CysLTs) have been implicated as important contributors in the pathophysiol. of asthma and their biol. effects are mediated by at least two distinct G-protein-coupled receptors.  CDNA sequences of cysteinyl leukotriene receptor 1 (CysLTR1) and cysteinyl leukotriene receptor 2 (CysLTR2) have recently been elucidated.  Objectives: Our aim is to explore gene expression and the comparative expression of CysLTR1 mRNA and CysLTR2 mRNA in human peripheral blood leukocytes.  Methods: Gene expression of CysLTR1 and CysLTR2 mRNAs in human peripheral blood eosinophils, neutrophils, monocytes and T lymphocytes has been measured by competitive reverse transcription-polymerase chain reactions using RNA or DNA competitors.  Results: (a) When cellular levels of CysLTR1 mRNA were normalized to those of G3PDH mRNA, the relative concn. of CysLTR1 mRNA in eosinophils (43.8 ± 37.2, n = 29) was significantly higher than that in neutrophils (18.7 ± 23.3, n = 11), monocytes (0.93 ± 1.1, n = 10) and T lymphocytes (3.4 ± 2.4, n = 11).  (b) When measured using each DNA competitor, mRNAs for both types of CysLTR coexisted in each type of leukocyte.  The ratio of CysLTR1 mRNA to CysLTR2 mRNA was significantly lower in eosinophils (0.65 ± 0.42, n = 12) than in neutrophils (6.9 ± 4.9, n = 12), monocytes (1.8 ± 0.9, n = 10) and T lymphocytes (4.5 ± 5.7, n = 10).  (c) Human umbilical vein endothelial cells expressed CysLTR2 mRNA, but not CysLTR1 mRNA.  Conclusion: These studies reveal that CysLTR1 mRNA and, in particular, CysLTR2 mRNA are abundantly expressed at high levels in eosinophils, raising the possibility that CysLTR2 may have an important physiol. role in eosinophils and a CysLTR2 antagonist may be a good target for preventing signal transduction by CysLTs in eosinophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhdxw-4oCXpLVg90H21EOLACvtfcHk0lg04L5YepdL-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslGitA%253D%253D&md5=4fc5144e7dbc95a482104ec27a22452c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2222.2001.01184.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2222.2001.01184.x%26sid%3Dliteratum%253Aachs%26aulast%3DMita%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DK.%26atitle%3DLevels%2520of%2520cysteinyl%2520leukotriene%2520receptor%2520mRNA%2520in%2520human%2520peripheral%2520leucocytes%253A%2520significantly%2520higher%2520expression%2520of%2520cysteinyl%2520leukotriene%2520receptor%25202%2520mRNA%2520in%2520eosinophils%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2001%26volume%3D31%26spage%3D1714%26epage%3D1723%26doi%3D10.1046%2Fj.1365-2222.2001.01184.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mellor, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodge, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austen, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, J. A.</span><span> </span><span class="NLM_article-title">Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">11589</span><span class="NLM_x">–</span> <span class="NLM_lpage">11593</span><span class="refDoi"> DOI: 10.1073/pnas.2034927100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1073%2Fpnas.2034927100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=11589-11593&author=E.+A.+Mellorauthor=N.+Frankauthor=D.+Solerauthor=M.+R.+Hodgeauthor=J.+M.+Loraauthor=K.+F.+Austenauthor=J.+A.+Boyce&title=Expression+of+the+type+2+receptor+for+cysteinyl+leukotrienes+%28CysLT2R%29+by+human+mast+cells%3A+Functional+distinction+from+CysLT1R&doi=10.1073%2Fpnas.2034927100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2034927100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2034927100%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DE.%2BA.%26aulast%3DFrank%26aufirst%3DN.%26aulast%3DSoler%26aufirst%3DD.%26aulast%3DHodge%26aufirst%3DM.%2BR.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DAusten%26aufirst%3DK.%2BF.%26aulast%3DBoyce%26aufirst%3DJ.%2BA.%26atitle%3DExpression%2520of%2520the%2520type%25202%2520receptor%2520for%2520cysteinyl%2520leukotrienes%2520%2528CysLT2R%2529%2520by%2520human%2520mast%2520cells%253A%2520Functional%2520distinction%2520from%2520CysLT1R%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D11589%26epage%3D11593%26doi%3D10.1073%2Fpnas.2034927100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gauvreau, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plitt, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baatjes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGlashan, D. W.</span><span> </span><span class="NLM_article-title">Expression of functional cysteinyl leukotriene receptors by human basophils</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1016/j.jaci.2005.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.jaci.2005.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=15990778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVWnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2005&pages=80-87&author=G.+M.+Gauvreauauthor=J.+R.+Plittauthor=A.+Baatjesauthor=D.+W.+MacGlashan&title=Expression+of+functional+cysteinyl+leukotriene+receptors+by+human+basophils&doi=10.1016%2Fj.jaci.2005.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of functional cysteinyl leukotriene receptors by human basophils</span></div><div class="casAuthors">Gauvreau, Gail M.; Plitt, Jim R.; Baatjes, Adrian; MacGlashan, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-87</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Synthesis of leukotriene (LT) C4 by basophils and mast cells is an important component of IgE-mediated inflammation, resulting in increased levels of the cysteinyl leukotrienes (cysLTs) LTC4, LTD4, and LTE4.  Receptors for cysLTs are expressed on a variety of peripheral blood leukocytes, but of interest, they are also expressed on cells that synthesize LTC4, such as eosinophils and mast cells.  Here, the authors examd. human basophils for expression and function of cysLT receptor type 1 (cysLT1) and cysLT receptor type 2 (cysLT2).  Basophils were purified from human blood and analyzed by RT-PCR, Western blotting, and flow cytometry for receptor expression.  Basophils were also examd. for functional responses to LTD4, including cytosolic calcium flux, histamine release, viability, and chemotaxis.  The authors found that basophils express mRNA for cysLT1 and cysLT2.  CysLT1 and cysLT2 were also detectable by flow cytometry, but only cysLT2 was detectable by Western blotting with available antibodies.  Increases in cytosolic calcium induced by LTD4-stimulated basophils were inhibited by the cysLT1 receptor antagonist zafirlukast, confirming the presence of functional cysLT1 receptors on basophils.  There was no effect of LTD4 on histamine release; however, LTD4 decreased CD95 (Fas) expression on basophils in several-day cultures.  Thus, basophils express the cysLT receptors cysLT1 and cysLT2, and some functional responses to LTD4 can be obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5uSggnbqf97Vg90H21EOLACvtfcHk0lhuAYl-QUbQRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVWnsLk%253D&md5=16f2db9bac7aabf338f80796896a3b8f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2005.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2005.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DGauvreau%26aufirst%3DG.%2BM.%26aulast%3DPlitt%26aufirst%3DJ.%2BR.%26aulast%3DBaatjes%26aufirst%3DA.%26aulast%3DMacGlashan%26aufirst%3DD.%2BW.%26atitle%3DExpression%2520of%2520functional%2520cysteinyl%2520leukotriene%2520receptors%2520by%2520human%2520basophils%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2005%26volume%3D116%26spage%3D80%26epage%3D87%26doi%3D10.1016%2Fj.jaci.2005.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sjöström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmblad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeggström, J. Z.</span><span> </span><span class="NLM_article-title">Dominant expression of the CysLT<sub>2</sub> receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">37e</span><span class="NLM_x">–</span> <span class="NLM_lpage">41e</span><span class="refDoi"> DOI: 10.1161/01.ATV.0000082689.46538.DF</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1161%2F01.ATV.0000082689.46538.DF" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=37e-41e&author=M.+Sj%C3%B6str%C3%B6mauthor=A.-S.+Johanssonauthor=O.+Schr%C3%B6derauthor=H.+Qiuauthor=J.+Palmbladauthor=J.+Z.+Haeggstr%C3%B6m&title=Dominant+expression+of+the+CysLT2+receptor+accounts+for+calcium+signaling+by+cysteinyl+leukotrienes+in+human+umbilical+vein+endothelial+cells&doi=10.1161%2F01.ATV.0000082689.46538.DF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000082689.46538.DF&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000082689.46538.DF%26sid%3Dliteratum%253Aachs%26aulast%3DSj%25C3%25B6str%25C3%25B6m%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DA.-S.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DO.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DPalmblad%26aufirst%3DJ.%26aulast%3DHaeggstr%25C3%25B6m%26aufirst%3DJ.%2BZ.%26atitle%3DDominant%2520expression%2520of%2520the%2520CysLT2%2520receptor%2520accounts%2520for%2520calcium%2520signaling%2520by%2520cysteinyl%2520leukotrienes%2520in%2520human%2520umbilical%2520vein%2520endothelial%2520cells%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D37e%26epage%3D41e%26doi%3D10.1161%2F01.ATV.0000082689.46538.DF" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Montuschi, P.</span><span> </span><span class="NLM_article-title">Role of leukotrienes and leukotriene modifiers in asthma</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1792</span><span class="NLM_x">–</span> <span class="NLM_lpage">1811</span><span class="refDoi"> DOI: 10.3390/ph3061792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.3390%2Fph3061792" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=1792-1811&author=P.+Montuschi&title=Role+of+leukotrienes+and+leukotriene+modifiers+in+asthma&doi=10.3390%2Fph3061792"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3390%2Fph3061792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3061792%26sid%3Dliteratum%253Aachs%26aulast%3DMontuschi%26aufirst%3DP.%26atitle%3DRole%2520of%2520leukotrienes%2520and%2520leukotriene%2520modifiers%2520in%2520asthma%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26spage%3D1792%26epage%3D1811%26doi%3D10.3390%2Fph3061792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Dahlén, S. E.</span><span> </span><span class="NLM_article-title">Treatment of asthma with antileukotrienes: First line or last resort therapy?</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">533</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2005.12.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.ejphar.2005.12.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=16510137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVKgsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2006&pages=40-56&author=S.+E.+Dahl%C3%A9n&title=Treatment+of+asthma+with+antileukotrienes%3A+First+line+or+last+resort+therapy%3F&doi=10.1016%2Fj.ejphar.2005.12.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of asthma with antileukotrienes: First line or last resort therapy?</span></div><div class="casAuthors">Dahlen, Sven-Erik</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">40-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Twenty five years after the structure elucidation of slow reacting substance of anaphylaxis, antileukotrienes are established as a new therapeutic modality in asthma.  The chapter reviews the biochem. and pharmacol. of leukotrienes and antileukotrienes with particular focus on the different usage of antileukotrienes for treatment of asthma and rhinitis in Europe and the US.  Further research needs and new areas for leukotriene involvement in respiratory diseases are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjbWuBm2YIO7Vg90H21EOLACvtfcHk0lgmKFfGguGTRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVKgsL8%253D&md5=4cf7641bd1ab493b5a31558f210e7cea</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.12.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.12.070%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.%2BE.%26atitle%3DTreatment%2520of%2520asthma%2520with%2520antileukotrienes%253A%2520First%2520line%2520or%2520last%2520resort%2520therapy%253F%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D533%26spage%3D40%26epage%3D56%26doi%3D10.1016%2Fj.ejphar.2005.12.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kumlin, M.</span><span> </span><span class="NLM_article-title">Measurement of leukotrienes in humans</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">S102</span><span class="NLM_x">–</span> <span class="NLM_lpage">S106</span><span class="refDoi"> DOI: 10.1164/ajrccm.161.supplement_1.ltta-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1164%2Fajrccm.161.supplement_1.ltta-20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2000&pages=S102-S106&author=M.+Kumlin&title=Measurement+of+leukotrienes+in+humans&doi=10.1164%2Fajrccm.161.supplement_1.ltta-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.161.supplement_1.ltta-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.161.supplement_1.ltta-20%26sid%3Dliteratum%253Aachs%26aulast%3DKumlin%26aufirst%3DM.%26atitle%3DMeasurement%2520of%2520leukotrienes%2520in%2520humans%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2000%26volume%3D161%26spage%3DS102%26epage%3DS106%26doi%3D10.1164%2Fajrccm.161.supplement_1.ltta-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Higashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawagishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osame, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, K.</span><span> </span><span class="NLM_article-title">Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1016/j.jaci.2003.10.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.jaci.2003.10.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14767442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtV2gur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=277-283&author=N.+Higashiauthor=M.+Taniguchiauthor=H.+Mitaauthor=Y.+Kawagishiauthor=T.+Ishiiauthor=A.+Higashiauthor=M.+Osameauthor=K.+Akiyama&title=Clinical+features+of+asthmatic+patients+with+increased+urinary+leukotriene+E4+excretion+%28hyperleukotrienuria%29%3A+Involvement+of+chronic+hyperplastic+rhinosinusitis+with+nasal+polyposis&doi=10.1016%2Fj.jaci.2003.10.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria) Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis</span></div><div class="casAuthors">Higashi, Noritaka; Taniguchi, Masami; Mita, Haruhisa; Kawagishi, Yukio; Ishii, Toyota; Higashi, Ai; Osame, Mitsuhiro; Akiyama, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The urinary leukotriene E4 (U-LTE4) concn. is significantly increased in patients with aspirin-intolerant asthma (AIA).  However, the relationship between the clinicopathogenetic factors of asthma and the U-LTE4 concn. remains undetd.  We sought to examine the clin. features of asthmatic patients with increased excretion levels of U-LTE4 (hyperleukotrienuria).  We measured the U-LTE4 concns. in 137 asthmatic patients (including 64 patients with AIA) who were in clin. stable condition.  A U-LTE4 concn. of 150 pg/mg creatinine or greater (mean U-LTE4 + 3 SDs of normal healthy control subjects) was indicative of hyperleukotrienuria.  The basal concn. of U-LTE4 was significantly higher in the patients with AIA than in those with aspirin-tolerant asthma (ATA; median, 227.2 vs 90.3 pg/mg creatinine; P < .01).  Compared with normal leukotrienuria in the patients with AIA, hyperleukotrienuria in the patients with AIA was assocd. with older age and decrease in pulmonary function.  On the other hand, compared with normal leukotrienuria in the patients with ATA, hyperleukotrienuria in the patients with ATA was assocd. with severe asthma and chronic hyperplastic rhinosinusitis with nasal polyposis (CHRS/NP), which are well-known symptoms of the aspirin triad, as well as hypereosinophilia and anosmia.  The patients with ATA with CHRS/NP excreted U-LTE4 at significantly high concns.  There were significant decreases in the U-LTE4 concns. before and after the sinus surgery in both the AIA and ATA groups (P < .05).  Cysteinyl leukotrienes are not strictly assocd. with aspirin intolerance itself but rather with clin. features, such as CHRS/NP, that are similar to those seen in AIA.  CHRS/NP might be involved in cysteinyl leukotriene overprodn. in asthmatic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozYdEM8FQ7LVg90H21EOLACvtfcHk0ljEP-3teffeaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtV2gur8%253D&md5=57e5650deb96caecdc1f424a8d2ebda0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2003.10.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2003.10.068%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DN.%26aulast%3DTaniguchi%26aufirst%3DM.%26aulast%3DMita%26aufirst%3DH.%26aulast%3DKawagishi%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DHigashi%26aufirst%3DA.%26aulast%3DOsame%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DK.%26atitle%3DClinical%2520features%2520of%2520asthmatic%2520patients%2520with%2520increased%2520urinary%2520leukotriene%2520E4%2520excretion%2520%2528hyperleukotrienuria%2529%253A%2520Involvement%2520of%2520chronic%2520hyperplastic%2520rhinosinusitis%2520with%2520nasal%2520polyposis%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2004%26volume%3D113%26spage%3D277%26epage%3D283%26doi%3D10.1016%2Fj.jaci.2003.10.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Abraham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antó, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bel, E. H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellsagud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahién, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahién, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dews, Ń.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djukanovic, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkerts, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratziou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holgate, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanniess, F.</span><span> </span><span class="NLM_article-title">The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1183/09031936.03.00261903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1183%2F09031936.03.00261903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14516137" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=470-477&author=B.+Abrahamauthor=J.+M.+Ant%C3%B3author=E.+Barreiroauthor=E.+H.+D.+Belauthor=J.+Bousquetauthor=J.+Castellsagudauthor=P.+Chanezauthor=B.+Dahi%C3%A9nauthor=S.+E.+Dahi%C3%A9nauthor=%C5%83.+Dewsauthor=R.+Djukanovicauthor=L.+M.+Fabbriauthor=G.+Folkertsauthor=M.+Gagaauthor=C.+Gratziouauthor=S.+T.+Holgateauthor=P.+H.+Howarthauthor=S.+L.+Johnstonauthor=F.+Kanniess&title=The+ENFUMOSA+cross-sectional+European+multicentre+study+of+the+clinical+phenotype+of+chronic+severe+asthma&doi=10.1183%2F09031936.03.00261903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1183%2F09031936.03.00261903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.03.00261903%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DB.%26aulast%3DAnt%25C3%25B3%26aufirst%3DJ.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%26aulast%3DBel%26aufirst%3DE.%2BH.%2BD.%26aulast%3DBousquet%26aufirst%3DJ.%26aulast%3DCastellsagud%26aufirst%3DJ.%26aulast%3DChanez%26aufirst%3DP.%26aulast%3DDahi%25C3%25A9n%26aufirst%3DB.%26aulast%3DDahi%25C3%25A9n%26aufirst%3DS.%2BE.%26aulast%3DDews%26aufirst%3D%25C5%2583.%26aulast%3DDjukanovic%26aufirst%3DR.%26aulast%3DFabbri%26aufirst%3DL.%2BM.%26aulast%3DFolkerts%26aufirst%3DG.%26aulast%3DGaga%26aufirst%3DM.%26aulast%3DGratziou%26aufirst%3DC.%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DHowarth%26aufirst%3DP.%2BH.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DKanniess%26aufirst%3DF.%26atitle%3DThe%2520ENFUMOSA%2520cross-sectional%2520European%2520multicentre%2520study%2520of%2520the%2520clinical%2520phenotype%2520of%2520chronic%2520severe%2520asthma%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2003%26volume%3D22%26spage%3D470%26epage%3D477%26doi%3D10.1183%2F09031936.03.00261903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Green, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malice, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzi, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, T. F.</span><span> </span><span class="NLM_article-title">Increase in urinary leukotriene LTE<sub>4</sub> levels in acute asthma: correlation with airflow limitation</span> <span class="citation_source-journal">Thorax</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1136/thorax.2003.006825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1136%2Fthorax.2003.006825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=100-104&author=S.+A.+Greenauthor=M.+P.+Maliceauthor=W.+Tanakaauthor=C.+A.+Tozziauthor=T.+F.+Reiss&title=Increase+in+urinary+leukotriene+LTE4+levels+in+acute+asthma%3A+correlation+with+airflow+limitation&doi=10.1136%2Fthorax.2003.006825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1136%2Fthorax.2003.006825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthorax.2003.006825%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DS.%2BA.%26aulast%3DMalice%26aufirst%3DM.%2BP.%26aulast%3DTanaka%26aufirst%3DW.%26aulast%3DTozzi%26aufirst%3DC.%2BA.%26aulast%3DReiss%26aufirst%3DT.%2BF.%26atitle%3DIncrease%2520in%2520urinary%2520leukotriene%2520LTE4%2520levels%2520in%2520acute%2520asthma%253A%2520correlation%2520with%2520airflow%2520limitation%26jtitle%3DThorax%26date%3D2004%26volume%3D59%26spage%3D100%26epage%3D104%26doi%3D10.1136%2Fthorax.2003.006825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wunder, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kast, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hütter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ergüden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Härter, M.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene2 (CysLT<sub>2</sub>) receptor</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00730.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1111%2Fj.1476-5381.2010.00730.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=20423349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslyqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=399-409&author=F.+Wunderauthor=H.+Tinelauthor=R.+Kastauthor=A.+Geertsauthor=E.+M.+Beckerauthor=P.+Kolkhofauthor=J.+H%C3%BCtterauthor=J.+Erg%C3%BCdenauthor=M.+H%C3%A4rter&title=Pharmacological+characterization+of+the+first+potent+and+selective+antagonist+at+the+cysteinyl+leukotriene2+%28CysLT2%29+receptor&doi=10.1111%2Fj.1476-5381.2010.00730.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor</span></div><div class="casAuthors">Wunder, F.; Tinel, H.; Kast, R.; Geerts, A.; Becker, E. M.; Kolkhof, P.; Huetter, J.; Ergueden, J.; Haerter, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">399-409</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cysteinyl leukotrienes (CysLTs) have been implicated in the pathophysiol. of inflammatory and cardiovascular disorders.  Their actions are mediated by CysLT1 and CysLT2 receptors.  Here we report the discovery of 3-({[(1S,3S)-3-carboxycyclohexyl]amino}carbonyl)-4-(3-{4-[4-(cyclo-hexyloxy)butoxy]phenyl}propoxy) benzoic acid (HAMI3379), the first potent and selective CysLT2 receptor antagonist.  Pharmacol. characterization of HAMI3379 was performed using stably transfected CysLT1 and CysLT2 receptor cell lines, and isolated, Langendorff-perfused, guinea pig hearts.  In a CysLT2 receptor reporter cell line, HAMI3379 antagonized leukotriene D4- (LTD4-) and leukotriene C4- (LTC4-) induced intracellular calcium mobilization with IC50 values of 3.8 nM and 4.4 nM resp.  In contrast, HAMI3379 exhibited very low potency on a recombinant CysLT1 receptor cell line (IC50 > 10 000 nM).  In addn., HAMI3379 did not exhibit any agonistic activity on both CysLT receptor cell lines.  In binding studies using membranes from the CysLT2 and CysLT1 receptor cell lines, HAMI3379 inhibited [3H]-LTD4 binding with IC50 values of 38 nM and >10 000 nM resp.  In isolated Langendorff-perfused guinea pig hearts HAMI3379 concn.-dependently inhibited and reversed the LTC4-induced perfusion pressure increase and contractility decrease.  The selective CysLT1 receptor antagonist zafirlukast was found to be inactive in this exptl. setting.  HAMI3379 was identified as a potent and selective CysLT2 receptor antagonist, which was devoid of CysLT receptor agonism.  Using this compd., we showed that the cardiac effects of CysLTs are predominantly mediated by the CysLT2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPXKwyaOtBz7Vg90H21EOLACvtfcHk0ljEP-3teffeaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslyqsb4%253D&md5=c603b4f0c541500e5c78ef3f0898949e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00730.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00730.x%26sid%3Dliteratum%253Aachs%26aulast%3DWunder%26aufirst%3DF.%26aulast%3DTinel%26aufirst%3DH.%26aulast%3DKast%26aufirst%3DR.%26aulast%3DGeerts%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DE.%2BM.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DH%25C3%25BCtter%26aufirst%3DJ.%26aulast%3DErg%25C3%25BCden%26aufirst%3DJ.%26aulast%3DH%25C3%25A4rter%26aufirst%3DM.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520first%2520potent%2520and%2520selective%2520antagonist%2520at%2520the%2520cysteinyl%2520leukotriene2%2520%2528CysLT2%2529%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26spage%3D399%26epage%3D409%26doi%3D10.1111%2Fj.1476-5381.2010.00730.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ni, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantyne, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barajas-Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Amand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C. D.</span><span> </span><span class="NLM_article-title">A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1124/jpet.111.186031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1124%2Fjpet.111.186031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=21903747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=768-778&author=N.+C.+Niauthor=D.+Yanauthor=L.+L.+Ballantyneauthor=A.+Barajas-Espinosaauthor=T.+St.+Amandauthor=D.+A.+Prattauthor=C.+D.+Funk&title=A+selective+cysteinyl+leukotriene+receptor+2+antagonist+blocks+myocardial+ischemia%2Freperfusion+injury+and+vascular+permeability+in+mice&doi=10.1124%2Fjpet.111.186031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice</span></div><div class="casAuthors">Ni, Nathan C.; Yan, Dong; Ballantyne, Laurel L.; Barajas-Espinosa, Alma; St. Amand, Tim; Pratt, Derek A.; Funk, Colin D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">768-778</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cysteinyl leukotrienes (CysLTs) are potent inflammatory mediators that predominantly exert their effects by binding to cysteinyl leukotriene receptors of the G protein-coupled receptor family.  CysLT receptor 2 (CysLT2R), expressed in endothelial cells of some vascular beds, has been implicated in a variety of cardiovascular functions.  Endothelium-specific overexpression of human CysLT2R in transgenic mice (hEC-CysLT2R) greatly increases myocardial infarction damage.  Investigation of this receptor, however, has been hindered by the lack of selective pharmacol. antagonists.  Here, we describe the characterization of 3-(((3-carboxycyclohexyl)amino)car-bonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)-propoxy)benzoic acid (BayCysLT2) and explore the selective effects of this compd. in attenuating myocardial ischemia/reperfusion damage and vascular leakage.  Using a recently developed β-galactosidase-β-arrestin complementation assay for CysLT2R activity, we detd. BayCysLT2 to be ∼20-fold more potent than the nonselective dual CysLT receptor 1 (CysLT1R)/CysLT2R antagonist 4-(((1R,2E,4E,6Z,9Z)-1-((1S)-4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraen-1-yl)thio)benzoic acid (Bay-u9773) (IC50 274 nM vs. 4.6 μM, resp.).  Intracellular calcium mobilization in response to cysteinyl leukotriene administration showed that BayCysLT2 was >500-fold more selective for CysLT2R compared with CysLT1R.  I.p. injection of BayCysLT2 in mice significantly attenuated leukotriene D4-induced Evans blue dye leakage in the murine ear vasculature.  BayCysLT2 administration either before or after ischemia/reperfusion attenuated the aforementioned increased myocardial infarction damage in hEC-CysLT2R mice.  Finally, decreased neutrophil infiltration and leukocyte adhesion mol. mRNA expression were obsd. in mice treated with antagonist compared with untreated controls.  In conclusion, we present the characterization of a potent and selective antagonist for CysLT2R that is useful for discerning biol. activities of this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj8FNIMQvhPLVg90H21EOLACvtfcHk0lgTat9n9Ii1-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSks70%253D&md5=79c59e2a08ad2ac6d36b629f2760d323</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.186031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.186031%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DN.%2BC.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DBallantyne%26aufirst%3DL.%2BL.%26aulast%3DBarajas-Espinosa%26aufirst%3DA.%26aulast%3DSt.%2BAmand%26aufirst%3DT.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26aulast%3DFunk%26aufirst%3DC.%2BD.%26atitle%3DA%2520selective%2520cysteinyl%2520leukotriene%2520receptor%25202%2520antagonist%2520blocks%2520myocardial%2520ischemia%252Freperfusion%2520injury%2520and%2520vascular%2520permeability%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D768%26epage%3D778%26doi%3D10.1124%2Fjpet.111.186031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nothacker, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Molecular Cloning and Characterization of a Second Human Cysteinyl Leukotriene Receptor: Discovery of a Subtype Selective Agonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span><span class="refDoi"> DOI: 10.1124/mol.58.6.1601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1124%2Fmol.58.6.1601" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1601-1608&author=H.-P.+Nothackerauthor=Z.+Wangauthor=Y.+Zhuauthor=R.+K.+Reinscheidauthor=S.+H.+S.+Linauthor=O.+Civelli&title=Molecular+Cloning+and+Characterization+of+a+Second+Human+Cysteinyl+Leukotriene+Receptor%3A+Discovery+of+a+Subtype+Selective+Agonist&doi=10.1124%2Fmol.58.6.1601"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fmol.58.6.1601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.58.6.1601%26sid%3Dliteratum%253Aachs%26aulast%3DNothacker%26aufirst%3DH.-P.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DLin%26aufirst%3DS.%2BH.%2BS.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DMolecular%2520Cloning%2520and%2520Characterization%2520of%2520a%2520Second%2520Human%2520Cysteinyl%2520Leukotriene%2520Receptor%253A%2520Discovery%2520of%2520a%2520Subtype%2520Selective%2520Agonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1601%26epage%3D1608%26doi%3D10.1124%2Fmol.58.6.1601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Bäck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlén, S. E.</span><span> </span><span class="NLM_article-title">The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/S0014-2999(96)00700-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2FS0014-2999%2896%2900700-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=8982726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A280%3ADyaK2s7jsleruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=1996&pages=107-113&author=M.+B%C3%A4ckauthor=E.+W.+Jonssonauthor=S.+E.+Dahl%C3%A9n&title=The+cysteinyl-leukotriene+receptor+antagonist+BAY+u9773+is+a+competitive+antagonist+of+leukotriene+C4+in+the+guinea-pig+ileum&doi=10.1016%2FS0014-2999%2896%2900700-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum</span></div><div class="casAuthors">Back M; Jonsson E W; Dahlen S E</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-13</span>
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Two main classes of receptors exist for leukotrienes C4, D4 and E4, collectively named cysteinyl-leukotrienes (CysLTs).  The CysLT1 receptor is blocked by currently available leukotriene antagonists, and the CysLT2 receptor is defined by the absence of selective antagonists.  The contractile response to leukotriene C4 in guinea-pig ileum longitudinal muscle is resistant to CysLT1 receptor antagonists.  However, the leukotriene E4 analogue BAY u9773 (6(R)-(4'-carboxyphenylthio)-5(S)-hydroxy-7(E),9(E),11(Z), 14(Z)-eicosatetraenoic acid) has recently been reported to inhibit CysLT2 responses.  Therefore BAY u9773 was evaluated for antagonism of the effect of leukotriene C4 in the guinea-pig ileum longitudinal muscle.  We found that BAY u9773 (0.3-10 microM) did not contract the preparation, but produced a concentration-dependent rightward shift in the concentration-response relation for leukotriene C4.  Schild plot analysis yielded a slope which was not significantly different from unity and a pA2 value of 6.1.  The inhibition of leukotriene C4 by BAY u9773 was not altered by antagonism of CysLT1 receptors by ICI 198,615 {[1-[[2-methoxy-4-[[(phenylsulfonyl)amino]carbonyl]-phenyl] methyl]-1H-indazol-6-yl]carbamic acid cyclopentyl ester}(100 nM).  The CysLT1 receptor agonist, leukotriene E4 (1 microM), contracted the preparation but did not inhibit the contraction induced by leukotriene C4.  Taken together, the antagonism exerted by BAY u9773 appeared unrelated to actions on CysLT1 receptors.  In conclusion, BAY u9773 was a useful selective competitive antagonist of leukotriene C4, and the findings support the classification of the receptors for leukotriene C4 in the guinea-pig ileum as CysLT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXvxsacXhd8eLt9HypzAgQfW6udTcc2eZmGy63jgwvXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7jsleruw%253D%253D&md5=a7738288bd555245f3d11e3443a818a0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900700-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900700-5%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ck%26aufirst%3DM.%26aulast%3DJonsson%26aufirst%3DE.%2BW.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.%2BE.%26atitle%3DThe%2520cysteinyl-leukotriene%2520receptor%2520antagonist%2520BAY%2520u9773%2520is%2520a%2520competitive%2520antagonist%2520of%2520leukotriene%2520C4%2520in%2520the%2520guinea-pig%2520ileum%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D317%26spage%3D107%26epage%3D113%26doi%3D10.1016%2FS0014-2999%2896%2900700-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Akai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, Y.</span><span> </span><span class="NLM_article-title">Preparation of Benzo[<i>b</i>]furans having five-membered heterocycles at the 2-position and 2-(4-alkylcarbamoylbuta-1,3-dienyl)benzo[<i>b</i>]furans, and their cysteinyl leukotriene receptor (CysLT<sub>1</sub>, CysLT<sub>2</sub>) inhibitory activity</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span><span class="refDoi"> DOI: 10.1248/cpb.c12-00560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1248%2Fcpb.c12-00560" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=1461-1467&author=Y.+Akaiauthor=Y.+Tabuchiauthor=K.+Andoauthor=A.+Itoauthor=Y.+Sakataauthor=I.+Kawasakiauthor=T.+Ohishiauthor=M.+Yamashitaauthor=S.+Ohtaauthor=K.+Nishideauthor=Y.+Ohishi&title=Preparation+of+Benzo%5Bb%5Dfurans+having+five-membered+heterocycles+at+the+2-position+and+2-%284-alkylcarbamoylbuta-1%2C3-dienyl%29benzo%5Bb%5Dfurans%2C+and+their+cysteinyl+leukotriene+receptor+%28CysLT1%2C+CysLT2%29+inhibitory+activity&doi=10.1248%2Fcpb.c12-00560"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c12-00560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c12-00560%26sid%3Dliteratum%253Aachs%26aulast%3DAkai%26aufirst%3DY.%26aulast%3DTabuchi%26aufirst%3DY.%26aulast%3DAndo%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DSakata%26aufirst%3DY.%26aulast%3DKawasaki%26aufirst%3DI.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DNishide%26aufirst%3DK.%26aulast%3DOhishi%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520Benzo%255Bb%255Dfurans%2520having%2520five-membered%2520heterocycles%2520at%2520the%25202-position%2520and%25202-%25284-alkylcarbamoylbuta-1%252C3-dienyl%2529benzo%255Bb%255Dfurans%252C%2520and%2520their%2520cysteinyl%2520leukotriene%2520receptor%2520%2528CysLT1%252C%2520CysLT2%2529%2520inhibitory%2520activity%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2012%26volume%3D60%26spage%3D1461%26epage%3D1467%26doi%3D10.1248%2Fcpb.c12-00560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Tsuji, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, Y.</span><span> </span><span class="NLM_article-title">Preparation of 3-acetoacetylaminobenzo[<i>b</i>]furan derivatives with cysteinyl leukotriene receptor 2 antagonistic activity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">3139</span><span class="NLM_x">–</span> <span class="NLM_lpage">3141</span><span class="refDoi"> DOI: 10.1039/b307468d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1039%2Fb307468d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14527142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntV2nurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=3139-3141&author=E.+Tsujiauthor=K.+Andoauthor=J.+Kunitomoauthor=M.+Yamashitaauthor=S.+Ohtaauthor=S.+Kohnoauthor=Y.+Ohishi&title=Preparation+of+3-acetoacetylaminobenzo%5Bb%5Dfuran+derivatives+with+cysteinyl+leukotriene+receptor+2+antagonistic+activity&doi=10.1039%2Fb307468d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 3-acetoacetylaminobenzo[b]furan derivatives with cysteinyl leukotriene receptor 2 antagonistic activity</span></div><div class="casAuthors">Tsuji, Eriko; Ando, Kumiko; Kunitomo, Jun-ichi; Yamashita, Masayuki; Ohta, Shunsaku; Kohno, Shigekatsu; Ohishi, Yoshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3139-3141</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Novel 3-acetoacetylaminobenzo[b]furan derivs. with a modified triene system at the 3-position were prepd. through acylation of the 3-aminobenzo[b]furans with 5-methylisoxazole-4-carboxylic acid chloride followed by basic cleavage of the isoxazole ring and several of these compds. showed moderate cysteinyl leukotriene receptor 2 antagonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSGa4DhPygi7Vg90H21EOLACvtfcHk0lgAE9ecto1kmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntV2nurw%253D&md5=7f3974ea50dd52bdf482e4afb242ce32</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2Fb307468d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb307468d%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DE.%26aulast%3DAndo%26aufirst%3DK.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DKohno%26aufirst%3DS.%26aulast%3DOhishi%26aufirst%3DY.%26atitle%3DPreparation%2520of%25203-acetoacetylaminobenzo%255Bb%255Dfuran%2520derivatives%2520with%2520cysteinyl%2520leukotriene%2520receptor%25202%2520antagonistic%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D3139%26epage%3D3141%26doi%3D10.1039%2Fb307468d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ando, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunitomo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, Y.</span><span> </span><span class="NLM_article-title">Syntheses of 3-acetoacetylaminobenzo[<i>b</i>]furan derivatives having cysteinyl leukotriene 2 receptor antagonistic activity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1039/b312682j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1039%2Fb312682j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=625-635&author=K.+Andoauthor=E.+Tsujiauthor=Y.+Andoauthor=N.+Kuwataauthor=J.+Kunitomoauthor=M.+Yamashitaauthor=S.+Ohtaauthor=S.+Kohnoauthor=Y.+Ohishi&title=Syntheses+of+3-acetoacetylaminobenzo%5Bb%5Dfuran+derivatives+having+cysteinyl+leukotriene+2+receptor+antagonistic+activity&doi=10.1039%2Fb312682j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fb312682j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb312682j%26sid%3Dliteratum%253Aachs%26aulast%3DAndo%26aufirst%3DK.%26aulast%3DTsuji%26aufirst%3DE.%26aulast%3DAndo%26aufirst%3DY.%26aulast%3DKuwata%26aufirst%3DN.%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DKohno%26aufirst%3DS.%26aulast%3DOhishi%26aufirst%3DY.%26atitle%3DSyntheses%2520of%25203-acetoacetylaminobenzo%255Bb%255Dfuran%2520derivatives%2520having%2520cysteinyl%2520leukotriene%25202%2520receptor%2520antagonistic%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2004%26volume%3D2%26spage%3D625%26epage%3D635%26doi%3D10.1039%2Fb312682j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Itadani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span> </span><span class="NLM_article-title">Discovery of highly potent dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span><span class="refDoi"> DOI: 10.1021/ml500298y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500298y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1230-1234&author=S.+Itadaniauthor=S.+Takahashiauthor=M.+Imaauthor=T.+Sekiguchiauthor=M.+Fujitaauthor=Y.+Nakayamaauthor=J.+Takeuchi&title=Discovery+of+highly+potent+dual+CysLT1+and+CysLT2+antagonist&doi=10.1021%2Fml500298y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fml500298y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500298y%26sid%3Dliteratum%253Aachs%26aulast%3DItadani%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DIma%26aufirst%3DM.%26aulast%3DSekiguchi%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520dual%2520CysLT1%2520and%2520CysLT2%2520antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1230%26epage%3D1234%26doi%3D10.1021%2Fml500298y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Itadani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aratani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egashira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonetomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span> </span><span class="NLM_article-title">Discovery of a potent, orally available dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist with dicarboxylic acid</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2079</span><span class="NLM_x">–</span> <span class="NLM_lpage">2097</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.bmc.2015.03.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2079-2097&author=S.+Itadaniauthor=S.+Takahashiauthor=M.+Imaauthor=T.+Sekiguchiauthor=Y.+Arataniauthor=H.+Egashiraauthor=N.+Matsumuraauthor=A.+Inoueauthor=Y.+Yonetomiauthor=M.+Fujitaauthor=Y.+Nakayamaauthor=J.+Takeuchi&title=Discovery+of+a+potent%2C+orally+available+dual+CysLT1+and+CysLT2+antagonist+with+dicarboxylic+acid&doi=10.1016%2Fj.bmc.2015.03.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DItadani%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DIma%26aufirst%3DM.%26aulast%3DSekiguchi%26aufirst%3DT.%26aulast%3DAratani%26aufirst%3DY.%26aulast%3DEgashira%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DYonetomi%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520orally%2520available%2520dual%2520CysLT1%2520and%2520CysLT2%2520antagonist%2520with%2520dicarboxylic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2079%26epage%3D2097%26doi%3D10.1016%2Fj.bmc.2015.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Smith, H. W.</span><span> </span><span class="NLM_article-title">Observation on the flora of the alimentary tract of animals and factors affecting its composition</span> <span class="citation_source-journal">J. Pathol. Bacteriol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1002/path.1700890112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1002%2Fpath.1700890112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=14263502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A280%3ADyaF2M%252FmvVSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1965&pages=95-122&author=H.+W.+Smith&title=Observation+on+the+flora+of+the+alimentary+tract+of+animals+and+factors+affecting+its+composition&doi=10.1002%2Fpath.1700890112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">OBSERVATIONS ON THE FLORA OF THE ALIMENTARY TRACT OF ANIMALS AND FACTORS AFFECTING ITS COMPOSITION</span></div><div class="casAuthors">SMITH H W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pathology and bacteriology</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-122</span>
        ISSN:<span class="NLM_cas:issn">0368-3494</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyyZWw8WFtoUGy1nwu7K2mfW6udTcc2eaTIS1-m15bEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2M%252FmvVSgtQ%253D%253D&md5=af24fdc98570d299f15c9cdada0e3636</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fpath.1700890112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1700890112%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DH.%2BW.%26atitle%3DObservation%2520on%2520the%2520flora%2520of%2520the%2520alimentary%2520tract%2520of%2520animals%2520and%2520factors%2520affecting%2520its%2520composition%26jtitle%3DJ.%2520Pathol.%2520Bacteriol.%26date%3D1965%26volume%3D89%26spage%3D95%26epage%3D122%26doi%3D10.1002%2Fpath.1700890112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lindahl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungell, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lennernäs, H.</span><span> </span><span class="NLM_article-title">Characterization of fluids from the stomach and proximal jejunum in men and women</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1023/A:1012107801889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1023%2FA%3A1012107801889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=9144738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADyaK2sXjtVWrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=497-502&author=A.+Lindahlauthor=A.-L.+Ungellauthor=L.+Knutsonauthor=H.+Lennern%C3%A4s&title=Characterization+of+fluids+from+the+stomach+and+proximal+jejunum+in+men+and+women&doi=10.1023%2FA%3A1012107801889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of fluids from the stomach and proximal jejunum in men and women</span></div><div class="casAuthors">Lindahl, Anders; Ungell, Anna-Lena; Knutson, Lars; Lennernaes, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">497-502</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">The fluids available for drug dissoln. in the human upper gastrointestinal tract were investigated during the fasted state, and variations and potential gender differences regarding the physicochem. properties of these fluids were examd.  Healthy men and women were intubated, and fluids from the stomach and upper jejunum were collected sep.  Bulk pH, osmolality, electrolytes and total concns. of bile acids and proteins were assessed.  To study intraindividual variations, the individuals were studied on more than one occasion.  The stomach and upper jejunal fluids varied significantly in all the entities measured, except the total concn. of proteins.  The intraindividual variability was pronounced in some of the individuals, both in the stomach and the upper jejunum.  No gender differences were obsd.  This study demonstrates the complex nature of the fluids available for drug dissoln. in the stomach and the upper small intestine in humans.  The results can be used when designing a more physiol. in vitro dissoln. media representative of the fasted state.  When designing such a medium, it is suggested that gender differences not be taken into account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkWYadeuAwLLVg90H21EOLACvtfcHk0lhX4r9XioyrNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtVWrsbk%253D&md5=39741d8e8f26b74f179ac0410ca4bee8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1012107801889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1012107801889%26sid%3Dliteratum%253Aachs%26aulast%3DLindahl%26aufirst%3DA.%26aulast%3DUngell%26aufirst%3DA.-L.%26aulast%3DKnutson%26aufirst%3DL.%26aulast%3DLennern%25C3%25A4s%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520fluids%2520from%2520the%2520stomach%2520and%2520proximal%2520jejunum%2520in%2520men%2520and%2520women%26jtitle%3DPharm.%2520Res.%26date%3D1997%26volume%3D14%26spage%3D497%26epage%3D502%26doi%3D10.1023%2FA%3A1012107801889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lakshminarayana, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravindran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiricek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjundappa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayyar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurumurthy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span> </span><span class="NLM_article-title">Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e105222</span><span class="refDoi"> DOI: 10.1371/journal.pone.0105222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1371%2Fjournal.pone.0105222" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105222&author=S.+B.+Lakshminarayanaauthor=H.+I.+M.+Boshoffauthor=J.+Cherianauthor=S.+Ravindranauthor=A.+Gohauthor=J.+Jiricekauthor=M.+Nanjundappaauthor=A.+Nayyarauthor=M.+Gurumurthyauthor=R.+Singhauthor=T.+Dickauthor=F.+Blascoauthor=C.+E.+Barryauthor=P.+C.+Hoauthor=U.+H.+Manjunatha&title=Pharmacokinetics-Pharmacodynamics+Analysis+of+Bicyclic+4-Nitroimidazole+Analogs+in+a+Murine+Model+of+Tuberculosis&doi=10.1371%2Fjournal.pone.0105222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105222%26sid%3Dliteratum%253Aachs%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DRavindran%26aufirst%3DS.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DNanjundappa%26aufirst%3DM.%26aulast%3DNayyar%26aufirst%3DA.%26aulast%3DGurumurthy%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26atitle%3DPharmacokinetics-Pharmacodynamics%2520Analysis%2520of%2520Bicyclic%25204-Nitroimidazole%2520Analogs%2520in%2520a%2520Murine%2520Model%2520of%2520Tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105222%26doi%3D10.1371%2Fjournal.pone.0105222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>Singulair; <span class="NLM_series">Center for Drug Evaluation and Research Application Number 20-829</span>; <span class="NLM_publisher-name">Center for Drug Evaluationa and Research, U.S. Food and Drug Administration</span>,<span class="NLM_x"> </span><span class="NLM_year">1998</span><span class="NLM_x">; </span><a href="http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020829s000_Singular_Pharma.pdf" class="extLink">http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020829s000_Singular_Pharma.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Singulair%3B+Center+for+Drug+Evaluation+and+Research+Application+Number+20-829%3B+Center+for+Drug+Evaluationa+and+Research%2C+U.S.+Food+and+Drug+Administration%2C+1998%3B+http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F98%2F020829s000_Singular_Pharma.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DSingulair%26pub%3DCenter%2520for%2520Drug%2520Evaluationa%2520and%2520Research%252C%2520U.S.%2520Food%2520and%2520Drug%2520Administration%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkison, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, J.W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppugalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björnsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavé, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulin, P.</span><span> </span><span class="NLM_article-title">PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4090</span><span class="NLM_x">–</span> <span class="NLM_lpage">4110</span><span class="refDoi"> DOI: 10.1002/jps.22552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1002%2Fjps.22552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=21541938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVylurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4090-4110&author=B.+J.+Ringauthor=J.+Y.+Chienauthor=K.+K.+Adkisonauthor=H.+M.+Jonesauthor=M.+Rowlandauthor=R.+D.+Jonesauthor=J.W.+T.+Yatesauthor=M.+S.+Kuauthor=C.+R.+Gibsonauthor=H.+Heauthor=R.+Vuppugallaauthor=P.+Maratheauthor=V.+Fischerauthor=S.+Duttaauthor=V.+K.+Sinhaauthor=T.+Bj%C3%B6rnssonauthor=T.+Lav%C3%A9author=P.+Poulin&title=PhRMA+CPCDC+initiative+on+predictive+models+of+human+pharmacokinetics%2C+part+3%3A+comparative+assessement+of+prediction+methods+of+human+clearance&doi=10.1002%2Fjps.22552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">PhRMA CPCDC initiative on predictive models of human pharmacokinetics, Part 3: Comparative assessment of prediction methods of human clearance</span></div><div class="casAuthors">Ring, Barbara J.; Chien, Jenny Y.; Adkison, Kimberly K.; Jones, Hannah M.; Rowland, Malcolm; Jones, Rhys Do; Yates, James W. T.; Ku, M. Sherry; Gibson, Christopher R.; He, Handan; Vuppugalla, Ragini; Marathe, Punit; Fischer, Volker; Dutta, Sandeep; Sinha, Vikash K.; Bjoernsson, Thorir; Lave, Thierry; Poulin, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4090-4110</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The objective of this study was to evaluate the performance of various allometric and in vitro-in vivo extrapolation (IVIVE) methodologies with and without plasma protein binding corrections for the prediction of human i.v. clearance (CL).  The objective was also to evaluate the IVIVE prediction methods with animal data.  Methodologies were selected from the literature.  Pharmaceutical Research and Manufacturers of America member companies contributed blinded datasets from preclin. and clin. studies for 108 compds., among which 19 drugs had i.v. clin. pharmacokinetics data and were used in the anal.  In vivo and in vitro preclin. data were used to predict CL by 29 different methods.  For many compds., in vivo data from only two species (generally rat and dog) were available and/or the required in vitro data were missing, which meant some methods could not be properly evaluated.  In addn., 66 methods of predicting oral (p.o.) area under the curve (AUCp.o.) were evaluated for 107 compds. using rational combinations of i.v. CL and bioavailability (F), and direct scaling of obsd. p.o. CL from preclin. species.  Various statistical and outlier techniques were employed to assess the predictability of each method.  Across methods, the max. success rate in predicting human CL for the 19 drugs was 100%, 94%, and 78% of the compds. with predictions falling within 10-fold, threefold, and twofold error, resp., of the obsd. CL.  In general, in vivo methods performed slightly better than IVIVE methods (at least in terms of measures of correlation and global concordance), with the fu intercept method and two-species-based allometry (rat-dog) being the best performing methods.  IVIVE methods using microsomes (incorporating both plasma and microsomal binding) and hepatocytes (not incorporating binding) resulted in 75% and 78%, resp., of the predictions falling within twofold error.  IVIVE methods using other combinations of binding assumptions were much less accurate.  The results for prediction of AUCp.o. were consistent with i.v. CL.  However, the greatest challenge to successful prediction of human p.o. CL is the est. of F in human.  Overall, the results of this initiative confirmed predictive performance of common methodologies used to predict human CL. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 100:4090-4110, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppzhGQYZ2u-7Vg90H21EOLACvtfcHk0lgziii861jxGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVylurrK&md5=5892df5a4c1c57bc65a2d5307882f6ad</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.22552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22552%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DChien%26aufirst%3DJ.%2BY.%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DRowland%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DR.%2BD.%26aulast%3DYates%26aufirst%3DJ.W.%2BT.%26aulast%3DKu%26aufirst%3DM.%2BS.%26aulast%3DGibson%26aufirst%3DC.%2BR.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DVuppugalla%26aufirst%3DR.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DDutta%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DV.%2BK.%26aulast%3DBj%25C3%25B6rnsson%26aufirst%3DT.%26aulast%3DLav%25C3%25A9%26aufirst%3DT.%26aulast%3DPoulin%26aufirst%3DP.%26atitle%3DPhRMA%2520CPCDC%2520initiative%2520on%2520predictive%2520models%2520of%2520human%2520pharmacokinetics%252C%2520part%25203%253A%2520comparative%2520assessement%2520of%2520prediction%2520methods%2520of%2520human%2520clearance%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4090%26epage%3D4110%26doi%3D10.1002%2Fjps.22552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argikar, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennehy, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunduz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liric Rajlic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1177/0091270012440282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1177%2F0091270012440282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=23436263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ynsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=178-191&author=F.+Lombardoauthor=N.+J.+Watersauthor=U.+A.+Argikarauthor=M.+K.+Dennehyauthor=J.+Zhanauthor=M.+Gunduzauthor=S.+P.+Harrimanauthor=G.+Berelliniauthor=I.+Liric+Rajlicauthor=R.+S.+Obach&title=Comprehensive+assessment+of+human+pharmacokinetic+prediction+based+on+in+vivo+animal+pharmacokinetic+data%2C+part+2%3A+clearance&doi=10.1177%2F0091270012440282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance</span></div><div class="casAuthors">Lombardo, Franco; Waters, Nigel J.; Argikar, Upendra A.; Dennehy, Michelle K.; Zhan, Jenny; Gunduz, Mithat; Harriman, Shawn P.; Berellini, Giuliano; Rajlic, Ivana Liric; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-191</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A comprehensive anal. on the prediction of human clearance based on i.v. pharmacokinetic data from rat, dog, and monkey for approx. 400 compds. was undertaken.  This data set has been carefully compiled from literature reports and expanded with some inhouse detns. for plasma protein binding and rat clearance.  To the authors' knowledge, this is the largest publicly available data set.  The present examn. offers a comparison of 37 different methods for prediction of human clearance across compds. of diverse physicochem. properties.  Furthermore, this work demonstrates the application of each prediction method to each charge class of the compds., thus presenting an addnl. dimension to prediction of human pharmacokinetics.  In general, the observations suggest that methods employing monkey clearance values and a method incorporating differences in plasma protein binding between rat and human yield the best overall predictions as suggested by approx. 60% compds. within 2-fold geometric mean-fold error.  Other single-species scaling or proportionality methods incorporating the fraction unbound in the corresponding preclin. species for prediction of free clearance in human were generally unsuccessful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD0VWrLLqed7Vg90H21EOLACvtfcHk0lgziii861jxGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ynsL%252FK&md5=a87b8d0a0025910b592a3e757fb35d54</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1177%2F0091270012440282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270012440282%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DDennehy%26aufirst%3DM.%2BK.%26aulast%3DZhan%26aufirst%3DJ.%26aulast%3DGunduz%26aufirst%3DM.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DLiric%2BRajlic%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DComprehensive%2520assessment%2520of%2520human%2520pharmacokinetic%2520prediction%2520based%2520on%2520in%2520vivo%2520animal%2520pharmacokinetic%2520data%252C%2520part%25202%253A%2520clearance%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D53%26spage%3D178%26epage%3D191%26doi%3D10.1177%2F0091270012440282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Orning, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarström, S.</span><span> </span><span class="NLM_article-title">Inhibition of leukotriene C and leukotriene D biosynthesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8026</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=8023-8026&author=L.+Orningauthor=S.+Hammarstr%C3%B6m&title=Inhibition+of+leukotriene+C+and+leukotriene+D+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrning%26aufirst%3DL.%26aulast%3DHammarstr%25C3%25B6m%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520leukotriene%2520C%2520and%2520leukotriene%2520D%2520biosynthesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D8023%26epage%3D8026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umemoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span> </span><span class="NLM_article-title">Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT<sub>2</sub>) mediates cell proliferation and intracellular calcium mobilization by LTC<sub>4</sub> and LTD4</span> <span class="citation_source-journal">BMB Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.5483/BMBRep.2008.41.2.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.5483%2FBMBRep.2008.41.2.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=18315950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVeisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=139-145&author=Y.+Itoauthor=M.+Hiranoauthor=N.+Umemotoauthor=L.+Zangauthor=Z.+Wangauthor=T.+Okaauthor=Y.+Shimadaauthor=Y.+Nishimuraauthor=I.+Kurokawaauthor=H.+Mizutaniauthor=T.+Tanaka&title=Guinea+pig+cysteinyl+leukotriene+receptor+2+%28gpCysLT2%29+mediates+cell+proliferation+and+intracellular+calcium+mobilization+by+LTC4+and+LTD4&doi=10.5483%2FBMBRep.2008.41.2.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4</span></div><div class="casAuthors">Ito, Yoshiyuki; Hirano, Minoru; Umemoto, Noriko; Zang, Liqing; Wang, Zhipeng; Oka, Takehiko; Shimada, Yasuhito; Nishimura, Yuhei; Kurokawa, Ichiro; Mizutani, Hitoshi; Tanaka, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">BMB Reports</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-145</span>CODEN:
                <span class="NLM_cas:coden">BRMEC2</span>;
        ISSN:<span class="NLM_cas:issn">1976-6696</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We cloned and pharmacol. characterized the guinea pig cysteinyl leukotriene (CysLT) 2 receptor (gpCysLT2).  GpCysLT2 consists of 317 amino acids with 75.3%, 75.2%, 73.3% identity to those of humans, mice and rats, resp.  The gpCysLT2 gene is highly expressed in the lung, moderately in eosinophils, skin, spleen, stomach, colon, and modestly in the small intestine.  CysLTs accelerated the proliferation of gpCysLT2-expressing HEK293.  Leukotriene C4 (LTC4) and leukotriene D4 (LTD4) enhanced the cell proliferation higher than Bay-u 9773, a CysLT2 selective partial agonist and a nonselective antagonist for CysLT receptors.  Bay-u 9773 did not antagonize the cell proliferation by LTC4 and LTD4.  Despite the equipotency of the mitogenic effect among these chems., calcium mobilization (CM) levels were variable (LTC4 > LTD4 > > Bay-u 9773), and Bay-u 9773 antagonized the CM by LTC4.  Moreover, the Gi/o inhibitor pertussis toxin perfectly inhibited agonist-induced cell proliferation.  These results reveal that cell proliferation via CysLT2 signaling was mediated by Gi/o signaling but independent of calcium mobilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl5c7MZJDfzLVg90H21EOLACvtfcHk0lijhzhHnWbuHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVeisbY%253D&md5=47cadd02d10442f2da9c7b166a8f9de5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.5483%2FBMBRep.2008.41.2.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5483%252FBMBRep.2008.41.2.139%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DY.%26aulast%3DHirano%26aufirst%3DM.%26aulast%3DUmemoto%26aufirst%3DN.%26aulast%3DZang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DKurokawa%26aufirst%3DI.%26aulast%3DMizutani%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26atitle%3DGuinea%2520pig%2520cysteinyl%2520leukotriene%2520receptor%25202%2520%2528gpCysLT2%2529%2520mediates%2520cell%2520proliferation%2520and%2520intracellular%2520calcium%2520mobilization%2520by%2520LTC4%2520and%2520LTD4%26jtitle%3DBMB%2520Rep.%26date%3D2008%26volume%3D41%26spage%3D139%26epage%3D145%26doi%3D10.5483%2FBMBRep.2008.41.2.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Yonetomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadode, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, K.</span><span> </span><span class="NLM_article-title">Leukotriene C<sub>4</sub> induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexylglutathione-treated guinea pigs</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">754</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.ejphar.2015.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=25704617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1artbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=754&publication_year=2015&pages=98-104&author=Y.+Yonetomiauthor=T.+Sekiokaauthor=M.+Kadodeauthor=T.+Kitamineauthor=A.+Kamiyaauthor=N.+Matsumuraauthor=M.+Fujitaauthor=K.+Kawabata&title=Leukotriene+C4+induces+bronchoconstriction+and+airway+vascular+hyperpermeability+via+the+cysteinyl+leukotriene+receptor+2+in+S-hexylglutathione-treated+guinea+pigs&doi=10.1016%2Fj.ejphar.2015.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs</span></div><div class="casAuthors">Yonetomi, Yasuo; Sekioka, Tomohiko; Kadode, Michiaki; Kitamine, Tetsuya; Kamiya, Akihiro; Matsumura, Naoya; Fujita, Manabu; Kawabata, Kazuhito</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">754</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-104</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cysteinyl leukotrienes act through G-protein-coupled receptors termed cysteinyl leukotriene 1 (CysLT1) and cysteinyl leukotriene 2 (CysLT2) receptors.  However, little is known about the pathophysiol. role of CysLT2 receptors in asthma.  To elucidate the possible involvement of CysLT2 receptors in bronchoconstriction and airway vascular hyperpermeability, we have established a novel guinea pig model of asthma.  In vitro study confirmed that CHO-K1 cells, expressing guinea pig CysLT2 and CysLT1 receptors are selectively stimulated by LTC4 and LTD4, resp.  However, when LTC4 was i.v. injected to guinea pigs, the resulting bronchoconstriction was fully abrogated by montelukast, a CysLT1 receptor antagonist, indicating rapid metab. of LTC4 to LTD4 in the lung.  We found that treatment with S-hexyl glutathione (S-hexyl GSH), an inhibitor of gamma-glutamyl transpeptidase, significantly increased LTC4 content and LTC4/(LTD4 plus LTE4) ratio in the lung.  Under these circumstances, LTC4-induced bronchoconstriction became resistant to montelukast, but sensitive to Compd. A, a CysLT2 receptor antagonist, depending on the dose of S-hexyl GSH.  Combination with montelukast and Compd. A completely abrogated this spasmogenic response.  Addnl., we confirmed that LTC4 elicits airway vascular hyperpermeability via CysLT2 receptors in the presence of high dose of S-hexyl GSH as evidenced by complete inhibition of LTC4-induced hyperpermeability by Compd. A, but not montelukast.  These results suggest that CysLT2 receptors mediate bronchoconstriction and airway vascular hyperpermeability in guinea pigs and that the animal model used in this study may be useful to elucidate the functional role of CysLT2 receptors in various diseases, including asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMaPpteksLt7Vg90H21EOLACvtfcHk0lijhzhHnWbuHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1artbw%253D&md5=0745caffdf18ca0963b4a8a7326418d4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DYonetomi%26aufirst%3DY.%26aulast%3DSekioka%26aufirst%3DT.%26aulast%3DKadode%26aufirst%3DM.%26aulast%3DKitamine%26aufirst%3DT.%26aulast%3DKamiya%26aufirst%3DA.%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DKawabata%26aufirst%3DK.%26atitle%3DLeukotriene%2520C4%2520induces%2520bronchoconstriction%2520and%2520airway%2520vascular%2520hyperpermeability%2520via%2520the%2520cysteinyl%2520leukotriene%2520receptor%25202%2520in%2520S-hexylglutathione-treated%2520guinea%2520pigs%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D754%26spage%3D98%26epage%3D104%26doi%3D10.1016%2Fj.ejphar.2015.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Harter, M.; Erguden, J.; Wunder, F.; Tinel, H.; Kobberling, J.; Becker, E.-M.; Munter, K.; Schlemmer, K.-H.; Kast, R.; Kolkhof, P.; Karig, G.; Barfacker, L.; Hubsch, W.; Schuhmacher, J.; Zuleger, S.; Concepcion, A.; Shimizu, H.</span><span> </span><span class="NLM_article-title">Isophthalic acid derivatives</span>. US20060154912,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">, </span>(Example 31).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Harter&author=J.+Erguden&author=F.+Wunder&author=H.+Tinel&author=J.+Kobberling&author=E.-M.+Becker&author=K.+Munter&author=K.-H.+Schlemmer&author=R.+Kast&author=P.+Kolkhof&author=G.+Karig&author=L.+Barfacker&author=W.+Hubsch&author=J.+Schuhmacher&author=S.+Zuleger&author=A.+Concepcion&author=H.+Shimizu&title=Isophthalic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarter%26aufirst%3DM.%26atitle%3DIsophthalic%2520acid%2520derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sekioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadode, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabe, T.</span><span> </span><span class="NLM_article-title">Expression of CysLT<sub>2</sub> receptors in asthma lung, and their possible role in bronchoconstriction</span> <span class="citation_source-journal">Allergol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1016/j.alit.2015.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2Fj.alit.2015.04.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=T.+Sekiokaauthor=M.+Kadodeauthor=M.+Fujiiauthor=K.+Kawabataauthor=T.+Abeauthor=M.+Horibaauthor=S.+Kohnoauthor=T.+Nabe&title=Expression+of+CysLT2+receptors+in+asthma+lung%2C+and+their+possible+role+in+bronchoconstriction&doi=10.1016%2Fj.alit.2015.04.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.alit.2015.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.alit.2015.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DSekioka%26aufirst%3DT.%26aulast%3DKadode%26aufirst%3DM.%26aulast%3DFujii%26aufirst%3DM.%26aulast%3DKawabata%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DT.%26aulast%3DHoriba%26aufirst%3DM.%26aulast%3DKohno%26aufirst%3DS.%26aulast%3DNabe%26aufirst%3DT.%26atitle%3DExpression%2520of%2520CysLT2%2520receptors%2520in%2520asthma%2520lung%252C%2520and%2520their%2520possible%2520role%2520in%2520bronchoconstriction%26jtitle%3DAllergol.%2520Int.%26date%3D2015%26doi%3D10.1016%2Fj.alit.2015.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Watanabe-Kohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohata, K.</span><span> </span><span class="NLM_article-title">Significant role of peptide leukotrienes (p-LTs) in the antigen-induced contractions of human and guinea pig lung parenchymas and bronchi or tracheas in vitro</span> <span class="citation_source-journal">Jpn. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1254/jjp.60.209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1254%2Fjjp.60.209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1283422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADyaK3sXnvFansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1992&pages=209-216&author=S.+Watanabe-Kohnoauthor=K.+Yasuiauthor=T.+Nabeauthor=H.+Yamamuraauthor=M.+Horibaauthor=K.+Ohata&title=Significant+role+of+peptide+leukotrienes+%28p-LTs%29+in+the+antigen-induced+contractions+of+human+and+guinea+pig+lung+parenchymas+and+bronchi+or+tracheas+in+vitro&doi=10.1254%2Fjjp.60.209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Significant role of peptide leukotrienes (p-LTs) in the antigen-induced contractions of human and guinea pig lung parenchymas and bronchi or tracheas in vitro</span></div><div class="casAuthors">Watanabe-Kohno, Shigekatsu; Yasui, Kiyoshi; Nabe, Takeshi; Yamamura, Hideki; Horiba, Michiaki; Ohata, Katsuya</div><div class="citationInfo"><span class="NLM_cas:title">Japanese Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-16</span>CODEN:
                <span class="NLM_cas:coden">JJPAAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-5198</span>.
    </div><div class="casAbstract">Chem. mediators responsible for the antigen-induced contractions of isolated, passively sensitized human and guinea pig lung parenchymas and bronchi or tracheas were evaluated by several antagonists and enzyme inhibitors, with emphasis on the effects of the potent and selective peptide leukotriene (p-LT) antagonist MCI-826.  All of these prepns. showed long-lasting contractions in response to an antigen challenge which lasted for >60 min.  In either the human lung parenchyma and bronchus or guinea pig lung parenchyma, pretreatment with 10-6 g/mL (2.4 × 10-6M) MCI-826 significantly inhibited the late phase at 10-60 min after the challenge of the contraction following slight suppression of the early phase.  The early phase contractions of these prepns. were moderately antagonized by 10-6 g/mL mepyramine, but the late phases were not influenced or were even enhanced.  The combination treatment of MCI-826 with mepyramine addnl. and markedly inhibited both phases of these prepns.  On the other hand, although mepyramine apparently inhibited the early phase of the guinea pig tracheal contraction but not the late phase, no synergistic inhibitions of the contraction were obsd. when it was combined with MCI-826.  The p-LT antagonist FPL 55712, atropine and indomethacin at 10-6 g/mL either slightly inhibited or enhanced the contractions of human lung parenchymas, guinea pig tracheas and lung parenchymas, but the effects were not significant.  Thus, p-LTs largely contribute to induction of the anaphylactic contractions of human lung parenchymas as well as human bronchi and guinea pig lung parenchymas but not guinea pig tracheas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqveD41JDzzC7Vg90H21EOLACvtfcHk0lgX3bagChODEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXnvFansw%253D%253D&md5=64308f1eeb7ac969792c33f10f325f62</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1254%2Fjjp.60.209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjjp.60.209%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe-Kohno%26aufirst%3DS.%26aulast%3DYasui%26aufirst%3DK.%26aulast%3DNabe%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DH.%26aulast%3DHoriba%26aufirst%3DM.%26aulast%3DOhata%26aufirst%3DK.%26atitle%3DSignificant%2520role%2520of%2520peptide%2520leukotrienes%2520%2528p-LTs%2529%2520in%2520the%2520antigen-induced%2520contractions%2520of%2520human%2520and%2520guinea%2520pig%2520lung%2520parenchymas%2520and%2520bronchi%2520or%2520tracheas%2520in%2520vitro%26jtitle%3DJpn.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D60%26spage%3D209%26epage%3D216%26doi%3D10.1254%2Fjjp.60.209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Buckner, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedyna, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krell, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saban, R.</span><span> </span><span class="NLM_article-title">An examination of the influence of the epithelium on contractile responses to peptideleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=2153812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFalurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1990&pages=77-85&author=C.+K.+Bucknerauthor=J.+S.+Fedynaauthor=J.+L.+Robertsonauthor=J.+A.+Willauthor=D.+M.+Englandauthor=R.+D.+Krellauthor=R.+Saban&title=An+examination+of+the+influence+of+the+epithelium+on+contractile+responses+to+peptideleukotrienes+and+blockade+by+ICI+204%2C219+in+isolated+guinea+pig+trachea+and+human+intralobar+airways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways</span></div><div class="casAuthors">Buckner, C. K.; Fedyna, J. S.; Robertson, J. L.; Will, J. A.; England, D. M.; Krell, R. D.; Saban, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-85</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The influence of the epithelium on inhibition by the leukotriene antagonist ICI 204,219 of contractile responses to peptide leukotriene agonists was examd. in guinea pig tracheal and human bronchial rings.  The -log molar KB values for ICI 204,219 were independent of the epithelium in both tissues.  Even though uninfluenced by the epithelium, the -log molar KB values for ICI 204,219 were about 10-fold smaller in human airways than in guinea pig trachea.  Removal of the epithelium from guinea pig trachea resulted in small lefward shifts of the concn.-response curves to LTC4 and LTD4 and rightward shifts of the concn.-response curves to LTE4 when examd. in the presence of indomethacin.  The lipoxygenase inhibitors nordihydroguaiaretic acid, BW 755C, Rev 5901 and AA861 antagonized responses to LTE4 in the presence, but not in the absence, of epithelium.  In human airways, epithelium removal resulted in a small leftward shift of the concn.-response curve to LTD4, whereas responses to LTC4 and LTE4 were unaltered.  This effect was not obsd. in the presence of indomethacin, relating it to reduced release of cyclooxygenase products.  Apparently, the contractile responses of guinea pig trachea to LTE4 are modulated by LTE4-induced release of 5-lipoxygenase product(s) only when the epithelium is present.  Regardless of the mechanisms, the epithelium-dependent effects of leukotriene agonists do not appear responsible for the difference in potency of ICI 204,219 obsd. between the two species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9z_IJZJdalbVg90H21EOLACvtfcHk0lgX3bagChODEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFalurc%253D&md5=b1389585b7791f20546e9c9a9f1a1733</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuckner%26aufirst%3DC.%2BK.%26aulast%3DFedyna%26aufirst%3DJ.%2BS.%26aulast%3DRobertson%26aufirst%3DJ.%2BL.%26aulast%3DWill%26aufirst%3DJ.%2BA.%26aulast%3DEngland%26aufirst%3DD.%2BM.%26aulast%3DKrell%26aufirst%3DR.%2BD.%26aulast%3DSaban%26aufirst%3DR.%26atitle%3DAn%2520examination%2520of%2520the%2520influence%2520of%2520the%2520epithelium%2520on%2520contractile%2520responses%2520to%2520peptideleukotrienes%2520and%2520blockade%2520by%2520ICI%2520204%252C219%2520in%2520isolated%2520guinea%2520pig%2520trachea%2520and%2520human%2520intralobar%2520airways%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1990%26volume%3D252%26spage%3D77%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giossi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, A.</span><span> </span><span class="NLM_article-title">Comparative analysis of isolated human bronchi contraction and biosynthesis of cysteinyl leukotrienes using a direct 5-lipoxygenase inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span><span class="refDoi"> DOI: 10.1016/S0006-2952(97)00055-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;key=10.1016%2FS0006-2952%2897%2900055-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=437-442&author=M.+Bollaauthor=P.+Carusoauthor=M.+Giossiauthor=G.+Folcoauthor=M.+Civelliauthor=A.+Sala&title=Comparative+analysis+of+isolated+human+bronchi+contraction+and+biosynthesis+of+cysteinyl+leukotrienes+using+a+direct+5-lipoxygenase+inhibitor&doi=10.1016%2FS0006-2952%2897%2900055-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2897%2900055-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252897%252900055-5%26sid%3Dliteratum%253Aachs%26aulast%3DBolla%26aufirst%3DM.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DGiossi%26aufirst%3DM.%26aulast%3DFolco%26aufirst%3DG.%26aulast%3DCivelli%26aufirst%3DM.%26aulast%3DSala%26aufirst%3DA.%26atitle%3DComparative%2520analysis%2520of%2520isolated%2520human%2520bronchi%2520contraction%2520and%2520biosynthesis%2520of%2520cysteinyl%2520leukotrienes%2520using%2520a%2520direct%25205-lipoxygenase%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D54%26spage%3D437%26epage%3D442%26doi%3D10.1016%2FS0006-2952%2897%2900055-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i128"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00741">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50128"></div></div></div></div></div><hr /></hr><p class="last">This information includes the experimental details for data collection, data reduction, and refinement statistics of the X-ray crystallography of <b>35</b> (PDF). Molecular formula strings (XLSX). The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00741">10.1021/acs.jmedchem.5b00741</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00741/suppl_file/jm5b00741_si_001.pdf">jm5b00741_si_001.pdf (141.73 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00741/suppl_file/jm5b00741_si_002.xlsx">jm5b00741_si_002.xlsx (11.92 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00741&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00741%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-15" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00741" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c29eddfa248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
